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Population genetic studies of Trichomonas vaginalis have detected high genetic diversity 
associated with phenotypic differences in clinical presentations. In this study, microscopy and 
multi-locus sequence typing (MLST) were used to identify and genetically characterise T. 
vaginalis isolates from patients in Australia and Ghana. Epidemiological data were also 
obtained from the Ghanaian population. Of 479 women recruited from Ghana, 63 (13.2%; 
95% CI 9.5-17.6) and 78 (16.8%; 95% CI 12.2-21.1) had T. vaginalis based on microscopy 
and PCR respectively. Regional prevalence of T. vaginalis infection was 21.7% (95% CI 
17.1-26.9%) and 12.8% (95% CI 8.6-18.3%) for Volta and Greater Accra regions 
respectively. There was a significant difference in prevalence between the two regions 
(Fisher exact test, P =0.013). Trichomonas vaginalis infection was significantly associated 
with vaginal itch (OR = 1.38, P = 0.04), a prior history of stillbirth (OR = 3.62, P = 0.04) and 
participation in oral sex (OR = 1.10, P = 0.04). There were no significant associations 
between genotypes at any locus and clinical presentation score. Seventy-one polymorphic 
nucleotide sites, 36 different alleles, 48 sequence types, 24 of which were novel, were 
identified among 178 isolates, revealing a geneticallly diverse T. vaginalis population. 
Polymorphism was found at most loci among both Australian and Ghanaian isolates, 
although there was some variation between countries. The number of alleles for each locus 
ranged from two to nine. Study results confirmed geographic expansion and diversity of the 
T. vaginalis population. Two-type population were identified in this study. Linkage 
disequilibrium was observed, suggesting that the T. vaginalis population is highly clonal. 
Multillocus disequilibrium was observed even when analysing clades separately, as well as 
widespread clonal genotypes, suggesting that there is no evidence of recent recombination. 
The potential impact of genetic diversity on varied pathology observed among T. vaginalis 
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infected individuals requires further research. Ethical clearance for this study was granted by 
the Ethics and Review Committee of Murdoch University and the Human Ethics Committee 
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CHAPTER ONE 
1.0 GENERAL INTRODUCTION 
1.1 TRICHOMONADS 
Trichomonads are anaerobic flagellated protozoa inhabiting the genitourinary and digestive tracts of 
humans and other vertebrates (Maritz et al., 2014). Trichomonas vaginalis and Tritrichomonas 
foetus are the aetiological agents of human and bovine genitourinary trichomoniasis respectively. 
Vaginal trichomoniasis is considered the most common non-viral sexually transmitted disease of 
humans, affecting an estimated 170 million people worldwide every year (Ginocchio et al., 2012). 
Infection is concentrated mainly in developing countries as well as in socio-economically 
disadvantaged groups (Sutton et al., 2007) and has major medical, social and economic 
implications.  
 
Trichomonas vaginalis is known to elicit a broad range of clinical symptoms (Petrin et al., 1998). In 
women, the presentation of the infection ranges from totally asymptomatic to a severe vaginitis 
characterized by foul-smelling discharge, itching and occasionally pain. In pregnant women, T. 
vaginalis infection has been linked to significant morbidity. It is noted for its role in the causation of 
a number of Trichomonas-associated reproductive complications, including premature membrane 
rupture, preterm labour and low birth weight, as well as vaginitis, cervicitis, urethritis, and pelvic 
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inflammatory disease (Cotch et al., 1997; Nanda, 2006). In recent times, the parasite has also been 
linked with urethritis and prostate cancer in men (Stark et al., 2009; Tsai & Li, 2013; Menezes et 
al., 2016), and has been found to increase the risk of infection with human immunodeficiency virus 
(HIV) (McClelland et al., 2007; Shafir et al., 2009; Kissinger & Adamski, 2013).  
 
The parasite inhabits the mucosal surfaces of the genitourinary tract of humans (Fichorova, 2009). 
Despite being extracellular in nature, T. vaginalis, through a variety of mechanisms, can cause 
damage to the mucosal membrane. Some of these mechanisms depend on epithelial cell contact 
(e.g. adherence-based cytotoxicity) while others do not (e.g. release of soluble factors such as 
proteinases) (Fichorova, 2009). Trichomonas vaginalis infection is also known in most cases to 
excite the host immune response, resulting in inflammation and further mucosal damage (Fichorova 
et al., 2006; Fichorova, 2009).  
 
Despite being one of the most common non-viral sexually transmitted infections, the epidemiology, 
genetic variation and pathogenicity of the T. vaginalis remains poorly studied. In particular, there is 
a paucity of information on the extent to which genetic variation in T. vaginalis impacts on the 
clinical presentation of the infection. Also, previous studies on the phenotypic characteristics of T. 
vaginalis, have often been limited to small sample size, and not considered clinical phenotypes.  
 
Parabasalia are single-celled flagellated eukaryotes that belongs to the supergroup Excarvata and 
subgroup Metamonada (Simpson, 2003; Adl et al., 2005; Hampl et al., 2009), including parasites 
and commensals of vertebrate hosts, commensals and endosymbionts of invertebrates, and a few 
described free-living species. Among the parasitic parabasalids, several are important agents of 
human urogenital, subgingival, oral, bronchial and gastrointestinal infections (Malik et al., 2011). 
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Morphological and molecular phylogenetic analysis in recent years have led to the identification six 
parabasal groups; Trichomonadea, Tritrichomonadea, Hypotrichmonadea, Cristamonadea, 
Spirotrichonymphea and Trichonymphea (Ohkuma et al., 2009; Carpenter et al., 2010; Cepicka et 
al., 2010; Noda et al., 2012), different from previous identification of two groups based on 
morphological characters observed, using light microscopy: large (∼200 µm) multiflagellated forms 
typically found in termite and cockroach hindguts are commonly referred to as “hypermastigotes” 
and smaller (∼10–20 µm) flagellates, found in both vertebrate and invertebrate hosts, are called 
“trichomonads (Malik et al., 2011). The use of morphological characteristics has resulted in the 
description of over 80 genera and 400 parabasalid species. Eleven genera have been identified in the 
family Trichomonadidae; Tetratrichomonas, Pseudotrypanosoma, Pentatrichomonas, 
Pentatrichomonoides, Lacusteria, Cochlosoma, Trichomitopsis, Tritrichomonas, Histomonas, 
Dientamoeba and Trichomonas. Several species of these genera have been reportedly found 
harbouring different sites in a wide range of vertebrate hosts (Gould et al., 2014). About 36 species 
of the genus Trichomonas have so far been identified (https://www.ncbi.nlm.nih.gov/Taxonomy). 
 
Trichomonads are anaerobic protists with modified mitochondria. They have one or more flagellae 
and are mostly symbionts or commensals. Trichomonads generally have between three to five 
anterior flagellae and an undulating membrane which is a recurrent flagellum running along the 
surface of the cell in a wave. They also have an axostyle, which runs centrally through the body, 
protruding at the posterior end, except for Dientamoeba fragilis and Pentatrichomonoides spp., 
which have a peripheral axostyle that tapers and protrudes posteriorly. While some trichomonads 
are free-living, a number of parasitic species exist (Table 1.1). Among the parasitic group are those 
of human importance, harbouring the urogenital, subgingival, oral, bronchial and gastrointestinal 
tracts (Malik et al., 2011). Four species have been identified; Dientamoeba fragilis, 
Pentatrichomonas hominis, Trichomonas vaginalis and Trichomonas tenax. Trichomonas vaginalis 
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and T. tenax are human-specific, while D. fragilis and P. hominis have also been isolated from 
domestic and farm animals, indicating a varied host range and the possibility of zoonotic 
transmission (Maritz et al., 2014). Pentatrichomonas hominis and T. tenax are morphologically 
identical with Trichomonas vaginalis but inhabit different sites; T. vaginalis in the genitourinary 
tract, P. hominis in the gut and T. tenax in the oral cavity. Epidemiological and clinical studies have 
suggested the possibility of human trichomonads other than T. vaginalis being involved in the 
causation of vaginal trichomoniasis. For example, P. hominis has been isolated from vaginal swab 
specimens using nucleic acid amplification techniques, although this may arise from specimen 
contamination during sampling or handling, and has also been attributed to short ano-vaginal 



















Table 1.1 Some trichomonad species with host, site of infection and pathogenicity 
Host   Parasite species   Site of infection  Pathogenicity 
Human    Trichomonas tenax  mouth   commensal 
Trichomonas vaginalis  genitourinary tract trichomoniasis 
Pentatrichomonas hominis caecum & colon  commensal 
Tritrichomonas foetus  lungs   pulmonary trichomoniasis 
Dientamoeba fragilis  gastrointestinal tract commensal 
Other mammals 
Rhesus monkey Trichomonas macacovaginae vagina/ urethra  vaginal trichomoniasis     
Pig   Tritrichomonas foetus   genital tract  vaginal trichomoniasis 
Sheep   Trichomonas ovis  intestinal tract  commensal 
Dogs   Trichomonas canistomae   mouth   commensal 
Tritrichomonas foetus  intestinal tract  diarrhoea 
Cats    Trichomonas felistomae  mouth   not known 
Tritrichomonas. foetus  intestinal tract  diarrhoea 
Horses   Tritrichomonas equi   caecum & colon  diarrhoea 
Horse & donkeys Trichomonas equibuccalis  mouth   not known 
Pig    Trichomonas buttreyi  caecum & colon  diarrhoea 
(Cattle)   Tritrichomonas rotunda   caecum & colon  non-pathogenic 
   Tritrichomonas suis   intestine, nasal passage diarrhoea 
`   Trichomonas foetus  intestine   diarrhea 
   Trichomonas pavlovi  large intestine  diarrhoea 
   Tritrichomonas enteris  caecum & colon  diarrhoea 
Rodents   Tritrichomonas muris   caecum   commensal 
Tritrichomonas wenoni   caecum & colon  not known 
Tritrichomonas minuta   caecum & colon  not known 
Trichomonas microti  caecum   not known 
Guinea pig  Tritrichomonas caviae  caecum   non-pathogenic 
Birds  
Duck   Trichomonas anatis   intestine   not known 
Domestic fowl  Tritrichomonas eberthi   caecum   not known 
Pigeon    Trichomonas gallinae   upper digestive tract metastatic lesions 
Pigeon   Trichomonas gallinarum  caecum & liver  hepatic lesions 
Birds   Histomonas meleagridis  liver and caecum  enterohepatitis, histomonas 





1.2 REPRODUCTION AND LIFE CYCLE 
Although the general outline of the life cycle of T. vaginalis (Figure 1.1) is well known, the details 
are poorly understood. The parasite is found in the urogenital tract of both male and female hosts 
where it exists only in the trophozoite form with no cystic stage (Petrin et al., 1998). The 
trophozoites reproduce asexually by mitosis, followed by longitudinal binary fission occurring 
every 8-12 hours under favourable conditions. A previous study, however, indicated that there may 
be preceding developmental stages before the appearance of the mononuclear flagellates (Abonyi, 
1995). These round forms are believed to be morphologically different from the smaller, flagellated 
forms and are thought to undergo amitotic budding instead of mitotic division (Abonyi, 1995; Petrin 
et al., 1998). These round forms of the parasite have not been found in the human host, however, 
but only in dividing growth phase culture. They include aflagellate forms, flagellate forms with 
dividing nuclei, and flagellate forms without dividing nuclei, and are presumed to occur only under 
unfavourable conditions, such a high level of Lactobacillus acidophilus during menstruation or very 
high vaginal pH (Petrin et al., 1998). This is yet to be studied extensively in the human host and 
remains speculative. To date, no direct evidence of meiosis and sexual reproduction has been 
observed in T. vaginalis or other trichomonads, although recomination events have been inferred 







Figure 1.1. Transmission of T. vaginalis in humans. 
 
 
1.3 CLINICAL FEATURES OF INFECTION  
The clinical impact of T. vaginalis infection is largely restricted to women and is often associated 
with a well outlined clinical syndrome and considerable morbidity, with regimented diagnostic 
procedures for detection of infection. This is often not the case in men, where the infection is 
associated with poorly defined clinical signs and symptoms, uncertain morbidity and no clearly 
structured diagnostic procedures.  
 
In women, clinical features may range from asymptomatic, subclinical, to overt vaginitis (Shafir et 
al., 2009; Van Der Pol, 2016). What accounts for this is not yet clear, but could be attributed to 
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differences in the virulence of individual trichomonad strains as well as host susceptibility. Vaginal 
discharges and inflammatory responses are common clinical features of T. vaginalis infection. The 
vaginal discharges may be of any colour or characteristic (Swygard et al., 2004) and range from 
whitish to a yellowish colouration, which may be malodorous with pH ˃6.0 (Garber, 2005) and 
purulent. This is often accompanied by erythema of the vagina and vulva and abnormal vaginal 
odour (Hainer & Gibson, 2011). Pruritus, dysuria, lower abdominal pain, irritation of the vulva and 
inflammation have all been associated with the infection in women (Hussein et al., 2015), as well as 
colpitis macularis (strawberry cervix, believed to result from microscopic, punctate haemorrhages 
of the cervix) and cervical friability (Seña et al., 2007; Van Der Pol, 2016). Complications in 
women have been frequently described, particularly pelvic inflammatory disease in those patients 
co-infected with HIV, cervical intraepithelial neoplasia and reproductive health sequelae including 
premature rupture of membranes, preterm delivery and low-birth-weight infants (Cotch et al., 1997; 
Viikki et al., 2000; Moodley et al., 2002).  
 
In males, infection is largely asymptomatic, although it has been implicated as a cause of urethritis, 
dysuria, and prostatitis (Krieger, 1990; Abdolrasouli et al., 2007). Spontaneous resolution of male 
trichomonal urethritis may occur (Kanno & Sobel, 2003), although this is not consistent with earlier 
findings (Watt & Jennison, 1960). Epididymitis and infertility have also been reported as 
complications (Krieger, 1995; Seña et al., 2007), although in most cases the infection is self-
limiting (Valadkhani et al., 2008).  
 
 
1.4 DIAGNOSIS OF INFECTION 
Most persons infected with T. vaginalis show no symptoms therefore over-reliance on clinical 
manifestations to commence treatment is not recommended. The poor predictive value of the signs 
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and symptoms of infection makes it imperative for an efficient laboratory diagnostic technique to be 
adopted to ensure early therapy and the avoidance of transmission to other sexual partners. There 
are, however, controversies regarding which diagnostic method is most appropriate for detection of 
this parasite. 
 
1.4.1 Wet mount microscopy 
Wet mount microscopy is the most cost effective laboratory diagnostic method for the detection of 
T. vaginalis. This technique, also called saline wet mount, involves the examination of vaginal or 
cervical secretions for the characteristic motility and morphological features of the protozoon. 
 
There is reported variation in the sensitivity of wet mount microscopy, ranging from 38%-82% 
(Leli et al., 2016). This variation can be attributed, at least in part, to different reference culture 
media (Patel, 2000). Other reasons for reduced sensitivity include delayed examination of wet 
mount specimens resulting in reduced parasite motility (Kingston, 2003), the presence of non-
motile trichomonads amongst copious epithelial cells and polymorphonuclear leucocytes in the 
vaginal and cervical exudates, impairing the visualization of the parasite (Garber, 2005) and low 
protozoan numbers in exudates (Fouts & Kraus, 1980). 
 
These shortcomings notwithstanding, the wet mount technique generally has a high specificity and 
considered in most health facilities to be the most acceptable routine method for diagnosis. Recent 
studies have reported a specificity rate of 100% for this diagnostic technique (Leli et al., 2016; 





Cultivation of T. vaginalis is considered a more sensitive diagnostic method than wet mount 
preparation, as it permits low numbers of the protozoan present in exudates to be amplified and 
identified (Garber, 2005; Patil et al., 2012). Although this technique can be more sensitive, it is time 
consuming and labour intensive. A swabbed sample is immersed in culture broth contained in a 
pouch and is incubated at 37°C. Observation of the culture is performed daily until the seventh day 
for the presence of trichomonads. Different culture media exist for this purpose. The constituents 
are often buffered salt solution, protein hydrolysates, liver digests or yeast extracts, reducing agents 
and serum. Antibiotics and antifungals are added to eliminate bacterial and fungal growth which 
may serve as contaminants. Penicillin, streptomycin, gentamycin, neomycin, and chloramphenicol 
are some antibiotics that may be included in the media. Antifungals such as nystatin, amphotericin 
and miconazole may also be used. 
 
A modification of the standard culturing technique is the in-pouch system, which is a two-
chambered bag which allows immediate wet mount microscopy and culture to be performed 
through the bag without the traditional daily sampling (Petrin et al., 1998). This method has been 
found to perform equally well as culturing and daily sampling using the modified trypticase-yeast 




Trichomonas vaginalis is reported to have eight serotypes (Garber et al., 1986). Previous studies 
have demonstrated the use of wide range serological techniques for the detection of circulating T. 
vaginalis antibodies in infected persons, including complement fixation, haemagglutination, gel 
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diffusion, fluorescent antibody and ELISA. (Jaakmees et al., 1966; Teras et al., 1966; Mason, 1979; 
Mathews & Healy, 1983; Sibau et al., 1987). Most of these studies have demonstrated the presence 
of Immunoglobulin (Ig) G in the sera of the infected persons. The antibody response to the 
pathogen has been attributed to several factors; the live or inactivated form, inoculum size, and the 
frequency and the length of exposure (Bhatt et al., 1996). ELISA has successfully been used to 
detect the presence of circulating antibodies, using whole cell and aqueous protein extracts as 
antigens (Alderete & Garza, 1984). This study also detected antibodies in persons with no current or 
previous infection history. This could be attributed to the presence of natural antibodies. 
Nevertheless, compared to haemagglutination and fluorescence antibody, ELISA has been shown to 
better correlate with past and current infection, suggesting its use as an alternative method of 
diagnosis (Cogne et al., 1985). 
 
1.4.4 Molecular techniques 
Nucleic acid amplification tests, including PCR and transcription-mediated amplification, have 
previously been developed and validated for the detection of T. vaginalis (Crucitti et al., 2003; Lee 
et al., 2012). A number of different primer sequences have been developed for this purpose (Table 
1.2). 
 
The high sensitivity of this technique makes it highly susceptible to contamination with minute 
quantities of exogenous DNA. This can be amplified together with the target template. A common 
type of contamination is carry-over contamination. This occurs usually when previous amplicons 
are introduced into new reaction mixture yet to be amplified. This can, however, be reduced when 
strict adherence to standard operating procedures is observed during PCR. Using aerosol barrier 
pipette tips, designing separate working areas for DNA extraction, PCR sample set-up and post 
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amplification analysis, assigning different pipettes for each working area and changing of gloves 
before preparing new samples are some of the procedures that can be adhered to. Adopting the use 
of premixed reaction components also minimizes contamination. Setting up of negative controls 




Table 1.2 List of some primers used in T. vaginalis identification 
Primer used  Target region of parasite   Reference 
TV16S   18S rRNA gene    (Simpson et al., 2007) 
BTUB9/2*  3β-tubulin gene    (Wendel et al., 2002) 
TV8/9   actin gene    (Spotin et al., 2016) 
TV10/11  actin gene    (Spotin et al., 2016) 
TFR1/2   5.8S rRNA & ITS regions   (Rivera et al., 2009) 
TV18S   first half of 18S rRNA region  (Mao & Liu, 2015) 
TVK3/7   unspecified    (dos Anjos Gatti et al., 2017) 
TVA5/6   A6p target sequence conserved region (Riley et al., 1992) 
TricV-O/TricV-I  not specified    (Lawing et al., 2000; Naing et al., 2010) 
Actin-As1/Actin-S1 actin gene    (Matini et al., 2014) 
Actin-As2/Actn-O actin gene    (Matini et al., 2014) 
TVA 5/6  A6p genome of T. vaginalis**   (Shaio et al., 1997; Madico et al., 1998) 
AP65 A/B  conserved region in the ap65 adhesin gene (Alderete et al., 1995a) 
Hydrogenase A  entire hydrogenosome gene  (Bui & Johnson, 1996) 
α-succinyl CoA                 entire α subunit of the hydrogenosomal                                                              
synthetase                          succinyl-coenzyme A synthetase protein  (Lahti et al., 1994) 
TV1/2   18S rRNA region ***   (Mayta et al., 2000) 
TVK3/4/7       (Kengne et al., 1994) 
*Although the use of the B-tubulin has successfully been used to identify the parasite, it fails to detect some 
strains due to strain variations.  
**The A6p region is found to be highly selective for a broad range of T. vaginalis isolates. This presents a 
relatively high potential for its use in diagnosis of the parasite                






1.5 INFECTION AND PATHOGENESIS 
Despite the severe outcomes that can occur in T. vaginalis infection, the mechanisms 
underlying pathogenesis are poorly understood, even less so in the male than the female host. 
The following discussion therefore focuses on processes of infection and pathogenesis in 
women. 
 
1.5.1 Invasion and adhesion 
The usual mode of transmission of T. vaginalis is through sexual contact. The parasite is 
believed to undergo an incubation period of 4- 28 days (Harp & Chowdhury, 2011) when it 
enters the female host, with the vaginal mucus layer being the first point of contact. The 
mucus layer is rich in mucin, which presents a fortified barrier to the parasite. Adhesion to the 
vaginal epithelial cells is paramount in the pathogenesis of the parasite as the parasite’s 
ability to colonize the host depends mainly on the outcome of this interaction with the host’s 
mucus layer (Alderete & Pearlman, 1984; Alderete & Garza, 1985). Trichomonas vaginalis 
has between 11 and 23 different cellular proteins, most of which are lysosomal in their 
activities (Arroyo & Alderete, 1989; Garber & Lemchuk-Favel, 1994). Beside these proteins 
playing a major role in adhesion of the parasite to the mucus layer, they also have the ability 
to degrade host immunoglobulins G and A (IgG and IgA) (Provenzano & Alderete, 1995).  
 
After adhering to the vaginal wall, the parasite assumes an amoeboid form with increasing 
cellular surface contact interaction. This leads to the formation of cytoplasmic projections that 
interdigitate with host target cells (Harp & Chowdhury, 2011). The cellular surface of T. 
vaginalis plays a vital role in this, as well as in host-parasite interaction and nutrient 
acquisition (Sommer et al., 2005). Mucin secretion follows adhesion and this results in the 
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dissolution of the mucosal matrix of the host, thus detaching the parasite from the mucosal 
layer (Lehker & Sweeney, 1999). The parasite, aided by its flagellar movement, penetrates 
the dissolved matrix and colonizes the underlying epithelial cells (Lehker & Sweeney, 1999). 
As well as the cell-to-cell interaction, several other mechanisms are believed to contribute to 
the establishment of infection. These include haemolysis (Dailey et al., 1990; Fiori et al., 
1993) and the excretion of soluble factors such as proteinases (Garber & Lemchuk-Favel, 
1994; Mallinson et al., 1994) and cell- detaching factors (CDF) (Pindak et al., 1986).  
 
During colonization of the vaginal microenvironment, constant changes occur. There is a 
drastic change during menstruation with the influx of erythrocytes, host molecules and serum 
constituents, as well as significant pH change (Petrin et al., 1998). The influx of erythrocytes 
provides nutrients for the parasite, as well as iron required for gene regulation (Petrin et al., 
1998). The influx of the iron and its utilization by the parasite in the vaginal host results in 
oxidative stress, which in turn leads to upregulation of diverse heat shock proteins and 
various adhesins, immunogens, and C3-degrading proteinases (Sorvillo & Kerndt, 1998; Ryu 
et al., 2004). These are known to be cardinal in the parasite’s ability to deal with stresses in 
its host environment and persist in causing infection (Petrin et al., 1998).  
 
1.5.2 Erythrocytic lysis 
Lipids and iron are major nutritional requirements for T. vaginalis, but the parasite lacks the 
ability to synthesize them. To meet these nutritional needs, T. vaginalis depends solely on the 
vaginal mucosal erythrocytes through lysis, which is related to virulence (Lehker, 1990). This 
process is optimal at the normal vaginal pH of 4.5 (Fiori et al., 1993). Erythrocytic lysis is 
mediated by protein receptors found on the surfaces of both the parasite cell and erythrocytes 
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in the vaginal mucosa (Fiori et al., 1993). Five adhesion proteins are known to be involved in 
this process; AP65, AP51, AP33, and AP23, all of which act as ligand receptors (Petrin et al., 
1998). There is release of porphyrin-like proteins following the adhesion of the parasite to the 
vaginal mucosal erythrocytes and this creates pores in the erythrocyte membrane (Petrin et 
al., 1998). Cell lysis occurs when the parasite detaches itself from the cell.  
 
1.5.3 Host Response to Infection 
The attachment of T. vaginalis to the vaginal cell surface results in leucocyte activation and 
secretion of interleukin-8 (IL-8), parasite-specific IgG, IgA, Th1 cytokines, leukotrienes, 
reactive nitrogen intermediates and macrophage inflammatory protein-3a, which induces 
nitric oxide synthase (iNOS), primes helper T cells, and promotes transmigration of 
neutrophils across the endothelium (Fichorova et al., 2006). While the overall response by the 
host to T. vaginalis invasion is not clearly understood, it is believed that the activities of these 
complexes are the primary means by which the host responds to infection (Shaio, 1994, 
1995). 
 
Recent studies into the structural composition of T. vaginalis suggest the parasite 
lipophosphoglycan (LPG) molecule, which plays a major role in parasite adherence, also has 
defined sites (an outer branch saccharide and ceramide phospho-inositol glycan core (CPI-
GC)) which possess pro-inflammatory properties, activating nucleus factor kappa B, 
extracellular signal-regulated kinase 1/2 and mitogen-activated protein kinase kinase1/2 in the 
host macrophages during infection (Harp & Chowdhury, 2011). The LPG CPI-GC contains 
terminal poly-n-acetylactosamine repeats that represent the ligand for the animal lectins 
called galectins (Singh, 2009). During T. vaginalis infection, the cervical and vaginal 
epithelial cells are thought to release galectin-1 and galectin-3. This results in a change in the 
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inflammatory responses in opposite mode; while galectin-1 suppresses inflammation, 
galectin-3 enhances leucocyte response to inflammation (Than, 2008; Fichorova, 2009). In-
depth knowledge and understanding of the mechanisms involved are, however, lacking. Also, 
T. vaginalis is known to induce COX-2 expression, and up-regulates and activates toll-like 
receptors 2, 4, and 9 via the p38 mitogen-activated protein kinase pathway (Fichorova, 2009).  
 
1.5.4 Immune system evasion 
Although attempts have been made to explain the virulence factors of T. vaginalis responsible 
for evasion of the host immune system and the severity of the pathologic inflammatory 
reaction, in-depth understanding is still limited (Singh, 2009). Upon entering the host, 
resistance to complement-mediated destruction, molecular mimicry and coating with host 
plasma proteins are mechanisms adopted by T. vaginalis to elude the host’s immune system 
(Harp & Chowdhury, 2011). The complex carbohydrates on the surface of the parasite, which 
are involved in host invasion, are also believed to play a critical role in the evasion of the 
host’s immune system (Fichorova et al., 2006). 
 
1.5.5 Resistance to complement mediated destruction 
Complement is deficient in the cervical mucus (Demes et al., 1988b; Alderete et al., 1995b) 
and the only source in the vagina is the menstrual blood. Although complement activity in 
menstrual blood is less than half that of venous blood (Demes et al., 1988b; Alderete et al., 
1995b), there is appreciable complement-mediated cytotoxic activity toward T. vaginalis in 
menstrual blood, leading to a depletion in the parasite population during menses (Demes et 




Demes et al. (1988a) found that fresh isolates of T. vaginalis differed in their susceptibility or 
resistance to complement-mediated lysis in serum and that complement-resistant fresh 
isolates became susceptible to complement after lengthy cultivation in vitro. Iron has been 
reported as a contributing factor in the resistance of T. vaginalis to complement (Alderete et 
al., 1995b). Cysteine proteinase expression, found to degrade the C3 portion of complement, 
appears to be upregulated by iron, allowing the parasite to evade complement-mediated 
destruction (Alderete et al., 1995b). 
 
1.5.6 Molecular mimicry  
In T. vaginalis, as in other parasitic protozoans, phenotypic variation and mimicry is a key 
factor in immune evasion. Two classes of markers expressed alternately on the parasite 
surface have been found. (Alderete, 1992): the highly immunogenic glycoproteins (P270) and 
the adhesins (AP65, AP51, AP33, and AP23) (Alderete, 1992). Whereas P270 is synthesized 
by all T. vaginalis strains, there is variation in the cytoplasmic and cell surface expression of 
the glycoproteins, leading to A1 B2 (P270 positive) and A2 B1 (P270 negative) phenotypes 
(Alderete, 1988). Unlike P270 negative phenotype organisms, P270 phenotype positive 
organisms lack adhesins and thus cannot cytoadhere to host cells (Alderete, 1992). The P270 
negative phenotype organisms lack cell surface expressions. This coupled with the presence 
of adhesins (which are immunorecessive in nature) enable the negative-phenotype organisms 
to avoid host antibody attack (Alderete, 1987a) by mimicking the host glycoproteins. The 
parasite may also evade the host’s immune response through the presence of P230, a high 
molecular weight immunogen on its surface. This immunogen also undergoes conformational 
change (epitope phenotypic variation), mimicking the host glycoproteins, thus, allowing it to 




1.5.7 Surface coating 
Another mechanism of immune system evasion is surface coating and degradation of IgG, 
IgM, and IgA by cysteine proteins secreted by T. vaginalis (Provenzano & Alderete, 1995). 
Secretion of highly immunogenic soluble antigens by the parasite neutralizes antibody or 
cytotoxic T lymphocytes thereby short-circuiting specific anti-T. vaginalis defence 
mechanisms (Alderete & Garza, 1984). The parasite also coats itself with host plasma protein, 
escaping recognition by the host immune system (Peterson & Alderete, 1982). Consequently, 




Humans are a natural host for T. vaginalis. The parasite is cosmopolitan, and found across all 
racial and socioeconomic groupings. The term socioeconomic used here is in relation to both 
the behaviours of people, including the ways they interact with one another and their income 
and financial status. An estimated 190 million cases are recorded annually (Poole & 
McClelland, 2013) with most of these cases occurring in developing countries and low 
socioeconomic groups. Over the years, different studies have reported varied estimates of 
prevalence (Table 1.3). Prevalence estimates are affected by a number of factors, including: 
the geographic locality, socioeconomic status, size and age profile of the study population, 
the sampling strategy (e.g. whether community or clinic-based); and the diagnostic method 
used. Prevalence appears to be lower in men than in women, although there are a paucity of 
data on T. vaginalis infection in men (Bowden, 2000). 
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Table 1.3 Global prevalence of T. vaginalis  
Region  Country Year      Sample size      Prevalence (%) Diagnostic method Sex  Group   Reference 
America  USA  1998  213  46.9  Vaginal swab culture  Female  New York city inmates (Shuter et al., 1998) 
2000  454  2.8  Urine: culture  Male  Denver   (Joyner et al., 2000) 
    2002  522  12.9  Vaginal swab: culture  Female  Birmingham/Alabama  (Crosby, 2002) 
    2005  268  6.0  Vaginal swab: PCR  Female  Indiana    (Van Der Pol et al., 2005) 
    2005  12449  1.7  Urine: PCR  Male  Overall US population (Miller, 2005) 
        4.1     Male  Native Americans 
        3.3     Male  Black Americans 
        1.3     Male  Whites 
        10.5     Female  African-American 
        1.1     Female  White-American 
        2.8     Female  General population 
        2.3     Male & Female  Overall population 
  2007  3754  3.1  Vaginal swab: PCR  Female  General US population (Sutton et al., 2007) 
        1.3       non-Hispanic white 
        1.8       Mexican-American 
13.3       non-Hispanic black 
Australasia   1999  63  11.0 (street) Vaginal swab: PCR  Female  Melbourne   (Morton, 1999) 
        0.53 (brothel) Vaginal swab: PCR 
2006-08  356  4.8  Vaginal swab: PCR  Female  Sydney   (Naing et al., 2010) 
Australia  1999  1090  25.0  Tampon: PCR  Female  Northern Territory  (Bowden, 1999) 
Samoa  2004  427  20.8  Vaginal swab: PCR  Female  Apia   (Sullivan et al., 2004) 
New Zealand 1998-99  88  2.0  Vaginal swab:microscopy Female  Auckland    (Lo et al., 2002) 
          and culture 
Europe  Portugal  2004  211  31.2  Vaginal Swab: microscopy Female  Lisbon   (Garcia, 2004) 
          and culture 
Belgium  2008  62944  0.37  Cervical specimen: PCR Female  Flanders   (Depuydt et al., 2010) 
  England  2001  31157  7.6  Vaginal swab: culture  Female  Bethesda   (Klebanoff et al., 2001) 
Asia  China  2006  504  3.2  Vaginal swab: culture  Female  Fuzhou   (Chen, 2006) 
Bangladesh 2005  439  7.5  Vaginal swab: microscopy Female  Nationwide  (Nessa, 2005) 
Indonesia  2003  288  5.0  Vaginal swab: culture  Female  Kupang   (Davies, 2003) 
Mongolia  2005  2000  6.7  Vaginal swab: PCR  Female  Nationwide  (Amindavaa, 2005) 






Table 1.3 Global Prevalence of T. vaginalis (Cont,) 
Region  Country  Year      Sample size       Prevalence (%)  Diagnostic method Sex  Group  Reference 
Africa  Zimbabwe  2005  363  19.3  Vaginal swab: culture  Female  Mashonaland West (Cowan, 2005) 
Uganda  2006  250  17.3  Vaginal swab: culture  Female  Entebbe  (Tann, 2006) 
2006  199  8.0  Vaginal swab: PCR  Female  Entebbe  (Tann, 2006) 
Kenya  2000  621  23.0  Vaginal swab: microscopy Female  Nairobi  (Fonck, 2000) 
Malawi  2004  756  19.8   Urethral swab: culture& PCR Male   Lilongwe  (Price, 2004) 
Tanzania  2000  1004  11.0  Urine & Urethral swab: Male  Mwanza  (Watson-Jones, 2000) 
          microscopy and culture 
2006  1440  10.7  Urine: PCR  Females  Moshi Urban District (Klinger, 2006) 
2006  588  6.3  Urine: PCR  Male partners Moshi Urban District (Klinger, 2006) 
Africa  Madagascar 2005  643  7.4/23.4  Urethral swab/vaginal swab: Male/Female Rural Madagascar (Leutscher, 2005) 
          Culture 
Zaire  1993  68  1.9  Vaginal swab  Female   Kinshasa  (Laga et al., 1993b) 
Zambia  2011  460  27.1  Vaginal swab: PCR  Female  Ndola  (Crucitti et al., 2011) 
Ghana 
  2004  3807  5.4  Vaginal swab: latex agglu- Female  Kumasi  (Adu-Sarkodie, 2004) 
          tination 
    2006  517  2.7  Vaginal swab: serology Female  Accra  (Apea-Kubi et al., 2006) 
Nigeria 
  2005  220  4.5  Vaginal swab: microscopy Female  Port Harcourt (Oluwayemisi, 2014) 
  2010  1500  23.7  Vaginal swab: microscopy Female  Abakaliki  (Alo et al., 2012) 
          and culture 
  2010  919  10.9  vaginal swab: culture  Female  Maidugri  (Mairiga et al., 2011) 
  2014  200  13.0  Vaginal swab: microscopy Female  Aba state  (Kanu, 2015) 
  2014  960  7.5  Vaginal swab: microscopy Female  Nasawara state (Abioye, 2014) 




The usual mode of transmission of T. vaginalis is through sexual contact (Figure 1.1). 
Transmission frequency differs between men and women. While 70%-77% of female sexual 
partners of infected males become infected with T. vaginalis (Seña et al., 2007; Meites et al., 
2015), only 14%-70% of male sexual partners of infected females have been found to be 
infected (Seña et al., 2007; Hoots et al., 2013; Kissinger, 2015; Meites et al., 2015). This may 
be partly due to inefficient transmission from females to males, but can also be explained by 
spontaneous resolution of the infection and inefficient T. vaginalis diagnostics in men. It 
could also be deduced that the proportion of male sex partners who can be infected at a given 
time will be dependent on the frequency of sex within the partnership, the likelihood of 
transmission per sex act, and the duration of infection in men. 
 
Although transmission of the parasite is usually by sexual intercourse, there have been reports 
of non-sexual transmission, through towels, soaps and toilet seats, occurring among 
households and school-children (Adu-Sarkodie et al., 2007; Crucitti et al., 2011). The 
frequency of non-sexual transmission of T. vaginalis is still controversial, however, and 
requires more detailed studies to eliminate the possibility of cross-contamination during 
sampling or specimen handling, establish infection routes and infer causative risk factors.  
 
Humans are the only natural host for T. vaginalis. Trichomonas vaginalis transmission from 
mother to Newborn babies during birth has also been reported (Smith et al., 2002). 
Transmission between same sexes via vulva contact among women practicing same-sex is 
also increasingly occurring (Bhunu & Mushayabasa, 2011). It is however believed that these 
women once thought to be straight, were likely to be harbouring the infection before 
becoming lesbians.  
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T. vaginalis transmission is influenced by several causal factors. These include 
sociodemographic, behavioural, age and racial/ethnicity (Shuter et al., 1998; Sorvillo et al., 
1998; Sutton et al., 2007; Helms et al., 2008; Silva et al., 2013). The transmission of T. 
vaginalis is reported to be prevalent in low socio-economic and demographic regions globally 
(Ryder et al., 2012; de Waaij et al., 2017; dos Anjos Gatti et al., 2017). Although not clearly 
understood how these directly impact on the transmission rate of the infection, behavioural 
patterns such as sex for money, use of recreational drugs, poor sexual practices and hygiene, 
douching, etc., commonly identified among persons dwelling in these regions, have been 
identified as predisposing factors for T. vaginalis infection (Cotch, 1991; Leon et al., 2009; 
Eshete, 2013; Miranda et al., 2014; Rogers et al., 2014).  
 
Another factor influencing transmission dynamics of T. vaginalis is age (Miller et al., 2008; 
Silva et al., 2013; Kissinger, 2015). Predictors of infection among adolescents and older age 
groups are not clearly identified. Vaginal microbiota and glycogen in vaginal fluids, which is 
high among young adolescents act as protective barriers, inhibiting transmission of T. 
vaginalis and other sexually transmitted infections (Eschenbach et al., 2000; Petrova et al., 
2013; Cone, 2014; Mirmonsef et al., 2014). However, high transmission among younger age 
groups has been reported (Van Der Pol et al., 2005; Crucitti et al., 2010; Swartzendruber et 
al., 2014; Kissinger, 2015). This could be attributed to poor and unsafe sexual practices and 
hygiene (i.e. having multiple sexual partners and having unsteady sexual partners, douching, 
etc.). High transmission of T. vaginalis has been attributed to vaginal epithelial and 
microbiota changes which occur with aging-epithelial thinning, glycogen depletion and 
vaginal flora depletion increase transmission of T. vaginalis among older women (Brotman et 
al., 2007; Brotman et al., 2010; Brotman et al., 2012). This phenomenon is not clearly 
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understood to date and an extensive study in this regard would provide increased knowledge 
on this.  
 
Racial patterns in T. vaginalis transmission are yet to be clearly understood. Globally, the 
incidence of T. vaginalis is reportedly high in sub-Saharan Africa with Europe and the USA 
following (Kenyon et al., 2014). This study is however, based on estimates and future study 
for accurate incidence rates is important. This phenomenon in ethnic/racial transmission 
disparity has been reported in several studies as well (Sorvillo et al., 2001; Shafir et al., 2009; 
Meites et al., 2013). For instance, in the USA, the infection is high among blacks and non-
Hispanic-blacks than whites (Ginocchio et al., 2012; Nijhawan et al., 2012). This trend is 
consistent with several other studies in the USA where high incidence of T. vaginalis is 
reported among black-dominated population than other ethnicity/race (Sorvillo et al., 2001; 
Boyer et al., 2006; Sutton et al., 2007). Several factors have been highlighted as possible 
causes for this trend, including decreased use of condoms for barrier protection, increased 
practice of douching among black women (Annang et al., 2006; Cottrell & Close, 2008), 
which has been identified as a causal factor for increased risk for other STIs (Scholes et al., 
1998). Disparities in education, the ability to consider accessing healthcare for what might be 
perceived as minor medical ailments, access to health care, access to good accurate diagnostic 
services and thereby access to appropriate and affordable treatment are some possible factors. 
Another possible factor, which could contribute to the ethnic/racial heightened disparity in T. 
vaginalis transmission, is genetic. This has however, not yet been studied and a future study 
in this area is worth considering. Strain differences in T. vaginalis could also be a possible 
attribute. For instance, a more virulent drug resistant T. vaginalis strain if found to infect 
blacks than whites, could prolong infection, contributing to increased transmission among 
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blacks. This is worth considering and a study to verify this would immensely contribute to 
understanding the existing racial trend of the infection. 
 
1.6.3 Risk factors for infection 
The prevalence of T. vaginalis infection is enhanced by a variety of risk factors, including 
geographic, socio-demographic, and socioeconomic as well as behavioural variables 
(Abdallah et al., 2017; de Waaij et al., 2017). Prevalence is relatively high in resource-poor 
countries (Gregson et al., 2001; Mgone et al., 2002; Wangnapi et al., 2015). In both 
developing and developed countries, women of lower socio-economic groups are reported to 
be at highest risk (Bowden, 2000), with up to 50% found among in women in minority groups 
(Bowden, 2000).  
 
Educational level has also been identified as a risk factor for T. vaginalis infection (Gregson 
et al., 2001; Mgone et al., 2002; McClelland et al., 2007; Madhivanan et al., 2009; Eshete, 
2013; Wangnapi et al., 2015). Although there is currently no reported study on how 
educational level directly influences high rates of T. vaginalis infection, some studies have 
linked high risk sexual behaviour, which is a common behavioural pattern among persons 
with lower education, as the major causal factor (Eshete, 2013). Low income, commonly 
associated with lower levels of education, has also been reported as an associated factor for T. 
vaginalis infection (Swartzendruber et al., 2014). 
 
Other studies have suggested multiple sexual partners, which could be common among 
unpartnered women; concurrent infection with other STIs and older age as risk factors for T. 
vaginalis infection (Madhivanan et al., 2009; Goo et al., 2016; dos Anjos Gatti et al., 2017), 
although there has been no explanations as to how each of these factors might directly 
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influence the infection rate. The need for an in-depth study on risk factors and how each of 
these is directly associated with T. vaginalis infection in a larger and more diverse study 
population cannot be over-emphasized. 
 
 
1.7 MOLECULAR EPIDEMIOLOGY 
In the last two decades, molecular epidemiological studies have provided epidemiologists and 
researchers not only opportunities and insights into diseases, their prevention and treatment, 
but also provided information that can be used to enhance the health of populations (Slattery, 
2002). Molecular epidemiological studies have provided important information on parasite 
phylogeny and classification; population genetic processes, such as mode of reproduction, 
breeding system, selection, isolation and genetic drift, and gene flow; transmission dynamics; 
and markers for traits such as virulence, drug resistance and antigenicity (Huyse et al., 2005; 
Barrett et al., 2008; Besser, 2013; Hawksworth et al., 2015). 
 
1.7.1 Molecular tools  
Studies on genetic variation of T. vaginalis have been limited until recently because of the 
lack of appropriate molecular tools. However, there are now many examples of the 
development and application of molecular methods to better understand the epidemiology of 
trichomoniasis in people (Table 1.4).  
 
Choosing an appropriate marker for molecular epidemiological studies requires consideration 
of the required level of resolution for the study, technical convenience and the precision of 
the genetic data collected (Lymbery & Thompson, 2012). Genetic variation is influenced by 
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evolutionary processes operating now and throughout the evolutionary history of a lineage, so 
choosing markers with a rate of genetic change appropriate to the level of question being 
posed (e.g. taxonomic assignment, species diagnosis or isolate tracking) is an essential first 
step. For example, a useful tool for the specific detection and identification of Trichomonas 
spp. is the amplification of the 5.8S rRNA gene. (Kikuta et al., 1997; Walker et al., 2003). 
The advantage of using this region is its presence in multiple copies in the parasite genome 
and the fact that although it is conserved in some regions, it is variable in others, even 
between closely related species. 
 
 There is also typically a trade-off between technical convenience and precision when 
choosing a marker. For example, markers such as randomly amplified polymorphic DNA 
(RAPD) and amplified fragment length polymorphism (AFLP) do not require specific 
sequence information and hence can be utilised for well-studied species, but their outcomes 
are often less discriminatory (Nybom et al., 2014), making it impossible to distinguish 
between alternative alleles at a locus. This limits the cope and strength of analysis, which can 
be generated from the data. It also reduces its comparability with other studies thus, limiting 
its usefulness.  
 
These include random amplified polymorphic DNA (RAPD) successfully used for molecular 
typing of T. vaginalis from clinical isolates (Kaul et al., 2004; Fraga et al., 2015; Oliaee et 
al., 2017), with emphasis on the genetic polymorphism and clinical phenotype of T. vaginalis. 
Even though the level of correlation between the RAPD data and the in vivo and in vitro 
properties of the parasite, geographic origin, and clinical presentation has successfully 
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indicated, there are some limitations using RAPD for phenotypic studies (e.g. reproducibility, 
homology inferences and artefact fragments).  
 
Multi-locus sequence typing (MLST) is an appropriate marker to study the relationships 
among strains. This is important because clones diversify with age as a result of mutation and 
recombination, and typing a single loci could result in error (Belén et al., 2009). It exploits 
nucleotide sequence data to characterize microbes, quantifying genetic relationships between 
isolates and output data from this analysis is transferrable between laboratories, making it 
suitable for global epidemiological studies (Cornelius et al., 2012). The utilisation of alleles 
based on nucleotide sequence determination of internal fragments from multiple 
housekeeping genes is clearly expressed and distinguishes more alleles per locus. This 
permits high discrimination between isolates (Belén et al., 2009). The use of MLST has 
enabled successful study on the population genetics and the genetic polymorphism of T. 




Table 1.4 Some molecular tools and their uses in the characterisation of genetic diversity of Trichomonads 
Molecular tool Level of resolution Purpose  Limitations   References 
RAPD  Intraspecific  Genetic polymorphism/ Reproducibility, homology (Kaul et al., 2004; Fraga et al., 2015; Oliaee et al., 2017) 
      clinical phenotype interferences and artefact  (Vanacova et al., 1997)     
      fragments/ 
MLST/SNP Intraspecific  Population genetics/  Labour intensive,  (Cornelius et al., 2012; Hawksworth et al., 2015) 
      identification of multiple Cost   (Conrad et al., 2012)     
      genotypes      (Matini et al., 2014; Masha et al., 2017) 
mPCR  Species assignment Systematics/diagnosis Prone to false positives  (McKechnie et al., 2009) 
Isoenzyme     Systematics/genetic     (Soliman et al., 1982; Salem et al., 1992)              
analysis/RFLP/ Species assignment/ variation population Cost/ labour intensive  (Upcroft et al., 2006; Crucitti, 2008)              
PFGE/RSH Intraspecific  structure sequence     (Paces et al., 1992)  
polymorphism 
EcoRI-RFLP Intraspecific  Phylogenetic analysis/  Cost   (Meade et al., 2009)    
      molecular epidemiology 
Microsatellite/ Intraspecific  Genetic variation, molecular Allelic band profiles  (Conrad et al., 2011; Mao & Liu, 2015)                    
18S rRNA     epidemiology, diagnosis difficult to interpret 
PCR-SSCP/ Intraspecific  molecular epidemiology- Cost, labour intensive (Matini et al., 2012; Matini et al., 2014)                  
PCR-RFLP Higher level   tracking transmission, course    (Masha et al., 2017)    
   taxonomy  of infection, competitive          
      interaction, /            
      Genotyping, drug suscep-          
      tibility, genetic diversity.          
      Phenotypic variations 
Abbreviations: AFLP – amplified fragment length polymorphism; ITS – internal transcribed spacer; mPCR – multiplex PCR; PCR – polymerase chain reaction; PCR-RFLP – 
PCR-coupled restriction fragment length polymorphism; PFGE – pulse field gel electrophoresis; RAPD– random amplified polymorphic DNA; SSCP – single-strand 
conformation polymorphism; RSH – repetitive sequence hybridization; MLST – multi-locus sequence typing; HSP – heat-shock protein; SNP – single nucleotide polymorphism 
48 
 
1.7.2 Phylogeny and classification 
Trichomonads belong to the primitive group of protists called Parabasalids (Viscogliosi et al., 
1999), which comprises of a monophyletic but complex assemblage of diverse species of 
protists characterised by the presence of parabasal body, which is a Golgi complex associated 
with striated fibres (Noda et al., 2012). The previous evolutionary relationships of 
parabasalids were based on light-microscopic details of living, fixed or stained material, 
dividing the into two classes - Trichomonadida and Hypermastigia (Brugerolle & Lee, 2001). 
However, recent classifications based on molecular phylogenetic analyses have identified six 
parabasal groups: Trichomonadea, Tritrichomonadea, Hypotrichomonadea, Cristamonadea, 
Spirotrichonymphea and Trichonymphea (Ohkuma et al., 2007; Noda et al., 2009; Ohkuma et 
al., 2009; Carpenter et al., 2010; Cepicka et al., 2010), although their relationships have not 
yet been resolved. The identified clades within the parabasalids include genera within the 
family Monocercomonadidae (Monotrichomonas, Ditrichomonas and Pseudotrichomonas) 
and almost all species from the subfamily Trichomonadinae (Trichomonas vaginalis, 
Trichomonas tenax, Tetratrichomonas gallinarum, PentaTrichomonas hominis, Trichomitus 
trypanoides and Pseudotrypanosoma giganteum) (Viscogliosi et al., 1999). 
 
Initial molecular studies inferred parabasalid taxonomic relationships using ribosomal DNA 
sequences (Gunderson et al., 1995; Silberman et al., 1996). Additionally, evolutionary 
relationships have been inferred for taxonomic representation of the six parabasal groups, 
using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Viscogliosi & Muller, 1998; 
Noda et al., 2012), malate dehydrogenase (MDH) (Wu et al., 1999), enolase (Keeling, 2004), 




The use of molecular phylogenetic analyses has changed many traditional groupings within 
the parabasalids. For example Trichomitus barachorium, which was previously classified in 
the Trichomonadinae family based on morphological characteristics, no longer belong to this 
cluster (Viscogliosi et al., 1999). Additionally, the phylogenetic relationship between 
trichomonads Tritrichomonas foetus, Monoceromonas spp. and Dientamoeba fragilis, which 
remained unresolved previously, has been resolved (Brugerolle, 1976; Viscogliosi et al., 
1999); Tritrichomonas and Dientamoeba have been classified in the same group, while 
Monoceromonas spp. grouped independently (Viscogliosi et al., 1999).  
  
1.7.3 Population genetic studies 
The analysis of genetic variation within and among the populations of T. vaginalis, has 
detected high levels of genetic diversity, inferred a two-type population structure, identified 
clinically relevant differences between these two groups, and uncovered evidence of genetic 
exchange in an organism once believed to be clonal (Hawksworth et al., 2015).  
 
Trichomonas vaginalis strain heterogeneity has previously been reported (Felleisen, 1997; 
Vanacova et al., 1997). More recently, high levels of genetic diversity of T. vaginalis have 
been demonstrated using a panel of twenty-one polymorphic microsatellite markers on 
populations of the parasite in the USA, Mexico, Chile, Italy, South Africa, Mozambique, 
Australia, Papua New Guinea (PNG) and India; examination of 231 isolates from these nine 
countries identified only four pair of isolates from different geographical regions sharing 
same haplotypes (Conrad et al., 2012). A Bristol study involving 23 isolates identified 19 
unique genotypes (Hawksworth et al., 2015). Similarly, a previous study involving 68 isolates 
from the USA, the United Kingdom and Austria, identified 60 unique genotypes in these 
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isolates, revealing a diverse T. vaginalis population (Cornelius et al., 2012). These studies, 
coupled with the findings by Conrad et al. (2012), indicate a globally diverse T. vaginalis 
population. 
 
Phylogenetic analyses of T. vaginalis isolates has identified two major groups; group I 
consisting of three subgroups (A, B, and C) and group II consisting of subgroups (D and E). 
Each of these groups and subgroups are characterized by deeply diverging branches 
containing individual T. vaginalis isolates (Meade et al., 2009). The two-type population 
structure identified by Meade et al. (2009), has been corroborated in other studies (Conrad et 
al., 2012; Cornelius et al., 2012; Hawksworth et al., 2015). Even though population types 
have been identified globally, their regional distribution has varied in some cases. For 
example, Conrad et al. (2012), identified nearly equal frequencies of both population types 
among all the geographical locations studied, with two exceptions observed; isolates from 
Southern Africa and Mexico were significantly biased towards Type 1 and Type 2, 
respectively. Hawksworth et al. (2015), contrary to findings by Cornelius et al. (2012), found 
amongst the Bristol isolates predominantly Type 2. The genetic diversity existing among 
isolates T. vaginalis has also been associated with metronidazole resistance. (Vanacova et al., 
1997). 
 
The use of molecular markers in molecular epidemiological studies could help to examine 
evolutionary patterns and processes, mode of reproduction, breeding system, mutation, 
migration and selection with much emphasis on the use of appropriate analysis to evaluate the 
characterisation and genetic diversity of pathogens at different specificity levels. 
Trichomonas vaginalis is thought to be a clonal organism which reproduces strictly by 
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mitosis (Tibayrenc et al., 1990), thus, the genetic stability of the T. vaginalis parasite, over 
time, which is a unique feature of clonally reproducing populations, cannot be over 
emphasized (Tibayrenc et al., 1990; Tibayrenc & Ayala, 2012). Recent studies involving the 
whole genome sequence of the parasite, however, have revealed components of meiotic 
recombination elements present, suggesting the capacity for homologous recombination and 
genetic exchange (Malik et al., 2011). Further evidence on the occurrence of sexual 
recombination has been suggested in other studies (Conrad et al., 2012; Cornelius et al., 
2012); no evidence for multi-locus linkage disequilibrium particularly among Type 1 isolates 
was observed, suggesting the likelihood of recombination. Furthermore, there also appears to 
be a much less frequent occurrence of recombination between Type 1 and Type 2 parasites, 
which suggests the existence of biological or special barriers to recombination between types 
(Conrad et al., 2012; Cornelius et al., 2012). 
 
1.7.4 Transmission dynamics 
Subtypes of T. vaginalis have been found in the general population and among sexual 
partners using HSP70 restriction fragment length polymorphism (Stiles et al., 2000). The 
presence of these multiple subtypes in persons within the same population makes it ideal as 
an epidemiologic tool for the study of sexual networks and the transmission dynamics of the 
infection. Multi-locus sequencing (MLST) can be utilized to study multiple locations of 
chromosome of an isolate or multiple isolates using a number of different housekeeping 
genes. Application of this tool is effective in epidemiological analysis and surveillance of 
pathogens (Belén et al., 2009) and can be used for the study of sexual networks and the 
transmission dynamics of the infection  
. Also, the use of Antigenic characterization, isoenzyme analysis, repetitive sequence 
hybridization, random amplified polymorphic DNA (RAPD), pulsed-field gel electrophoresis, 
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and sequence polymorphism in ribosomal RNA genes and intergenic regions of T. vaginalis 
have contributed to finding correlations between T. vaginalis genotypes and biologically 
relevant phenotypes or geographical distribution (Vanacova et al., 1997; Snipes et al., 2000; 
Hampl et al., 2001; Rojas et al., 2004; Upcroft et al., 2006; Crucitti et al., 2008), aiding in the 
epidemiological study and  disease surveillance and producing information for a number of 
different phenotypes including metronidazole resistance and geographical distribution, as 
well as the clinical manifestation of infection and virulence of T. vaginalis (Vanacova et al., 
1997; Snipes et al., 2000; Hampl et al., 2001; Rojas et al., 2004). 
 
1.7.5 Molecular markers for traits of clinical/epidemiological importance 
Molecular markers are specific segments of DNA, representative of the variation at the 
genome level that correlate with the expression of a phenotypic trait. The choice for an ideal 
molecular marker of a phenotypic trait should be based on the following criteria: 1) being 
polymorphic and evenly distributed throughout the genome, 2) providing adequate resolution 
of genetic differences, 3) generating multiple, independent and reliable markers, 4) being 
simple, quick and inexpensive, 5) requiring small amounts of tissue and DNA samples, 6) 
linkage to unique phenotypes and 7) need no prior information about the genome of the 
organism of interest (Botstein et al., 1980).  
 
Genetic diversity of T. vaginalis and the impact it has on clinical presentations has been 
reported in several studies across the globe, albeit with limited sample sizes. Eight different 
genotypes of the parasite have been identified using the actin gene in restriction fragment 
length polymorphism (RFLP) analysis in Zambia and Kinshasa. (Crucitti, 2008). The study 
however did not clearly indicate whether the variability observed impacted on the clinical 
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presentation. Two distinct clusters of T. vaginalis isolates from asymptomatic and 
symptomatic women in India have been identified and linked to the clinical presentation of 
the infection (Kaul et al., 2004). Although these findings have provided some useful 
information on the genetic population in these regions, the limited sample size used in each 
region means further work would be required with a larger regional sample size to make a 
definitive statistical inference.  
 
The two widely distributed clonal lineages of T. vaginalis may be differentially associated 
with varied clinical outcomes and health sequelae accompanying T. vaginalis (Cornelius et 
al., 2012). Strains or group of isolates of microbial organism exhibit differing clinical 
properties, suggesting the potential for the manifestation of different clinical symptoms and 
infection outcomes by the different population types (Meade & Carlton, 2013). The 
correlation between T. vaginalis genotypes and clinical presentation, as well as susceptibility 
to metronidazole has been demonstrated in previous studies (Vanacova et al., 1997; Snipes et 
al., 2000; Hampl et al., 2001; Rojas et al., 2004; Fraga et al., 2011). However, the evidence 
of association between genotypes and presenting clinical symptoms is not yet definitive. 
While some studies observed clustering of isolates based on their severity of clinical 
symptoms in a phylogenetic analysis, others showed no association (Vanacova et al., 1997; 





1.8 AIMS AND OBJECTIVES OF STUDY 
This study aimed to improve our knowledge of the genotypic and phenotypic variation that 
exists in isolates of Trichomonas vaginalis infecting people in two geographic regions; 
Western Australia and Ghana. Specifically, the study aimed to: 
1) Determine the level of genetic diversity of T. vaginalis in each region. 
2) Examine risk factors for infection by recording demographic data and (for Southern 
Ghana) behavioural and clinical information. 
3)  Assess how the genetic characteristics of isolates impact on the clinical presentations of T. 
vaginalis infection. 
The research questions addressed in this study were: 
1) Are there different species/genotypes of T. vaginalis circulating within the same 
geographical location? 
2) Are there different species/ genotypes of T. vaginalis circulating in the different regions? 
3) Does the genetic variation existing among T. vaginalis isolates in Southern Ghana have 










TRICHOMONAS VAGINALIS INFECTION IN SOUTHERN GHANA: RISK FACTORS 
AND CLINICAL SIGNS ASSOCIATED WITH THE INFECTION 
2.0 INTRODUCTION 
Trichomonas vaginalis is responsible for most non-viral sexually transmitted infections 
worldwide. Globally, an estimated 190 million new cases occur annually (Poole & McClelland, 
2013), mostly in developing countries and socioeconomically disadvantaged groups. The 
infection is associated with a wide range of clinical signs but none are definitive enough for its 
determination, with the commonest being vaginal discharge, vulval irritation, painful urination, 
strawberry punctate cervix, green-yellowish frothy vaginal discharge, and pain during coitus 
(Wølner-Hanssen et al., 1989). Trichomonas vaginalis infection is also associated with adverse 
pregnancy and birth outcomes such as miscarriage, pre-term labour, stillbirth and low birth 
weight, and has been linked with increased HIV susceptibility (Minkoff et al., 1984; Laga et 
al., 1993b; Cotch et al., 1997). Premature membrane rupture has also been reported in some 
cases (Draper et al., 1995; Sangkomkamhang et al., 2008).  
 
Increasing epidemiological evidence has also indicated the potential role of T. vaginalis in both 
acquisition (Johnston & Mabey, 2008) and transmission (McClelland et al., 2007) of HIV, and 
has been estimated to have facilitated 6% - 30% of all new HIV infection cases among African-
American women in the United States (Chesson et al., 2004). In Sub-Saharan Africa, an 
estimated 30 million new cases of T. vaginalis occur each year (WHO., 2001). Recent studies 
among general population in Zimbabwean and Uganda indicated as high as 3-fold HIV 
infection risk among women infection with T. vaginalis (Van Der Pol et al., 2008). Similarly, 
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an increased risk of HIV among T. vaginalis infected women has been reported in Kenya and 
Zaire (Laga et al., 1993a; McClelland et al., 2007)  
 
In Ghana, the National HIV Prevalence amongst pregnant women attending antenatal clinic in 
2016 was 2.4%. Among the young population (15-24 years), a proxy for new infections was 
1.1%. The prevalence by age group 45-49 was highest at 5.6%, followed by 35-39 at 3.5%, 
with 15-19 being the lowest at 0.6%. The regional HIV prevalence ranged from 2.7% in the 
Volta and Brong Ahafo regions as the regions with the highest prevalence to 0.7% in the 
Northern region, the lowest. The prevalence in the Greater Accra Region (GAR) was 2.4%. 
The national HIV prevalence amongst STI clients was 5.4% (Ghana AIDS Commission 
sentinel report, 2016). 
 
Despite the high incidence of T. vaginalis worldwide, there is a paucity of data on regional 
prevalence in most parts of the world. In Ghana, for example, only two previous studies have 
reported prevalence of T. vaginalis infection, with estimates of 5.4% (Adu-Sarkodie, 2004) and 
2.7% (Apea-Kubi et al., 2006). Furthermore, prevalence estimates that are available are 
influenced by the method of diagnosis, age bracket of study subjects, and the sample size 
(Fouts & Kraus, 1980; McLellan et al., 1982). The principal mode of diagnosis for T. vaginalis 
infection is wet preparation microscopy of vaginal fluid specimens, but this technique has a 
sensitivity as low as 50% (Wendel et al., 2002). Although wet preparation microscopy is 
considered the gold standard, a recent study has reported a higher sensitivity for PCR 
techniques (Nabweyambo et al., 2017). Problems with diagnostic sensitivity are compounded 
by the fact that almost 50% or more of women infected with T. vaginalis show few symptoms 
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or are asymptomatic (Fouts & Kraus, 1980; Spence et al., 1980; McLellan et al., 1982), 
thereby resulting in most cases going undetected.  
 
A number of studies have reported risk factors for T. vaginalis infection in women in various 
parts of the world (Mairiga et al., 2011; Ambrozio et al., 2016; Maufi et al., 2016; dos Anjos 
Gatti et al., 2017). These studies found that age, marital status, education and/or occupation 
may be associated with an altered risk of T. vaginalis infection. There has been no previous 
investigation of risk factors for T. vaginalis infections in Ghana and this presents a major 
setback in the management and treatment of the infection in public hospitals and health centres. 
The aim of this study was to estimate the prevalence of T. vaginalis in women attending health 
care clinics in Southern Ghana using two different techniques (microscopy and PCR), and to 
assess the clinical signs, sociodemographic and behavioural risk factors, and pregnancy 




2.1.1 Study design 
A cross-sectional study approach was adopted and carried out in four stages. It involved 
women attending gynaecological clinics in some selected hospitals in Southern Ghana. Cases 
of T. vaginalis were identified by screening the women who attended the gynaecological 
clinics. This helped to establish the association between infection and various socio-
demographic, genital hygiene and sexual behavioural factors as well as assessing the 
association between the infection and various clinical parameters. The study also looked at the 
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genetic strains in circulation, how these strains differ from each other among and within the 
study sites, and how the genetic variation impacts on the virulence of the protozoon. 
 
2.1.2 Study sites 
The study sites were Southern Ghana, which comprised of the Amasaman Municipal Hospital, 
and Mamprobi polyclinic in Greater Accra Region; the South Tongu district hospital and 
Comboni hospital in the Volta Region of Ghana. Fairly high prevalence rate for T. vaginalis 
has been recorded from a pilot study carried out in the South Tongu district in 2013 
(unpublished data). The Greater Region of Ghana on the other hand, has been reported to have 
an estimated prevalence of 2.7 % (Apea-Kubi et al., 2006). The clinical set up in these study 
sites made it possible for the clinical and behavioural data to be obtained from the African 
populations. The selected health centres in the Greater Accra region serve as primary health 
centres and receive clients from the entire Southern Ghana. Study findings from these sites are 
therefore expected to provide an accurate and detailed data on the age, sex, demography, 
clinical presentations, sexual behavioural patterns and history of previous infection. This 
should help the study answer questions on prevalence, incidence of infection by age and 
suburb, clinical presentation and how behavioural risk and demographic factors are associated 
with T. vaginalis infection.  
 
2.1.3 South Tongu district 
South Tongu district is one of the twenty-five districts in the Volta Region and lies in the 
Southern part of Ghana, with Sogakope as its administrative capital (figure 2.1). The district 
lies within the semi- equatorial and dry equatorial climatic zones. The district shares 
boundaries with the Central Tongu District to the north and north- west, the Akatsi South 
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District to the north- east, Keta Municipal to the south and the Dangbe- East District to the 
west and south- west with an area of 448 km2. The South Tongu district serves as a trade centre 
for all the adjoining districts hence, there is daily interaction of people with different 
behavioural practices. This also promotes compromised sexual activities for monetary gains. 
The 2010 population census in Ghana estimated the population of South Tongu at 87,950 
inhabitants, with an annual growth rate of 2.5% which is slightly higher than that of the region 
(Ghana statistical service, 2013). The district has two hospitals, the Sogakope district hospital 
and Comboni hospital and nine health centres. They serve as secondary referral hospitals which 
serve the entire district and adjoining ones as well. Apart from the public health facilities, there 
are other health facilities in the private sector in the district. The study will be located in 
Sogakope where all gynaecological cases from the other towns in the district are referred to. 





Figure 2.1 Map of theVolta Region 
 
2.1.4 Accra metropolis 
Accra is the capital and the largest city of Ghana, with an estimated urban population of 2.27 
million as reported in the 2010 national census report (Ghana statistical service, 2013). The 
Accra Metropolitan Area is the Greater Accra region’s administrative, educational, industrial 
and commercial centre, making it the major force for its population growth, with immigration 
contributing to over 35% of Accra’s population. Accra stretches along the Ghanaian Atlantic 
coast and extends north into Ghana’s interior. It serves as the Greater Accra region’s (the 
capital of Ghana) economic and administrative hub with a total area of 200 square kilometres 
(77 sq mm), (Figure 2.2). Accra is largely occupied by people from all tribes, culture, 
nationality and race, including African nationals and other nationals from all over the world.  
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Health services in Accra are organised around eleven sub-metro health teams, each with a 
hospital or more. The study was conducted at the Family and Sexual health clinics of 
Mamprobi polyclinic and Amasaman Municipal hospital. These are primary and secondary 
health facilities respectively. Apart from these public hospitals, there are other health facilities 
in the public and private sector in the metropolis.  
 
 
Figure 2.2 Map of Accra Metropolis 
 
2.1.5 Recruitment of study participants 
This included women who attended the gynaecology clinic at the selected study sites. This 
population was chosen for convenience and ease to reach. The selected clinic and their staff 
62 
 
were chosen because of their daily handling of gynaecological and reproductive health cases, 
thus the ease to enrol them in the study. 
 
A cross-sectional study approach was adopted and carried out in four stages. It involved 
women attending gynaecological clinics in some selected hospitals in Southern Ghana. This 
helped to establish the association between infection and various socio-demographic, genital 
hygiene and sexual behavioural factors as well as assessing the association between the 
infection and various clinical parameters. Recruitment of study participants and sample 
collection for the study sites in Ghana was from mid-February 2016 to April 2016, and October 
2015 to May 2016 respectively. Inclusion criteria for the study in Ghana were: 
i. Study subjects must be women and attending the gynaecological clinic of the relevant 
health facility. 
ii. They should give their consent of participation independently. 
iii. They should live within the selected study sites. 
Exclusion criteria for the study were: 
i. Women other than those attending the gynaecological clinic. 
ii. Women attending gynaecological clinic but not at the relevant health facility. 
iii. Women living outside the study sites. 
iv. Women who refused to give their consent of participation. 
Study interviewers (nurses/midwives) read out the study information sheet in the local 
language (or language best understood) to the potential study participants. Verbally witnessed 
consent was obtained from those who met the inclusion criteria and agreed to participate in the 
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study. Thumb printed consent was taken. Persons attending the gynaecological clinic were 
assured that non-participation would not affect the care they would receive at the clinic. 
Confidential interviews were conducted with a structured questionnaire (approved by the 
Murdoch University and the Ghana Health Service Human Ethics Committee) which sought 
information on socio-demographic factors, sexual practices and ano-genital hygiene practices 
(see Table 2.1). Participants were then passed on to other study staff for genital examination. 
Study interviewers informed participants on how the collection of vaginal samples will be 
done. They were also informed of being given 2 g metronidazole (single dose) therapy should 
















Table 2.1 Socio-epidemiological variables collected in questionnaire  
 Variable   Type   Range of values (Mean (± SD)) 
Clinical presentation 
Vaginal discharge   Categorical  Yes/No 
Abnormal vaginal discharge Categorical  Yes/No 
Vaginal sores   Categorical  Yes/No 
Vaginal itch   Categorical  Yes/No 
Painful urination   Categorical  Yes/No 
Vulva redness   Categorical  Yes/No 
Strawberry cervix   Categorical  Yes/No 
Discharge colour   Categorical  Clear/Yellowish-green 
Discharge consistency  Categorical  Clumpy/Cheesy 
Discharge frequency  Categorical  Normal/Moderate/Profuse 
Discharge odour   Categorical  Normal/Abnormal 
Pregnancy outcome history 
Miscarriage   Categorical  Yes/No 
Still birth   Categorical  Yes/No 
Risk factors 
Age    Continuous  (28.9±9.1) 
Educational level   Continuous  <HS/HS/Tertiary 
Marital status   Categorical  Yes/No 
Occupation   Categorical  Stud/trad/HW 
Region of residence  Categorical  urban/rural 
Pregnancy history  Categorical  Yes/NoTreatment mode for vaginal  
Sore    Categorical  Orth/Herb/DouchingTreatment mode for vaginal  
Discharge   Categorical  Orth/Herb/Douching 
Cleaning pattern after 
visiting the toilet   Categorical  Back-Front/Front-Back 
Cleaning material after 
toilet    Categorical  Toilet tissue, cloth, paper (other than toilet tissue) 
Age at first sex   Continuous  (18.8±2.8) 
Oral sex practice   Categorical  Yes/No 
Saliva lubrication during  
sexual intercourse  Categorical  Yes/No 
Multiple sexual partners  Categorical  Yes/No 






2.1.6 Vaginal examination and sampling 
Vaginal sampling was done in selected gynaecology health facilities in Ghana by trained, 
experienced midwives. The vaginal examination and specimen collection procedure were 
thoroughly explained to participants. A total of two vaginal swab samples per participant were 
taken. Vaginal examination was undertaken under illumination and participants partially 
undressed.  
 
The genitalia external was examined for any discharge, ulcer and/or vesicles and other 
pathologies. With a vaginal speculum carefully inserted, discharges and/or ulcers were 
observed in the vagina and cervix (especially punctate haemorrhage, characteristic of T. 
vaginalis infection). Two swabs from the posterior fornix were taken per participant and put in 
respective labelled tubes. All specimens were sent to the on-site laboratory immediately for 
examination. Examination findings were recorded on the Study Examination Form and 
forwarded to clinicians for treatment to commence. Abnormal discharge was defined as one 
with an abnormal odour and any colour other than clear. The quantity of discharge was 
described as normal (no noticeable discharge) or abnormal (copious discharge). A total of 1000 
vaginal samples (two pair participants) were taken from all the study sites. 
 
2.1.7 Metronidazole treatment 
Oral metronidazole (2 g stat) was administered to all study participants in Ghana in whose 
specimen T. vaginalis was detected by wet preparation microscopy at the end of each day. 
Participants, as a precautionary step, were counselled to stay away from alcohol for 48 hours 
after ingestion of the drug and to also abstain from sexual intercourse for seven days.  
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2.1.8 Storage of swabbed specimen 
One of each vaginal swabs collected from Ghana was kept in a dry sample tubes and stored at -
20°C for wet preparation microscopy examination. The other vaginal swabs were stored in 
TYM media, incubated at 37°C and transported to the molecular laboratory of the School of 
Biomedical and Allied Health Sciences, Korle-bu, Accra, Ghana for DNA extraction. The 
DNA extracts were shipped subsequently on dry ice to Murdoch University in Perth, and used 
in nucleic acid amplification tests. 
 
2.1.9 Laboratory analysis 
2.1.9.1 Wet preparation examination 
Sterile normal saline (0.9%) was added to one of the vaginal swabs obtained during vaginal 
examination and agitated. A drop of this was placed on a clean, dry grease-free slide and 
covered with a clean cover slide. This was initially scanned with the 10x objective light 
microscope for motile trichomonads, pus cells, epithelial cells and red blood cells, and then 
motility, flagella movement, and morphological features of T. vaginalis was confirmed with 
the 40x objective lens. 
 
2.1.9.2 DNA extraction 
Genomic DNA from 900 vaginal swabs for T. vaginalis isolate was extracted using QIAmp 
mini kit commercial kits (Qiagen, Australia), adhering to manufacturer’s instruction. 




2.1.9.3 Initial Polymerase Chain Reaction (PCR) Screening 
Five hundred DNA extracted samples from Ghana were taken through initial PCR screen at 
SABC to confirm the presence of T. vaginalis.  
Amplification of DNA extract was performed in a programmed thermo-cycler using primer-
Tryptophan(P1a)(5’CGTCAACATCGGTGGCTTCA3’/3’GCGACAGCGACGACATTCAT5’
) designed to amplify gene fragments of 489bp (protocol adopted from Cornelius et al (2012), 
and slightly modified). The PCR mixture consisted 1.25 U Taq DNA polymerase, ×1 PCR 
Buffer (MgCl2 free), 2 mM MgCl2, 0.2 mM of each deoxynucleotide triphosphate, 2 μL of 
DNA template, and 1 μM of each primer with PCR-grade water to make up a final volume of 
25 μL. Negative controls consisting of PCR mix with primers but no DNA template and a 
positive control from a known T. vaginalis reference strain were included in all PCR runs. PCR 
was performed with 1 cycle of 95°C for 5 min, followed by 40 cycles 95°C for 1min, 45 s of 
annealing at 60°C, and 1.5min of extension at 72°C, followed by final extension step at 72°C 
for 10 min. Two microliter (2μl) of each reaction was visualized on a 1% agarose gel to verify 
amplification.  
 
2.1.10 Data analysis 
All analyses were performed using the R statistical package (R Development Core Team 2013). 
Infection prevalence (with 95% confidence intervals calculated assuming a binomial 
distribution) was estimated from both microscopy and PCR data, and proportion of infected 
women were compared between diagnostic methods using a Fisher exact test. 
 
The relationship between infection with T. vaginalis, as determined by PCR (the more sensitive 
diagnostic technique; see Results), and epidemiological variables was investigated separately 
for clinical signs, previous childbirth history and risk factors for infection. First, for each set of 
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variables the association with infection status was examined by univariable tests (Fisher exact, 
Chi-squared or logistic regression) and an odds ratio calculated. For the clinical signs and risk 
factors variable set, those variables showing at least a moderate relationship with infection 
status (P < 0.3) were retained for a generalised linear model (GLM) analysis, with a binomial 
response variable (T. vaginalis infection present or absent) and a logit link function. Prior to 
GLM analysis, correlations among predictor variables were examined by Spearman’s Rho; and 
for any variables which were strongly correlated (ρ > 0.6), only one was retained for analysis. 
The significance of each predictor variable in the GLM was examined by a likelihood ratio test. 
In addition, I used a multimodel inference approach to determine the relative importance of 
predictor variables (Burnham & Anderson, 2002). A set of all possible models was generated 
from the full GLM using the R package MuMIn (Bartoñ, 2013). Models were then ranked by 
the Akaike Information Criterion, corrected for small sample size (AICc), and model averaging 
was performed using MuMIn across all models within three AICc values of the best model. 
The importance of each variable was determined by summing Aikaike likelihood weights 
across all models within the top ranked set in which the variable occurred, providing the 





2.2.1 Prevalence of T. vaginalis in women from southern Ghana 
A total of 492 women were enrolled in the present study. Of these, 290 (58.9%) were from the 
Volta region and 202 (41.1%) were from the Greater Accra region. The mean age of the 
participants was 28.5±8.0 years for the Volta region and 29.8±9.3 years for the Greater Accra 
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region. Of the study subjects from the Volta region, 76.3% (213/279) have had less than 12 
years of education (below senior high school education), while 23.7% (66/279) have had more 
than 21 years of education (senior high school and beyond). In the Greater Accra region, 67.8% 
(137/202) and 37.2% (65/202) of the subjects had history of education level below and above 
12 years respectively. Among the Volta subjects, 63.1% (176/279) were married and36.9% 
(103/279) were unmarried. The study subjects from the greater Accra region were made up of 
25.3% (51/202) (19.8-31.7%) married and 74,8% (151/202) unmarried women. 
 
The overall prevalence of T. vaginalis infection was 13.2% (65/492) (95% CI 9.5-17.6%) by 
wet mount microscopy and 18.1% (89/492) (95% CI 12.2-21.1%) by PCR. There was a 
significant difference in positivity rate between the two techniques (Fisher exact test, P 
<0.001). All samples which tested positive by wet mount microscopy were also positive by 
PCR, while an additional 13 samples which were negative by microscopy were positive by 
PCR.  
 
The regional prevalence of T. vaginalis infection by PCR was 21.7% (62/290) (95% CI 17.1-
26.9%) for the Volta region and 12.8% (26/202) (95% CI 8.6-18.3%) for the Greater Accra 
region. There was no significant difference in prevalence between the two regions (Fisher exact 
test, P =0.09).  
 
2.2.2 Association with epidemiological factors 
Eleven subjects who provided inadequate sociodemographic data were excluded from analyses, 
leaving 481 (78 positive and 403 negative) samples. Univariate analyses showed no significant 
association between any of the presenting clinical signs with the presence of T. vaginalis 
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(Table 2.2). Generalised linear model analysis of those predictor variables with P <0.30 
showed a residual deviance of 404.5 on 473 degrees of freedom, suggesting that no correction 
was necessary for overdispersion. The only significant effect was for vaginal itch (Table 2.3). 
Vaginal itch was also ranked highest in variable importance, occurring in 62% of the top eight 
AICc models; the only other variables to occur in the top set of models were discharge colour 
and discharge consistency (Table 2.3). Of the 89 infected participants in the study, 33 (37.1%) 
presented with vaginal itch, 61 (68.5%) presented with some sort of abnormal vaginal 
discharge, 45 (50.6%) with frothy malodorous discharge, and 22 (24.7%) with yellowish-green 
discharge. 
 
Trichomonas vaginalis infection was associated with vaginal itch (OR = 1.71, P = 0.04) and 
history of engaging in oral sex (OR = 1.90, P = 0.04). There was a significant association 
between the presence of T. vaginalis and previous history of still birth (OR = 3.62; χ21 = 4.39, 
P = 0.04), but not with prior history of miscarriage (χ21 = 0.15, P = 0.69) (Table 2.2).  
 
Univariate analyses found no significant associations between any of the sociodemographic 
and behavioural risk factors with the presence of T. vaginalis (Table 2.2). There was a strong 
correlation between treatment modes for vaginal sores and vaginal discharge, so only the 
vaginal sore treatment mode was included in the GLM analysis. The full GLM for those 
predictor variables with P <0.30 in the univariate analysis had a residual deviance of 410.6 on 
479 degrees of freedom, again indicating that the data were not overdispersed. The only 
variable with a significant effect was oral sex; people with a documented history of engaging in 
oral sex were more likely to be positive for T. vaginalis (Table 2.4). This was also ranked 
highest in variable importance (72%), with three other variables also occurring in the top 
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ranked set of models: cleaning material after toilet (66%), with using pieces of dirty cloth as 
cleaning material associated with a greater likelihood of infection; educational level (53%), 
with a lower level of education associated with a greater likelihood of infection; and treatment 























Table 2.2 Odds ratios and significance of association of each epidemiological variable with 
Trichomonas vaginalis infection. Variables with significant association in bold. 
Variable  Frequency TV+(%) Odds ratio  P-value  
Clinical signs 
Vulva redness      1.46  0.40 
Yes   48  10 (20.6) 
No   433  68 (15.7) 
Painful urination     1.02  1.00 
Yes   116  19 16.4) 
No   365  59 (16.2) 
Present vaginal discharge    1.17  0.65 
Yes   381  60 (15.8) 
No   100  18 (18.0) 
Strawberry cervix     1.61  0.23 
Yes   53  12 (22.6) 
No   428  66 (15.4) 
Vaginal sores      1.35  0.38 
Yes   113  15 (13.3) 
No   368  63 17.1) 
Vaginal itch      1.71  0.04* 
Yes   238  30 (12.6) 
No   243  48 (19.8) 
Discharge colour     1.64  0.08 
Whitish   371  54 (14.6) 
Greenish-yellow  110  24 (21.8) 
Vaginal discharge odour     1.36  0.27 
Normal   234  33 (14.1) 
Frothy   247  45 (18.2) 
Discharge consistency     1.52  0.10 
Clumpsy  205  40 (19.5) 
Cheesy   276  38 (13.8) 
Discharge frequency     1.67  0.10 
Copious   131  15 (11.5) 
Normal   350  63 18.0) 
Pregnancy outcome 
Miscarriage      1.12  0.69 
Yes   121  21 (17.4) 
No   360  57 (15.8) 
Stillbirth      3.62  0.04* 
Behavioural and demographic factors 
Age       1.07  0.86 
≤ 21yrs   70  12 (17.1) 
≥ 21yrs   411  66 (16.1) 
Education      1.45  0.22 
< 12yrs   348  61 (17.5) 
≥ 12yrs   133  17 (12.8) 
Marital status      1.19  0.54 
Single   254  44 (17.3) 
Married   227  34 (14.9) 
Region       1.55  0.09 
Greater Accra  202  26 (12.9) 




Table 2.2 (Cont’d) Odds ratios and significance of association of each epidemiological variable 
with Trichomonas vaginalis infection. Variables with significant association in bold. 
Variable  Frequency TV+(%) Odds ratio  P-value  
Saliva as lubricant     1.15  0.73 
Yes   75  11 (14.7) 
No   406  67 (16.5) 
Age at first sex      1.21  0.46 
≤ 18yrs   252  44 (17.5) 
≥ 18yrs   229  34 (14.9) 
*Multiple sex partners     1.31  0.78 
Yes   23  3 (13.0) 
No   458  75 (16.4) 
Pregnancy history     1.55  0.19 
Yes   365  64 (17.5) 
No   116  14 (12.1) 
Previous vaginal sore treatment    0.52  0.15 
Yes   62  6 (9.7) 
No   419  72 (17.2) 
Occupation      2.52  0.62 
Student   49  9 (18.4) 
Trader   188  32 (17.0) 
House wife  68  14 (20.6) 
Farmer   44  5 (11.4) 
Professional  132  18 (13.6) 
Oral sex      1.90  0.04* 
Yes   73  18 (24.7) 
No   408  60 (14.7) 
Vaginal discharge treatment mode   0.90  0.71 
Tablets   270  42 (15.6) 
Douching  211  36 (17.1) 
Vaginal sore treatment mode    3.22  0.06 
Tablets   432  75 (17.4) 
Douching  49  3 (6.1) 
Toilet cleaning material     1.82  0.12 
Tissue paper  386  68 (17.6) 
Piece of cloth  95  10 (10.5) 
NB: Eleven (11) participants, positive for T. vaginalis with incomplete data were excluded from this analysis. The 
total sample size and positives for T. vaginalis used for this analysis were 481 and 78 respectively.  









Table 2.3 Association of clinical signs with Trichomonas vaginalis infection from GLM 
analysis and model averaging.  
Source    Z value  P value Importance 
Vaginal itch   2.11   0.04*  0.62 
Discharge colour  1.14   0.25  0.57 
Discharge consistency 0.17   0.07  0.53 
Discharge frequency  0.63   0.14  0 
Strawberry cervix  1.56   0.19  0 
Discharge colour  1.14   0.25  0 
Vulvar redness  0.20   0.61  0 
*statistically significant (P-value <0.05).  
Variables are ranked by relative importance, which is the probability if selection in the AIC 
best-fit model. Variables significant in the global model are shown in bold. 
 
 
Table 2.4 Association of behavioural and demographic variables with Trichomonas vaginalis 
infection from GLM analysis and model averaging.  
Source     Z value P value Importance 
Oral sex    1.96  0.04*  0.72 
Cleaning material after toilet  1.22  0.10  0.66 
Education    1.46  0.10  0.53 
Treatment mode   1.82  0.07  0.38 
Variables are ranked by relative importance, which is the probability if selection in the AIC 




The overall prevalence of T. vaginalis infection in this study was 13.2% and 18.1% by wet 
mount microscopy and PCR respectively, with a significant difference in sensitivity between 
the two techniques. Regional prevalence of T. vaginalis infection by PCR was 21.7% and 
12.8% for Volta and Greater Accra region respectively, with a significant difference in 
prevalence between the two regions. Vaginal itch and a history of oral sex were the only 
variables found among the presenting clinical signs and behavioural risk factors to have a 
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strong association with T. vaginalis infection in this study, although infection was also 
associated with a previous history of still birth.  
 
2.3.1 Prevalence  
Trichomonas vaginalis infection is the most prevalent non-viral sexually transmitted infection 
worldwide (Menezes et al., 2016). In spite of this, the regional prevalence of the infection is 
yet to be established in most parts of the world, including Ghana; most likely due to the 
absence of national routine screening, management and control programmes as exists for other 
sexually transmitted infections. In most parts of the globe, T. vaginalis infection has not been 
considered a high health risk and has received little or no attention with regard to public health 
and clinical intervention (Van Der Pol, 2007). However, the high prevalence of T. vaginalis 
infection and the associated severe health sequelae observed in recent times requires a more 
coordinated national programme, similar to other STIs. 
 
In this study, the prevalence of T. vaginalis was higher than reported in the two other studies 
which have been conducted in Ghana (Adu-Sarkodie, 2004; Apea-Kubi et al., 2006) (see Table 
2.5). These previous studies sampled from only a single hospital and used serological and wet 
mount techniques to detect infection. The present study, by contrast, sampled women visiting a 
number of hospitals and clinics, and utilised both wet mount microscopy and PCR for 
diagnosis. The study found PCR to be a more sensitive diagnostic method, a finding which has 
also been reported by other studies (Wendel et al., 2002; Piperaki et al., 2010; Patil et al., 
2012). Because our study population was drawn from women visiting STI and gynaecological 
clinics, the prevalence found is likely to be greater than in the general female population in 
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Ghana, although it is similar to prevalence reported elsewhere in sub-Saharan Africa (see Table 
2.5). 
Table 2.5 Prevalence of T. vaginalis in Ghana and other countries in Sub-Saharan Africa  
Country  City  Study group  Prevalence Reference 
South Africa  Durban  women in high-risk 14.6  (Abbai et al., 2016) 
South Africa  Mopani  non-preg women  20.0  (de Waaij et al., 2017) 
Nigeria   Maidugri Pregnant women  10.99  (Mairiga et al., 2011) 
Nigeria     Pregnant women  18.7  (Oyeyemi et al., 2016) 
Nigeria   Abeokuta Pregnant women  10.3  (Etuketu et al., 2015) 
Southwest Ethiopia   Pregnant women  4.98  (Eshete, 2013) 
North-western  Mwanza  Pregnant women  10.41  (Maufi et al., 2016) 
Tanzania 
     High-risk women  19.0  (Francis SC et al., 2014) 
Kenya   Nairobi  Pregnant women  40.0  (Mullick et al., 2005) 
Ghana   Accra  Pregnant women  2.7  (Apea-Kubi et al., 2006) 
   Kumasi  Pregnant women  5.4  (Adu-Sarkodie, 2004) 
 
2.3.2 Association with clinical signs 
There was very little consistency in presenting signs of infection reported by participants in this 
study. Only vaginal itch showed a significant association with T. vaginalis infection, although 
the colour and consistency of vaginal discharge also featured in a high proportion of the top 
ranked GLMs. Other studies have also found that clinical manifestation of T. vaginalis 
infection is varied, with frothy, malodourous vaginal discharge and strawberry cervix being the 
most useful predictive signs for clinical diagnosis of infection (Fouts & Kraus, 1980; Wølner-
Hanssen et al., 1989). In this study, despite the variations in clinical signs among the study 
subjects, vaginal discharge and frothy malodourous discharge were presented in more than half 
of the cases, with less than a fifth of them presenting with strawberry cervix. This variation in 
clinical signs could be due to a number of reasons, including genetic polymorphism in the 
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parasite (Alderete et al., 1986; Rojas et al., 2004) and changes in signs with stages of the 
infection. For example, development of strawberry cervix is progressive with T. vaginalis 
infection, initially developing as an irritable erythema and then progressing into group of small 
punctate haemorrhagic spots of strawberry appearance on the vagina close to the mucosa of the 
cervix (Fouts & Kraus, 1980; Wølner-Hanssen et al., 1989). The clinical signs associated with 
T. vaginalis infection could also be related to the menstrual cycle (Simoes-Barbosa et al., 
2005). It is also possible that clinical signs could be altered with varying incubation period of 
the parasite and the presence of other infectious agents (Eshete, 2013; Maufi et al., 2016). 
Other plausible explanations for the variability in clinical presentations among infected 
participants in this study could be coinfections (for example, with HIV or other infectious 
agents) or repeated exposure to T. vaginalis from infected male sex partners who are not being 
treated for T. vaginalis infection. 
 
The absence of a positive association between most of the presenting signs and T. vaginalis 
infection is not unexpected considering the diverse aetiology of vaginal discharge but could 
have serious implications for a syndromic approach to managing infection, potentially resulting 
in under or over treatment, prolonged infection and increased spread in the population. This 
suggests the need for routine and structured screening and treatment approach to improve the 
recovery rate of T. vaginalis infection in asymptomatic women visiting the health and antenatal 
clinics in Ghana, incorporating T. vaginalis into the existing national health centre-based STI 
screening, testing and treatment programs as well as the approved national antenatal screening 
tests list. This will improve the recovery rate of T. vaginalis infection in asymptomatic and 
symptomatic women visiting health and antenatal clinics in Ghana.  
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2.3.3 Association with childbirth history 
A previous history of still-birth was significantly associated with current T. vaginalis infection 
in this study. Although we had no records to indicate previous history of T. vaginalis infection 
(i.e. at the time of the stillbirths), it is possible that these women might have had the infection 
over a long period of time without manifesting any symptoms and that this might have 
contributed to the adverse pregnancy outcome. Adverse pregnancy outcomes have been 
associated with T. vaginalis infection in previous studies (Minkoff et al., 1984; Draper et al., 
1995; Cotch et al., 1997; Sangkomkamhang et al., 2008). The mechanism by which T. 
vaginalis infection contributes to stillbirth is not known. An association has been found, 
however, between premature membrane rupture, which is sometimes associated with T. 
vaginalis infection, and intrapartum stillbirth (Yang et al., 2004). Further study is required to 
determine the risk posed to childbirth by infection with T. vaginalis and to help understand the 
underlying mechanisms of any association. 
 
2.3.4 Association with sociodemographic/behavioural risk factors 
The only risk factor significantly associated with T. vaginalis infection in our study was a 
previous history of engaging in oral sex, although there was some evidence of association with 
a lower level of education, using pieces of dirty cloth as cleaning material after the toilet and 
douching as treatment mode for vaginal discharge. It is important to note that the term “risk 
factor” in this study refers only to an association with infection and does not imply a direct 
causal relationship. 
 
It is not clear how engaging in oral sex may increase the risk of infection or whether there 
could be other underlying confounding factor(s). Trichomonas vaginalis is believed to be 
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confined to the urogenital tract and primarily transmitted through heterosexual vaginal 
intercourse, although other forms of transmission cannot be completely excluded– recent case 
of Trichomonas vaginalis causing oropharyngeal trichomoniasis in a male patient with a 
history of engaging in oro-vaginal sex with an infected female partner has been reported 
(Carter-Wicker et al., 2016). It is possible that oral sexual activity is correlated with 
unmeasured, confounding factors, but this is speculative at this stage. Previous studies have 
found evidence for an increased risk of T. vaginalis infection with decreased educational level, 
although the association was not strong (Yoshikawa, 1981; de Waaij et al., 2017). The linkage 
existing between level of education and sexually transmitted infection is not clearly 
understood. It is possible that persons with a lower level of education have limited knowledge 
on safe sexual hygiene and practices, although there could also be other confounding factors 
such as poverty and multiple sexual partners. The weak association of douching with T. 
vaginalis infection found in this study, agrees with findings from other studies (Sutton et al., 
2007; Luo et al., 2015). 
 
Although we found no association between infection and age, some studies have reported an 
increased risk of infection with aging (Yoshikawa, 1981, 1983, 1997; Casau, 2005). High 
prevalence among older age groups (>40 years) may be related to biological and hormonal 
changes resulting in thinning of the vaginal mucosa wall (which acts as barrier against 
infection) (Bachmann & Leiblum, 2004) increasing the risk of mucosal tear during sexual 
activity, thereby increasing the risk of infection. In contrast, other studies have found an 
increased frequency of infection among younger age groups, which could be attributed to 






POPULATION STRUCTURE AND GENETIC DIVERSITY OF TRICHOMONAS 
VAGINALIS AND THE CORRELATION WITH CLINICAL PRESENTATIONS 
3.0  INTRODUCTION 
Trichomonas vaginalis, a protozoan parasite is the causative agent of the most prevalent non-
viral sexually transmitted infection globally (Schmid et al., 2011) and infects over 275 million 
people each year (Rowley et al., 2012). The prevalence of the infection is, however, 
underestimated due to up to one half of cases being asymptomatic (Matini et al., 2017). The 
parasite infects both sexes with varied clinical presentations. In females, for example, the 
infection presentation ranges from asymptomatic to severe symptoms including vaginitis, vulva 
itch, vulva redness, strawberry cervix, urethritis and vaginal discharge (Wølner-Hanssen et al., 
1989), coupled with adverse pregnancy outcomes such as premature membrane rupture, still 
birth, miscarriages and low birth weight in some cases (Draper et al., 1995; Cotch et al., 1997; 
Guenthner et al., 2005; Swadpanich et al., 2008; Chinyere et al., 2012). In men, T. vaginalis 
infection is known to cause infertility, chronic prostatitis, and non-gonococcal urethritis 
(Krieger, 1999; Hobbs et al., 2006).  
 
The existence of different genotypes of T. vaginalis has become evident over the last decade 
(Meade et al., 2009; Conrad et al., 2012; Matini et al., 2012; Hawksworth et al., 2015; Mao & 
Liu, 2015; Masha et al., 2017) and may contribute to the varied clinical presentations observed 
in T. vaginalis infections. Although some studies have been conducted to assess the existence 
of genetic diversity of T. vaginalis in various countries (Meade et al., 2009; Conrad et al., 
2012; Cornelius et al., 2012; Matini et al., 2012; Hawksworth et al., 2015; Masha et al., 2017), 
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there still remain vast regions of the globe with no existing data. This presents a major setback 
to appropriate and effective control, management and treatment of the infection. 
 
Trichomonas vaginalis has a large genome, with an estimated size of 160 megabases and 
60,000 genes over six chromosomes (Woehle et al., 2014). Previous studies have reported two 
consistent outcomes: the existence of genetic heterogeneity at the regional and global level and 
the identification of two major genetic groups (types 1 and 2) (Snipes et al., 2000; Meade et 
al., 2009; Conrad et al., 2012; Cornelius et al., 2012). These genetic groups have been 
associated with different phenotypic traits: type 1 is more frequently found to be infected with 
T. vaginalis virus (TVV) and is linked with greater pathogenicity and type 2 is associated with 
increased metronidazole resistance (Snipes et al., 2000; Conrad et al., 2012). Type 1 is 
believed to be the ancestral lineage, with type 2 diverging from a type 1 clade (Conrad et al., 
2012). Their distribution has been found to be in equal proportions in regions where studies 
have been conducted, raising questions about the factors responsible the origin and persistence 
of the two types (Conrad et al., 2012).  
 
The persistence of the two genetic lineages of T. vaginalis and their phenotypic association 
suggests the need for the use of a more robust and sensitive method to assess the distinguishing 
features of these groups in studies on the epidemiology of T. vaginalis infection. Over the last 
two decades, several studies have utilised different techniques to study the genetic diversity of 
T. vaginalis, including restriction fragment length polymorphism (RFLP) (Oliaee et al., 2017), 
random amplified polymorphic DNA analysis (RAPD, internal transcribed spacer analysis 
(ITS) (Snipes et al., 2000; Ibanez-Escribano et al., 2014), microsatellite analysis (Cornelius et 
al., 2012) and multi-locus sequencing typing (MLST) (Hawksworth et al., 2015; van der Veer 
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et al., 2016). Multi-locus sequence typing has high discriminatory properties coupled with 
reproducibility and Conrad et al. (2012) used this method based on seven house-keeping genes 
and single nucleotide polymorphism (SNP) to identify individual sequence type (ST) 
combinations in T. vaginalis (Conrad et al., 2012). 
 
In this study, next generation-multi-locus sequence typing ( NG-MLST) was used to examine 
diversity in T. vaginalis in two countries where there is currently very limited genetic 
information: Australia and Ghana. The aim was to ascertain the different genotypes of T. 
vaginalis circulating in the general population in these countries. With the increasing 
prevalence and severe health sequelae associated with T. vaginalis infection, it is hoped that 
this genetic knowledge will contribute to the epidemiology, public health and clinical 




3.1.1 Study sites and sample collection 
The sampling for Australia (Western Australia and the Northern Territory) was undertaken at 
Western Diagnostics, in Perth where most of the Western Australian and the Northern Territory 
gynaecological diagnostic cases are sent for testing. Western Australia is a state occupying the 
western third of Australia and bounded by the Indian Ocean to the north and west, the Great 
Australian Bight and Southern Ocean to the south, the Northern Territory to the north-east and 
South Australia to the south-east (Figure 3.1). It has a total land area of 2,529.875 sq km with 
Perth as its capital city. The population of Western Australia as of June 2014 stood at 2.6 
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million (Australia bureau of statistics, 2014) and this is made up of the indigenous Aboriginal 
population as well as people from different nationalities. The Northern Territory has a total 
land area of 1,349,129 sq km. with an estimated population of 244,000 as of June 2015. 
Eighty-nine archival vaginal swab samples positive for T. vaginalis by PCR were collected 
between November 2015 and June 2016. In Ghana, sampling was undertaken in the Volta and 
Greater Accra regions of Southern Ghana. Sampling in Ghana is described in the previous 
chapter (Ghapter 2.1.6). 
 
3.1.2 Genomic DNA extraction 
Genomic DNA from the vaginal swabs positive for T. vaginalis was extracted using QIAmp 
mini kit commercial kits (Qiagen, Australia), following the manufacturer’s instructions. 
Extraction was done under strictly controlled conditions (use of safety cabinet hood, laboratory 
protective clothing, sterile disposable gloves and sterilised pipette tips, changed in between 
samples) to minimize laboratory-introduced contaminations from biological contaminants or 
PCR amplicons. 
 
3.1.3 PCR amplification and metabarcoding 
Trichomonas multi-locus gene sequences were PCR amplified from human vaginal samples 
using primers specific to seven housekeeping genes (Table 3.1). The multi-locus PCR primers 
also contained Illumina MiSeq adapter sequences on the 5’ end, as per the MiSeq platform 
standard protocols (Illumina Demonstrated Protocols: Metagenomic Sequencing Library 
Preparation). Selection of the seven housekeeping genes was based on two factors: their ability 
to be easily amplified and sequenced on both DNA strands and their previously reported 
genetic diversity (Cornelius et al., 2012). 
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Amplification of all genes was carried out as follows: 1.25 U Taq DNA polymerase, ×1 PCR 
Buffer (MgCl2 free), 2 mM MgCl2, 0.2 mM of each deoxynucleotide triphosphate, 2 μL of 
DNA template, and 1 μM of each primer with PCR-grade water to make up a final volume of 
25 μL. No template controls were included in the PCR runs. The amplification protocol was 
adapted from Cornelius et al (2012) and was the same for all loci. Amplification was 
performed with one cycle of 95°C for five minutes, followed by 40 cycles 95°C for one minute, 
45 s of annealing at 60°C, one and a half minutes of extension at 72°C and final extension step 
at 72°C for ten minutes. 
 
Amplification of a single product was confirmed by gel electrophoresis using 2% agarose gel 
containing SYBR safe Gel Stain (Invitrogen, USA), visualized with a dark reader trans-
illunimator (Clare Chemical Research, USA), and products corresponding to the correct length 
were selected for further analyses. Multi-locus amplicons from each sample were uniquely 
indexed with DNA barcodes and prepared for sequencing according to Illumina recommended 
protocols (Illumina Demonstrated Protocol: Metagenomic Sequencing Library Preparation).
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Table 3.1 Oligonucleotide primers used for T. vaginalis MLST 
     Primers       Size (bp)  
Locus (abbreviation)   Orientation Sequences (5’-3’)    Gene Amplicon 
Tryptopanase (P1)a   Forward CGTCAACATCGGTGGCTTCA  1,451 498 
     Reverse GCGACAGCGACGACATTCAT 
Glutaminase (P3)   Forward GTGCCATTACAACAGCATCG  886 451 
     Reverse CCAAGTATAGCTCCGCTGAC 
Family T2 aparaginase-like  Forward GAACAGGAGCACCAGCAGAA  990 412 
Threonine peptase (P6)  Reverse TCTCTAGCAACGCAGCCAAC 
Alanyl tRNA syn-   Forward TCTGTCCAGGATGGTGTCTT  3,075 494 
thetase (P8)    Reverse ACGCCTTCCTCCTTCATCTT 
DNA mismatch   Forward TCATCGGCCAATGGAACCAA  1,758 491 
repair protein (P13)b   Reverse TCCGTGCGGACAATTCCAAG 
Serine hydroxymethyl-  Forward GCTGAGTGACGGTGGACATT  1,356 449 
transferase (P14)   Reverse GAAGATGAGGTCCTCCTTGA 
Manose 6-phosphate   Forward AGCCAGTTGGCTTCTGAGTT  1,128 459 
isomerase (P16)   Reverse AACAATTCCGCAAGCTGGAC  
a Determined to have likely resulted from lateral gene transfer  (Conrad et al., 2011). 
b Single-copy gene used for population genetics analysis of T. vaginalis (Cooper & Feil, 2006; Cooper et al., 2008; Cornelius et al., 2012).
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3.1.4 Purification and quantification of barcoded PCR products 
Twenty-five microliters (25µl) of the indexed PCR products was purified by adding 28µl of 
Agencourt AMPure XP magnetic particle suspension (Agencourt Bioscience Corporation, 
Beckman Coulter, Beverly, Massachusetts, USA) in a reaction plate. The mixture was 
incubated at room temperature for five minutes. The reaction plate was then placed onto an 
Agencourt SPRIPlate Super Magnet Plate for two minutes to separate the beads from the 
solution. The supernatant was aspirated from the reaction plate on the magnetic plate and 
discarded. The beads were resuspended with 200 µl of 70% ethanol and incubated at room 
temperature for 30 seconds on the magnetic plate. The ethanol was aspirated at the end of the 
incubation period and the process repeated twice. The reaction plate was taken off the magnetic 
plate and 20 µl of elution buffer dispensed into reaction well containing magnetic beads. The 
mixture was incubated at room temperature for two minutes. The reaction plate was placed 
back on the magnetic plate for one minute to separate the beads from the solution. The final 
solution (purified product) was transferred into a new well plate. 
 
The purified PCR products were quantified using Invitrogen Qubit dsDNA HS Assay kit 
(ThermoFisher Scientific, USA) and measured with Qubit 2.0 fluorometer (Life Technologies, 
USA). The quantified products were normalised and sequenced on an Illumina MiSeq using 





3.1.5 Quality filtering and taxonomic assignment 
Raw paired-end reads were merged with USEARCH v. 9.2 (Edgar, 2017) with a minimum of 
50 bp overlap and no gaps allowed in the merged alignments. Only sequences that contained 
perfect (no mismatches) primer sequences were retained for analysis, and primer sequences and 
distal bases were trimmed from the sequences in Geneious v. 11.3 (Biomatters, New Zealand). 
Sequences were then quality filtered to allow only reads with < 1% expected error as calculated 
with USEARCH v. 9.2 fastq filter algorithm, and sequences > 300 nt remained in the dataset. 
Sequences with ≤ 10 replicate reads were also removed from the dataset. Chimeras were 
removed and sequences were denoised with UNOISE2 (Edgar, 2017) into zero-radius 
operational taxonomic units (ZOTUs). Taxonomic assignment was performed by aligning 
ZOTUs to a reference database of known T. vaginalis MLST reference sequences downloaded 
from GenBank (April/2018). This step was done to classify each ZOTU to an assigned 
taxonomic allele sequences using BLAST algorithm (stringency set at ≥99%). Sequences from 
individual isolates were concatenated and aligned to identify single nucleotide polymorphisms 
(SNPs), and allele names at each locus assigned based on unique SNP profiles. Sequence types 
(STs) were assigned based on unique allelic profiles, following the 60 STs previously 
identified (Cornelius et al., 2012) by aligning sequences with their reference sequences 
(GenBank accession numbers JX239643–JX239693). Allelic profiles were then assigned to 
isolates. The alleles were uploaded into the online sequence query software for T. vaginalis 
(http://pubmlst.org) to generate the sequence types (ST) for each isolate. New ST numbers 
were followed on consecutively from those previously described (Cornelius et al., 2012). 
 
3.1.6 Population genetics and phylogenetic analysis 
The discriminatory power of the MLST scheme was measured with Simpson’s index of 
diversity (Grundmann et al., 2001), using an online resource 
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(http://darwin.phylovis.net/ComparingPartitions). This measured the ability of the MLST tool 
used in this study to differentiate and assign the unique sequences at different loci.  Nucleotide 
diversity of sequences at individual loci were measured with Tajima’s estimator (θπ) (Tajima, 
1983). The Bayesian clustering program STRUCTURE 2.3.3 (Pritchard et al., 2000) was used 
to infer the number of populations K that isolates belong to according to allele frequencies at 
each locus. This program performs model-based analysis to assign isolates to populations, 
making use of MLST data. The admixture model was used with correlated allele frequencies to 
assess ancestry, whereby each isolate draws some fraction of its genome from each of K 
populations for a defined set of K values. STRUCTURE was run ten times for each of 11 K 
values (K = 1–11) with a burn-in period of 100 iterations, followed by a further 100 iterations. 
The DK method was used to infer the true number of populations to which isolates belong 
(Evanno et al., 2005). This method uses the first and second order rates of change of the log 
probability of the data, LnP(D), in order to calculate DK. Graphically the DK function displays 
a break in slope at the true value of K, allowing its detection, and inference of the true number 
of populations to which isolates belong. Relationships between STs and group-founding STs 
were found using goeBURST 1.2.1 (Francisco et al., 2009). A phylogenetic tree assessing the 
evolutionationary relatedness of the T. vaginalis isolates involving and reference isolates from 
previous studies was created with START software using Neighbour-joining (NJ) cluster 
method for tree construction (Jolley et al., 2001). 
 
3.1.7 Test of linkage disequilibrium and recombination 
The standardized index of association (IAS), which tests for linkage disquilibrium or the non-
random association of alleles across the genome, was calculated using LIAN v3.6 (Haubold & 
Hudson, 2000). The expected value of IAS for a population is linkage equilibrium is 0, and the 
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significance of deviations from 0 is tested by a resampling procedure which randomly shuffles 
alleles among haplotypes.  
 
Linkage disequilibrium provides information on the population history, the breeding system 
and pattern of geographic subdivision as well as portraying the history of natural selection, 
gene conversion, mutation and other forces causing gene-frequency evolution (Slatkin, 2008). 
It is based on the assumption that, when given enough evolutionary time, random evolutionary 
activities will result in an equilibrium distribution of alleles at each locus. Thereby particular 
allelic frequency at a given locus becoming independent of alleles at other linked loci 
(Robinson, 1998). A major advantage of this method of analysis is that, it can detect recent 
positive selection, including selective sweeps (selective alleles are not fixed) (Lai, 2012). 
Another advantage of this method is its ability to use the effects of past recombination to 
achieve fine-scale gene localization (Jorde, 1995). However a limitation to this method is that, 
past historical events such as admixture, genetic drift, multiple mutations and natural selection 
can affect LD analysis output. Also, allelic heterogeneity may be present at each loci and this 
can limit the strength of association between a given polymorphism and an observable 
phenotype (Jorde, 1995). 
 
The maximum Chi-squared test (Max X2) for recombination analysis was performed using 
START2 (Jolley et al., 2001). Max X2  performs pairwise allelic comparisons at individual loci 
using polymorphic site distributions to identify recombination events (Smith, 1992). Split Tree 




3.1.8 Association with clinical signs 
For the isolates from Ghana, scores were assigned to the presenting clinical signs in our quest 
to group the clinical isolates in pathotypes as described in a previous study (Simoes-Barbosa et 
al., 2005), and modified in this study as follows; vaginal discharge (score 1), yellowish-green 
discharge (score 1), vaginal sores (score 1), vaginal itching (score 1), frothy malodorous 
discharge (score 2), erythema of the vulva (score 3) and macular colpitis (strawberry cervix) 
(score 4). Pathotype scores varied from 0 (non-pathogenic) to 14 (highly pathogenic). 
 
Associations between alleles at each locus and pathotype scores, and between population 
membership (i.e. clonal group 1 or 2) and pathotype scores were examined with a non-
parametric Wilcoxon sign-rank test, implemented in the R statistical package (R Development 
Core Team 2013). 
 
3.1.9 Identification of mixed infection 
Mixed infection among isolates was determined by identifying isolates with multiple genotype 





3.2.1 Diversity detected using next generation-multi-locus sequence typing (NG-MLST) 
All seven house-keeping genes were successfully sequenced in the 178 vaginal swab samples, 
and 36 different alleles were obtained overall (Table 3.2). A total 2,542 nucleotides were 
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sequenced across the seven loci for each sample using next generation sequencing (NGS). 
Thirty-six alleles were detected among the seven loci sequenced for all 178 isolates, the 
number of alleles per locus ranging from two to nine (Table 3.2). Twenty nine of the identified 
alleles had been previously documented in the MLST database in GenBank 
(http://tvaginalis.mlst.net/); thus, seven new alleles were added to these existing ones (Table 
3.2). The mean nucleotide diversity over all loci was 0.0135 differences/site (Table 3.2). The 
discriminatory power of the MLST scheme in this study is 0.852 (95% CI= 0.832-1.00). A total 
of 71 SNPs were found, comprising 2.8% of 2,542 nucleotides. The number of SNPs varied by 
locus from two to 37, comprising 0.54% of P16 sequence length to 13% of P3 sequence length 
(Table 3.2). Each isolate was assigned a sequence type based on the alleles located at each of 
the seven gene loci in that isolate. 
 
Forty-seven individual sequence types (STs) were distinguished among the 178 isolates, 23 of 
which have previously been identified (Cornelius et al., 2012). This adds 24 new STs to the 
already existing 78, bringing the total number of STs to 102, with STs 1-60 identified by 
Cornelius et al. (2012), 61-78 by Hawksworth et al. (2015) and 79-102 described in this study. 
Twenty STs were represented by multiple isolates. Each of the STs represented by multiple 
isolates was comprised of isolates from both the same and different geographic sites. The 
remaining 27 STs (57.5%) were represented by single isolates. The data from the study will be 








Table 3.2. Genetic diversity detected at seven loci in 178 isolates of T. vaginalis from Australia 
and Ghana 








Tryptophanase (P1) 351 4 0.001 2 1 (6) 





318 4 0.004 4 1 (6) 
Alanyl tRNA 
synthetase (P8) 
430 5 0.005 8 0 (18) 
DNA mismatch 
repair protein (P13) 




339 4 0.002 2 1 (2) 
Mannose 6-phosphate 
isomerase (P16) 
372 2 0.002 2 1 (6) 
 
The seven MLST loci are those described by Cornelius et al., (2012). Sequences were trimmed to the previously 
defined, locus-specific length. The number of SNPs and alleles identified among the genotypes are given. The last 
column shows new alleles found in this study and total number of previously identified alleles for each locus in 
brackets. θπ: Nucleotide diversity per site/locus. 
 
3.2.2 Diversity among geographic regions 
Polymorphism was found at most loci in amongst both Australian and Ghanaian isolates, 
although there was some variation between countries, with one allele at the P3, two alleles at 
the P6 locus and five alleles at the P8 and P13 loci found only in Ghana (Figure 3.1). One 
allele (allele 2) and two other alleles (alleles 8 and 10) at the P1 and P13 loci respectively were 
found only in Australia. Sequence type polymorphism existed amongst both Australian and 
Ghanaian isolates, and there was some variation between countries. Allelic diversity was most 




A total of 48 sequence types were identified in both Australian and Ghanaian samples. 
Sequence type (ST) diversity was found amongst both Australian and Ghanaian isolates as well 
as between countries, with 23 STs and eight STs found only in Ghana and Australia 
respectively (Figure 3.2). Among the Australian isolates, nine STs were represented by single 
isolates, while 15 STs occurred in more than one isolate. Among the Ghanaian samples, 23 STs 
were represented by single isolates, while 15 STs occurred in more than one isolate (Figure 
3.2). Genetic overlap was observed, with 15 STs occurring in both Australian and Ghanaian 























              
 
Figure 3.1 Allelic abundance and diversity between Australian and Ghanaian isolates. TRYP: Tryptophanase (P1); GLUT: Glutaminase (P3); ALTS: 
FT2A: Family T2 asparaginase-like threonine peptidase (P6); Alanyl tRNA synthetase (P8); DRMP: DNA mismatch repair protein (P13); 

















Figure 3.2 Sequence type (ST) abundance and diversity between Australian and Ghanaian isolates 
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3.2.3 Population structure 
The goeBURST analysis of all isolates revealed seven clonal complexes of two more single 
locus variants (Figure 3.3). Clonal complex 7 contained isolates only from Ghana. Clonal 
complexes 1, 2, 3, 4. 5, 6 and 8 each contained isolates from both Australia and Ghana. 
Phylogenetic analysis of 48 STs from Australia and Ghana and 60 reference STs from 
Cornelius et al., (2012) (Figure 3.4), identified cluster grouping similarity with geoBURST 
analysis (see figure 3.3b) and ST clustering indicated by Cornelius et al., (2012). 
 
Population assignments using the model-based approach in STRUCTURE grouped (all 
isolates) into two populations (Figure 3.5a). Genotypes were assigned to a population if they 
had at least 70% ancestry from that population. Twenty-one genotypes were not assigned to 
any population based on this criterion. The two populations observed by STRUCTURE are 
present in almost equal frequencies in the samples, with 82 in one population (Type 1) and 94 
isolates in the other population (Type 2). Assignment of the test STs and reference STs from 
Cornelius et al., (2012) also identified two population types (Figure 3.5b) with a similar 
group assignment of the reference STs as indicated earlier by Cornelius et al. (2012).  
 
When the Ghanaian and Australian isolates analysed separately, two subgroup populations 
were again identified, with almost equal frequencies in the isolates representing each 




Figure 3.3 geoBURST analysis of 197 isolates representing 48 STs. geoBURST analysis showed eight clonal complexes with 10 singletons.  

























Figure 3.4 Phylogenetic tree of the evolutionary relationship of 48 STs (Australia and Ghana) and 
60 reference STs (in bold) previously identified by Cornelius et al., (2012).. Neigbour-joining 






Figure 3.5a Assignment of isolates into two subpopulations by STRUCTURE plot for 197 isolates (Australia and Ghana).  
Isolates were assigned to a subpopulation if they had 70% ancestry from that subpopulation. Eighty two isolates are assigned to subpopulation 1 
(Type 1, red) and 94 to subpopulation 2 (Type 2, green). The remaining 21isolates showed various degrees of joint ancestry and therefore could 











Figure 3.5b Assignment of isolates into two subpopulations by STRUCTURE plot for 48 STs (Australia and Ghana) and 60 reference STs.  
Genotype identification numbers 1-48 correspond to STs from present studies. Genotypes ids 49-108 correspond to reference STs 1-60 from 











Figure 3.6a Assignment of isolates into two subpopulations by STRUCTURE (Ghana).  
Isolates were assigned to a subpopulation if they had P80% ancestry from that subpopulation. STRUCTURE plot for the 93 Ghana isolates. Forty 
nine isolates are assigned to subpopulation 1 (type 1, red) and 36 to subpopulation 2 (type 2, green). The remaining eight isolates showed various 












Figure 3.6b Assignment of isolates into two subpopulations by STRUCTURE (Australia).  
Isolates were assigned to a subpopulation if they had P80% ancestry from that subpopulation. STRUCTURE plot for the 104 Australian isolates. 
Thirty eight isolates are assigned to subpopulation 1 (type 1, red) and 48 to subpopulation 2 (type 2, green). The remaining 18 isolates showed 











3.2.4 Linkage disequilibrium and recombination assessment 
 For the entire T. vaginalis population, the standard index of association (IAS) was 0.0624, 
which was significantly greater than zero (P<0.05) (Table 3.3a). Likewise, when each ST was 
treated as a single isolate, removing redundancy due to indistinguishable clones, the IAS was 
0.0285, which was also statistically different from zero (P<0.05) (Table 3.3a).. When 
multilocus linkage disequilibrium was analysed sparately for the type 1 and type 2 isolates 
ideitified in the Structure analysis,  IAS values were 0.1307 and 0.0659 respectively, which 
were bothsignificantly greater than zero (P< 0.05) (see Table 3.3b). 
 
The level of multi-locus linkage disequilibrium assessed among the Ghanaian isolates using 
LIAN is shown in Table 3.4a. For the entire T. vaginalis population, the IAS was 0.0720, 
which was significantly greater than zero (P<0.05). Likewise, when each ST was treated as a 
single isolate, removing redundancy due to indistinguishable clones, the IAS was 0.0241, 
which was also statistically different from zero (P<0.05) (Table 3.4a). The IAS for population 
Type 1 and 2 were 0.0058 and 0.0571 respectively, which were both significantly greater than 
zero (P< 0.05) (see Table 3.4b). 
 
Among the Australian isolates (IAS for the entire population) was 0.0536, which was 
significantly greater than zero (P<0.05) (Table 3.5a). Likewise, when each ST was treated as 
a single isolate, removing redundancy due to indistinguishable clones, the IAS  was 0.0036, 
which was also statistically different from zero (P<0.05) (Table 3.5a). The IAS for Type -1 and 
2 were 0.0354 and 0.0918 respectively, which were significantly greater than zero (P< 0.05) 
(see Table 3.5b). 
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There was insufficient allelic diversity to enable Max χ2 computation at any locus, except P3 
where no evidence was found for recombination (Max χ2=12.84, P=0.071). The most 
significant breakpoint found was between sequence P3 ZOTU 3_allele 1 and ZOTU 
5_allele3, between the 217th and 218th polymorphic site. The Phi test using concatenated 
sequence also found no evidence of recombination from Ghana and Australia isolates (n=48 
STs, P=0.069). 
 
Table 3.3a Analysis of multi-locus linkage disequilibrium for Australia and Ghana isolates 
   Variance in allelic        
mismatches     P (test that IAS = 0) 
Data set  Observed Expected IAS  Monte Carlo Parametric 
All isolates (197) 2.1133  1.5373  0.0624  0.0039  0.0038 
STs only (48)  1.9502  1.6656  0.0285  0.0102  0.0111 
 
 
Table 3.3b Analysis of multi-locus linkage disequilibrium between population types for 
Australia and Ghana isolates 
   Variance in allelic       
mismatches     P (test that IAS = 0) 
Data set  Observed Expected IAS  Monte Carlo Parametric 
Type 1 (94)  1.9375  1.0860  0.1307  0.0096  0.0088 








Table 3.4a Analysis of multi-locus linkage disequilibrium for Ghanaian isolates 
   Variance in allelic       
mismatches     P (test that IAS = 0) 
Data set  Observed Expected IAS  Monte Carlo Parametric 
All isolates (93) 2.3760  1.6592  0.0720  0.0089  0.0087 
STs only (42)  1.9249  1.6819  0.0241  0.0130  0.0147 
 
 
Table 3.4b Analysis of multi-locus linkage disequilibrium between population types for 
Ghanaian isolates 
   Variance in allelic        
mismatches     P (test that IAS = 0) 
Data set  Observed Expected IAS  Monte Carlo Parametric 
Type 1 (44)  1.0059  1.0420  0.0058  0.0143  0.0110 
Type 2 (36)  2.0768  1.5470  0.0571  0.0151  0.0132 
 
 
Table 3.5a Analysis of multi-locus linkage disequilibrium for Australian isolates 
   Variance in allelic        
mismatches     P (test that IAS = 0) 
Data set  Observed Expected IAS  Monte Carlo Parametric 
All isolates (104) 1.6452  1.2518  0.0536  0.0037  0.0034 
STs only (26)  1.4630  1.4321  0.0036  0.0297  0.0232 
 
 
Table 3.5b Analysis of multi-locus linkage disequilibrium between population types for 
Australian isolates 
   Variance in allelic        
mismatches     P (test that IAS = 0) 
Data set  Observed Expected IAS  Monte Carlo Parametric 
Type 1 (38)  0.7476  0.6166  0.0354  0.0015  0.0015 
Type 2 (48)  1.4838  0.9033  0.0918  0.0122  0.0141 
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3.2.5 Association with clinical signs 
Seventy-eight T. vaginalis isolates with clinical information were scored on a 20-point scale 
based on the number of symptoms and signs presents. Clinical signs manifested by the 78 
infected participants in this study indicated that six (6.7%) corresponded to asymptomatic 
infected group, 21 (23.6%) to the very low symptomatic, 39 (43.8%) to the low symptomatic 
and 12 (13.5%) to the high symptomatic group (Table 3.4). The most classic presented 
clinical symptoms in T. vaginalis infection, which are vaginal discharge, vaginal itch and 
frothy malodorous discharge, were frequently presented in this study; 61 (68.5%) infected 
persons presented with abnormal vaginal discharge, 45 (50.6%) with frothy malodorous 
discharge, 33 (37.1%) with vaginal itch and 22 (24.7) with yellowish-green discharge. 
However, only 15 (16.9%), 12 (13.5%) and 10 (11.2%) infected persons presented with 
vaginal sores, strawberry cervix and erythema of the vulva respectively (Table 3.6).
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Table 3.6 The distribution of clinical isolates of T. vaginalis based on symptoms exhibited by the patients 
Pathotype        Symptoms 
Level  Score (no. patients) Vaginal discharge Vaginal itch Vaginal sores Yellowish-green discharge Frothy discharge Vulvar redness Macular colpitis 
Non-pathogenic  0 (6)  No        No          No               No          No             No         No 
 
Very low pathogenic 1 (5) 
   2 (9)  21          07           02                03           02               01          No 
   3 (7) 
 
Low pathogenic  4 (16) 
   5 (8)  31           21            09                 16            33               02            01 
   6 (11)   
   7 (4) 
 
High pathogenic  8 (3) 
   9 (4) 
   10 (3)  09            05                              04                 03            10               07            11 
   11 (1) 
   12 (0) 
   13 (1) 
   14 (0) 
 
Total    89  61            33             15                   22             45               10             12 
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3.2.6 Population clustering and pathophysiology classification 
The distribution of pathotype scores among 78 isolates from Ghana is shown in Table 3.6. There were 
no significant associations between genotypes at any locus and pathotype score (Table 3.7), although 
there was a non-significant trend for genotype 2 at locus P1 to be associated with a greater score (P = 
0.11). There was also no significant difference in pathotype score between isolates from Type 1 and 
Type 2 populations (z = 1.11, P = 0.27).  
 
Table 3.7 Associations between genotypes and clinical presentation score 
Gene   ZOTU  Std Error 95% CI  F ratio  P value 
TRYP (P1)  1  0.46  (3.11-4.95)   
   2  0.56  (4.08-6.34)  2.64  0.11 
GLUT (P3)  1  0.45  (3.49-5.28)   
   2  0.99  (2.15-6.10)   
   3  0.81  (3.80-7.03)  1.02  0.39 
   6  2.79  (4.60-6.60) 
FTATP (P6)  1  0.39  (3.91-5.47)   
   2  0.93  (1.59-5.30)  1.52  0.22 
ALTS (P8)  1  0.39  (3.77-5.31)   
   2  1.42  (0.91-6.59)  0.18  0.84 
   3  2.01  (0.99-9.02)   
DMRP  (P13)  1  0.39  (3.83-5.38)   
   2  1.63  (0.92-5.59)  0.71  0.55 
   3  1.63  (1.08-7.59) 
   7  2.82  (0.36-11.64) 
SHMT (P14)  1  0.41  (3.60-5.23)      
 2  0.81  (3.21-6.46)  0.21  0.65 
 
 
3.2.7 Mixed infection amongst T. vaginalis isolates 
3.0 Multiple infections with different T. vaginalis genotypes were identified in 35 isolates from 35 
hosts, 22 from Ghana, representing 24.7% of Ghanaian isolates, and 13 from Australia, representing 
14.6% of Australian samples. Of these 35 isolates, multiple infections were detected at the P1 locus in 
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eight isolates (five from Ghana and three from Australia), P3 in five isolates (three from Ghana and two 
from Australia), P6 in 16 isolates (ten from Ghana and six from Australia), P8 in one isolate (from 





3.3.1 Genetic diversity 
This is the first study to investigate genetic diversity in T. vaginalis in Australia or Ghana.  Seven single 
copy house-keeping genes were sequenced as previously described (Cornelius et al., 2012), in 178 
isolates (89 from Australia and 89 from Ghana) and  a high level of allelic and nucleotide diversity at all 
loci was found in the T. vaginalis populations in both countries, consistent with the findings of  previous 
studies (Cornelius et al., 2012; Hawksworth et al., 2015): in this study, 48 unique ST were identified 
among 197 genetic variants in 178 isolates, of which 24 had previously been described (Cornelius et al., 
2012), indicating a moderately high ST percentage diversity (27%). This was, however, lower than 
findings in previous studies (88.2% and 83%) (Cornelius et al., 2012; Hawksworth et al., 2015). This 
brings the total number of T. vaginalis STs for the overall MLST scheme to 104 from a total of 269 
isolates genotyped so far. This moderately high ST to isolate diverty observed in this study indicates 
further unique STs are yet to be identified for the MLST genotyping scheme.  
 
Among the Australian and Ghanaian isolates, 71 SNPs defining 36 different alleles, 29 of which have 
previously been reported by Corenelius et al. (2012), were identified in 178 isolates, with multiple 
alleles found at each of the seven loci, underlining the extent of genetic diversity in T. vaginalis. 
Cornelius et al. (2012), had identified 43 SNPs, defining 51 alleles in 68 isolates of T. vaginalis in an 
earlier study. Hawksworth et al. (2015) likewise, had identified 23 SNPs, defining 25 alleles in 25 
isolates; 21 of which had previously been identified by Cornelius et al. (2012). 
 
The average nucleotide diversity in this study was 0.0135 differences/site. This is higher than that found 
among T. vaginalis isolates in previousl study (0.0035 difference/site) (Cornelius et al., 2012), with each 
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locus comprising more than one allele in this present study. The discriminatory power of the MLST 
scheme observed in this study was 0.852. Even though this value was slightly lower (0.996) than 
observed by Cornelius et al. (2012), it still indicates the strength of this MLST scheme to differentiate 
between isolates, underscoring the high dicriminatory power of the MLST scheme, as indicated in 
previous studies (Cornelius et al., 2012; Hawksworth et al., 2015). 
 
The high genetic diversity observed among isolates in this study could be due to genetic exchange or 
diversifying selection in a clonal population (Cornelius et al., 2010). Trichomonas vaginalis reproduces 
strictly by mitosis and no direct evidence of meiosis and sexual reproduction has been observed in the 
protozoan, even though meiotic recombinant genes have been found in the T. vaginalis genome (Ramesh 
et al., 2005; Malik et al., 2008). Indirect evidence for genetic recombination in T. vaginalis has been 
found in previous studies, however, (Conrad et al., 2012; Cornelius et al., 2012). Both studies found no 
linkage disequilibrium within type 1 and 2 isolates when the population groups were considered 
separately, suggesting recombination more likely occurred within types than between types.  
 
In the present study, however, significant linkage disquilibrium was found, whether type 1 and type 2 
isolates were analysed together or separately, whether Ghanaian and Australian populations were 
analysed together or separately, and whether individual isolates with multiple ST representation or STs 
considered as single isolates were used in the analysis, suggesting the likelihood of restrictive 
recombination within the two separate groups. Trichomonas vaginlis has previously been proposed to be 
a clonal orgamism which reproduces mainly by mitosis (Tibayrenc et al., 1990). This role of clonality is 
supported in this study, not only by the occurrence of linkage disequilibrium, but also because both 
Australian and Ghanaian isolates integrated into a clonal complex (CC). This inference is further 
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supported by over-representation of unique STs in the current study, which is a feature of clonally 
reproducing organisms (Tibayrenc et al., 1990; Asmundsson et al., 2006). The most abundant genotype 
identified in the present study was ST 58, which represented 27% and 14.6% of Australian and 
Ghanaian isolates, respectively. 
 
Split Tree program was unable to identify recombination breakpoints within the MLST gene fragments 
in this study. The Phi test for recombination showed no evidence of recombination when concatenated 
nucleotide sequences were analysed. Similarly, no evidence of recombination was detected using 
Maximum Chisquared test.  
 
The discripancy observed between results from this study and previous studies could be due to a number 
of reasons. First, , the analysis of linkage disequilibrium provides only an indirect assessment of 
recombination. Clonal reproduction does not produce linkage disequilibrium per se, rather it preserves 
allelic associations that arise through mutation and normally broken up by recombination during sexual 
reproduction (Tibayrenc et al., 1990; Smith et al., 1993). Linkage disequilibrium can be retained in 
populations, even when recombination is frequent, because of epistatic fitness interaction between loci 
(Smith et al., 1993; Tibayrenc & Ayala, 2015), an “epidemic” population structure (Smith et al., 1993) 
and restrained recombination (Tibayrenc & Ayala, 2015) 
 
Second, possible lack of power due to small sample size could have preented the detection of significant 
linkage disequilibrium in previous studies. A sample size of 178 T. vaginalis isolates has been used in 
this study, compared to sample sizes of 68 and 23 used in the study by Cornelius et al. (2102) and 
Hawksworth et al. (2015) respectively. The extent of sample size influence on population genetic 
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analyses, haplotype structures study and clinical research study has previously been documented (Sun et 
al., 2004; Suresh & Chandrashekara, 2012; Subramanian, 2016). Sun et al. (2004), observed that sample 
size when increased, had significant impact on the level of haplotype diversity within a chromosomal 
block and the total number of genetic representative markers identified. Suresh and Chandrashekara. 
(2012), had also observed that power proportionality inceased as the sample size for the study increased, 
therefore, a study had a higher chance of detecting a difference between groups, if it existed. 
Subramanian (2016), studying the effects of sample size on population genomic analyses and the 
implications for the tests of neutrality had revealed that, sample size greatly influenced the measure of 
molecular genetic variations, using the Watterson’s estimator (θ). They also observed that, the θ 
estimated for synonymous sites of genes using 512 human exomes was 1.9 times higher than obtained 
using 16 exomes, revealing the level of underestimation small sample size can cause and thus 
underscoring the importance of sample size in estimating a number of population genetic parameters. 
 
3.3.2 Population genetic structure 
Polymorphism among T. vaginalis genotypes was observed in this study (Figure 3.3a), clustering 
genotypes into eight major groups. This outcome is consistent with previous findings (Vanacova et al., 
1997; Ryu et al., 1998; Snipes et al., 2000; Hampl et al., 2001; Rojas et al., 2004) While other studies 
have shown less clustering of T. vaginalis genotypes (Rojas et al., 2004; Mao & Liu, 2015), nine 
clusters were identified, suggesting an extensive genetic diversity among the genotypes. This, however, 
fell behind other findings in Iraq (Valadkhani et al., 2011), where 21 clusters among 40 genotypes were 




The STRUCTURE analysis of T. vaginalis genotypes in this study, including reference STs from 
Cornelius et al.(2012), showed two major population distributions, Types1 and 2, when the genotypes 
were considered to be from one region, matching with the reference STs and when analysed for the 
separate regions, which again agrees with previous findings (Conrad et al., 2012; Cornelius et al., 2012; 
Hawksworth et al., 2015; Mao & Liu, 2015). Besides the two population types identified, a third 
unassigned (divergent) group has been observed in a Bristol study (Hawksworth et al., 2015). Similarly, 
in this study, a third unassigned group was observed, which demonstrated almost equal ancestry lineage 
of the Type-1 and 2 lineages amongst the Australian and Ghanaian samples. These findings suggest the 
existence of a group of T. vaginalis genotypes in circulation, which may have occurred as a result of 
recombination between population types in the past, followed by clonal divergence. Further study in this 
regard will be useful to help understand the entire process giving rise to the unassigned group. 
 
In the current study, there were almost equal frequencies of the genotypes falling within each of the two 
major population types (36 in type 1 and 49 in type 2). This is similar to a number of previous studies, 
which also found almost equal distribution of genotypes between types 1 and 2 (Conrad et al., 2012; 
Cornelius et al., 2012), but differs from Hawksworth et al., (2015), who found overrepresentation of 
type 2 among T. vaginalis isolates from Bristol, U.K. 
 
3.3.3 Association with clinical symptoms 
Clinical variability among infected groups was observed in this study, as with previous studies (Meade 
et al., 2009; Abou-kamar et al., 2017). It is not, however, clear whether the clinical variability observed 
in T. vaginalis infection is due to variations in phenotypic expressions of individual T. vaginalis 
genotypes or host factors. A previous study of the genetic characterisation of T. vaginalis isolates has 
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shown that the marked clinical variability manifested in T. vaginalis infection and disease outcomes is 
matched with genetic diversity in the organism, suggesting a correlation between the genetic diversity of 
the protozoan and presenting clinical symptoms (Meade & Carlton, 2013).  
 
In the present study, varied clinical symptoms were observed among study groups; 6.7% of infected 
groups were asymptomatic, 23.6% were very low symptomatic, 43.8% were low symptomatic and 
13.5% were high symptomatic. Vaginal discharge and frothy malodourous discharge were present in 
more than half of the cases, with more than a fifth presenting with strawberry cervix. This study found 
no significant associations between genotypes at any locus and clinical presentation score. The non-
significant trend for genotype 2 at locus P1 could be associated with a greater clinical score (P = 0.11) 
and is worthy of further investigation. The analyses did not have a lot of power because of the relatively 
small sample size. 
 
Cornelius et al. (2012) have suggested the two population clusters identified in T. vaginalis (i.e. type 1 
and type 2) may be differentially associated with various infection outcomes and health sequelae. Meade 
et al. (2013), similarly, had suggested the existence of the two genetic types may be associated with 
different clinical signs and outcomes in T. vaginalis infection. In the present study, however, there was 
no evidence for an association of population type with clinical score. Limitations in the present study 
include the absence of data on the association between strain/genotype and the development of 




3.3.4 Mixed infections 
Overall, mixed infections were identified among 35 of 178 isolates (19.7%), predominantly among 
isolates from Ghana (14.6% and 24.7% of Australian and Ghanaian isolates) and all were limited to two 
different genotype assignments at the same loci, as previously described (Cornelius et al., 2012; 
Hawksworth et al., 2015). These were higher than the previously documented T. vaginalis mixed 
infection frequency in human hosts (11.0%) (Conrad et al., 2012). This could be due to frequent re-
infection of the host or exposure to different sexual partners infected with the parasite (Cornelius et al., 
2012).  
 
Mixed infection is believed to impact on disease progression and treatment response (Perez et al., 2018). 
This could also be a reason for the varied presenting clinical symptoms and infection severity, similar to 
those found in a previous study involving Plasmodium vivax mixed infection and infection severity 
(Genton et al., 2008). Mixed infection could result in poor treatment outcome due to selective response 
of the different isolates to metronidazole, the treatment drug of choice for T. vaginalis (Theisen et al., 
1995; Baldeviano-Vidalon et al., 2005). This has been demonstrated in an earlier study on stored 
specimens collected from persons with multidrug resistance tuberculosis, demonstrating that mixed 
infections with strains of different resistance phenotypes could compromise treatment outcomes using 
standard combination treatment regimens (Van Rie et al., 2005). In addition to compromising the 
effectiveness of treatment, mixed infection could also promote superinfection sometime after the 










Trichomonads which are free-living and others parasitic, inhabit different hosts and sites in a wide range 
of vertebrate hosts (Gould et al., 2014). Among these are parasitic trichomonads of medical importance: 
Trichomonas vaginalis, found in the urogenital, Trichomonas tenax, in subgingival, oral and bronchial 
and Trichomonas hominis, in the gastrointestinal tracts (Malik et al., 2011).  
 
Trichomonas vaginalis is sexually transmitted and is the causative agent of the most prevalent non-viral 
STI with an annual global incidence of 276.4 million (Rowley et al., 2012), infecting both sexes with 
heterogeneous clinical presentations. Asymptomatic to severe clinical symptoms such as vaginitis, 
urethritis, vaginal discharge, as well as predisposing to adverse pregnancy outcome, such as preterm 
delivery, premature rupture of membrane, low birth weight, miscarriage and still birth have been 
identified in infection cases in women (Cotch et al., 1997; Petrin et al., 1998; Smith et al., 2002). 
Infertility, chronic prostatitis, and non-gonococcal urethritis have been indicated in male infection 
(Krieger, 1999; Hobbs et al., 2006). The varied clinical presentation observed in T. vaginalis infection 
could be due to the existence of genetic polymorphism of the parasite in circulation.  
 
Genetic population studies have revealed the existence of genetic diversity among T. vaginalis 
populations (Meade et al., 2009; Conrad et al., 2012; Cornelius et al., 2012; Matini et al., 2012; 
Hawksworth et al., 2015; Masha et al., 2017). However, there still remain vast regions of the world with 
limited or no data on the genetic population of T. vaginalis, presenting a major challenge for the 
effective control, management and treatment of the infection. 
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The increasing prevalence and associated severe health sequelae of T. vaginalis infections, coupled with 
the poor understanding and dearth of data on the different genotypes circulating within different 
geographical regions, especially Ghana, highlights the importance of this study, which was aimed at 
genetically characterizing clinical isolates of T. vaginalis by next generation multi-locus sequence typing 
(NG-MLST); correlating the genetic diversity with presenting clinical symptoms; and assessing the 
association between genetic markers and clinical symptoms, and their pathogenic significance in 
infection. The research undertaken in the present study has both clinical and public health relevance. The 
investigation of associated risk factors and presenting clinical signs for T. vaginalis infection will 
provide in depth knowledge and understading on the dynamics of T. vaginalis transmission and 
presenting clinical signs among infected persons. This will help to improve the clinical diagnosis, 
treatment and management T. vaginalis infection. Additionally, epidemiological data obtained from this 
study will help in policy formulation and public health education on the causation, prevention and 
control of T. vaginalis infection. Also, the outcome of this study will serve as a platform for future 
studies on the genetic markers of T. vaginalis and their role in the pathology of the infection, 
contributing immensely to future drug formulation and vaccine development for treatment and control of 
T. vaginalis infection. 
 
 
4.1 DIAGNOSIS OF T. VAGINALIS INFECTION 
Trichomonas vaginalis infection was detected in this study using wet preparation microscopy and 
conventional PCR. Wet mount microscopy is the primary and considered most effective and common 
laboratory diagnostic technique used for the detection of T. vaginalis because of its cost effectiveness 
and ease (Garber, 2005; Van Der Pol, 2016). However, results in this study revealed that the PCR 
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technique has significantly higher sensitivity than wet preparation microscopy, suggesting PCR can be 
used as a routine test for detecting T. vaginalis in the district and regional clinical laboratories in Ghana. 
District laboratories in Ghana provide services for an average population of 100,000–200,000 people in 
a clearly defined geographical area. These laboratories are part of the district hospitals which has a bed 
capacity of usually between 50 and 60 and served as the first referral point of healthcare, forming an 
integral part of the district health system. The district laboratories provide diagnostic and pathology 
services appropriate to the medical, surgical, and outpatient activities of the district hospital. Regional 
laboratories provide services to a larger population than the district laboratories and operate within a 
wider geographical coverage. They are part of the regional hospital which often has a bed capacity more 
than 100 and serve as a secondary point of care. The regional laboratories often perform the same 
diagnostic and pathology services as the primary laboratoes, serve as referral points for diagnostic and 
pathology services which the district laboratories do not have the capacity to perform and also have an 
oversight responsibility over the district laboratories in that region. The regional laboratories also serve 
as teaching laboratories for biomedical and medical students.  
 
Five hundred and six vaginal swab samples collected from women attending gynaecological clinics in 
four selected hospitals in Southern Ghana and tested for T. vaginalis, showed 63 were positive for T. 
vaginalis using wet preparation microscopy and 89 positive using PCR. The shortfall in wet preparation 
microscopy is the technique’s inability to detect immotile trophozoites of T. vaginalis (Garber, 2005; 
Stoner et al., 2013), which often results from delayed examination of vaginal swab specimens. Also, wet 





4.2 PREVALENCE, CLINICAL SIGNS AND RISK FACTORS ASSOCIATED WITH 
TRICHOMONAS VAGINALIS INFECTION IN SOUTHERN GHANA 
The prevalence of T. vaginalis infection is underestimated due to up to half of the infected cases being 
asymptomatic (Matini et al., 2012). An overall T. vaginalis prevalence of 13.2% and 16.8% was 
recorded in this study using wet preparation microscopy and PCR respectively, with a significant 
difference in sensitivity between the two techniques. This appeared higher than reported prevalences in 
some African Sub-regions (see Chapter 2, Table 2.5). Also, the regional prevalence using PCR was 
significantly higher in the Volta region (21.7% (95% CI 17.1-26.9%)) than the Greater Accra region 
(12.8% (95% CI 8.6-18.3%)). These values were found to be higher than previously reported 
prevalences in the Greater Accra region (2.7%) (Apea-Kubi et al., 2006) and Kumasi, in the Ashanti 
region (5.4%) (Adu-Sarkodie, 2004). The difference in prevalence observed in this study and the 
previous ones could be due to the use of a more sensitive diagnostic method and the greater population 
coverage in this study. 
 
Trichomonas vaginalis infection is associated with vaginal discharge, vulva irritation, painful urination, 
strawberry punctate cervix, green-yellowish frothy vaginal discharge, and pain during coitus (Wølner-
Hanssen et al., 1989). In this study, the most classically identified clinical presentations were abnormal 
vaginal discharge (68.5%), frothy malodorous discharge (50.6%), vaginal itch (37.1%) and yellowish-
green discharge (24.7). Additionally, 16.9% of infected persons were presented with vaginal sores, 
13.5% with macular colpitis (strawberry cervix) and 11.2% with erythema of the vulva. However, 
vaginal itch was the only clinical sign variable found to be significantly associated with T. vaginalis 
infection, with colour and consistency of vaginal discharge also featuring in the top ranked models using 




 Previous studies have attributed the heterogeneity of clinical presentations observed in T. vaginalis 
infection to a number of reasons, including the genetic polymorphism in the parasite (Alderete et al., 
1986; Rojas et al., 2004), and the infection stage in the individual (Fouts & Kraus, 1980; Wølner-
Hanssen et al., 1989). The activity of T. vaginalis is affected by menstrual activities of the host and this 
could be linked to the varied clinical presentations (Simoes-Barbosa et al., 2005). Also, the varying 
incubation period of the parasite could influence the variations in clinical signs (Eshete, 2013; Maufi et 
al., 2016). 
 
In the current study, T. vaginalis infection was significantly associated with a previous history of still-
birth. These women had no documented previous history of T. vaginalis infection at the time of the 
incident. Even though these women were likely to have had the infection over a long duration which had 
resulted in having stillbirth, this study did not test for the presence of the anti-T. vaginalis IgG antibodies 
which has previously been detected (Sibau et al., 1987). Cases of adverse pregnancy outcomes have 
been associated with T. vaginalis infection (Minkoff et al., 1984; Draper et al., 1995; Cotch et al., 1997; 
Sangkomkamhang et al., 2008), even though the underlying mechanism is not well established. For 
example, premature membrane rupture and intrapartum stillbirth which are sometimes associated with T. 
vaginalis infection has been documented (Yang et al., 2004) but the underlying mechanisms leading to 
these are not yet fully understood. Further studies would thus help to unravel the underlying mechanisms 
leading to these outcomes. 
 
Several risk factors associated with T. vaginalis infection in women in various parts of the world have 
been reported (Mairiga et al., 2011; Ambrozio et al., 2016; Maufi et al., 2016; dos Anjos Gatti et al., 
2017). Among the risk factors analysed in this study (see Chapter 2, Table 2.2), a history of engaging in 
oral sex was the only one found to be significantly associated with T. vaginalis infection. This is the first 
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time history of engaging in oral sex has been viewed as a risk factor for T. vaginalis infection and that 
this variable could contribute to increased infection risk which is worth further investigation. Other 
variables that also showed some level of association with T. vaginalis infection are lower level of 
education, use of pieces of dirty cloth as cleaning material after toilet and douching as treatment mode 
for vaginal discharge (see Chapter 2, Table 2.4). The evidence of asscociation between low educational 
level and increased risk of T. vaginalis infection, albeit weak, has also been reported in previous studies 
(Yoshikawa, 1981; de Waaij et al., 2017). Even though association between level of education and STI 
is not clearly understood, persons with a lower level of education are likely to have limited knowledge 
on safe sexual hygiene and practices, which increases infection risk. Notwithstanding, other confounding 
factors such as poverty and multiple sexual partners may also feature. The weak association between 
douching and T. vaginalis infection was observed in this study. This finding has been reported in 
previous studies (Sutton et al., 2007; Luo et al., 2015). 
 
 
4.3 POPULATION STRUCTURE AND GENETIC DIVERSITY OF TRICHOMONAS 
VAGINALIS 
The multi-locus next-generation sequencing tool used in this study revealed the existence of high genetic 
diversity, using seven house-keeping genes to successfully characterise 178 T. vaginalis isolates 
obtained from vaginal swabs in Australia and Ghana. Seventy-one polymorphic nucleotide sites, 36 
different alleles, 48 sequence types (ST), 24 of which were novel, were identified among 197 genetic 
variants in these 178 isolates, revealing a diverse T. vaginalis population. The ST diversity in this study 
was 27%, compared to previous findings of 88.2% (Cornelius et al., 2012) and 83% (Hawksworth et al., 
2015). The reason for the discripancy in the ST diversity between this study and the previous studies 
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could be due to one of two reasons: the coverage of a wider sampling area and/or sample size. In the 
study by Cornelius et al. (2012), samples analysed included 16 reference strains of T. vaginalis obtained 
from nine different states between 1939 and 1986 and 52 isolates from patients presenting to two clinics 
in Jacksonville, Mississippi, from 2001 to 2010, presenting a wider sampling period. The sampled 
population also included persons from diverse racial origin; African-American and caucasians. 
Hawksworth et al. (2015) on the other hand, obtained their samples from a single hospital in Bristol. 
Since the determination of ST diversity takes into consideration the number of STs identified and total 
sample size, the smaller sample size used in the study; 68 samples (Cornelius et al., 2012) and 23 
samples (Hawksworth et al., 2015), may have also contributed to the high ST diversity obtained in these 
studies.  
 
Similar to the previous studies, this study showed a large pool of genetic variants of T. vaginalis in the 
Ghanaian and Australian populations, stressing the importance of identifying the different phenotypic 
properties associated with these variants. The discovery of novel alleles STs of T. vaginalis amongst the 
Ghanaian and Australian populations also lead to questions regarding the origin and transmission of 
these genotypes, their implication in disease manifestation and treatment response, and how this may 
enhance the invasion of their hosts. 
 
Among the Australian isolates, the level of ST diversity observed was minimal. This is contrary to what 
was observed among the Ghanaian isolates. The reason for the occurrence among the Australian isolates 
could be because the sampled population was not truly independent and was conserved, considering that 
a greater proportion of the sampled population was from the Northern Territory, a predominantly 
Aboriginal community who are mostly conservative in their social interactions (Gray & Auld, 2000; 
Carson et al., 2007). Ghanaian isolates were sampled from a population of a more diverse background 
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with a much less conservative socio-behavioural pattern (Anarfi, 2003; Agyei-Mensah & Aikins, 2010), 
which could promote multiple sexual practice among the population, promoting possible mixed 
infection, genetic material exchanges between different T. vaginalis strains, and natural selection. 
Further studies on the role of socio-behavioural patterns in determining the genetic diversity patterns of 
T. vaginalis would be helpful to confirm whether these patterns influence the genetic diversity pattern in 
a population and the dynamics involved in this process. 
 
Two population groups, Type 1 and Type 2, and a third unsigned group have been identified in previous 
studies. (Cornelius et al., 2012; Hawksworth et al., 2015). Similarly, this study identified two population 
types and a third unidentified group which may have resulted from the processes of recombination in the 
past. Previous studies have found evidence for recombination between, but not within Type 1 and Type 
2 clades (Cornelius et al., 2012; Hawksworth et al., 2015). This study found multi-locus disequilibrium 
even when analysing clades separately, as well as widespread clonal genotypes, suggesting that there is 
no evidence of recent recombination. However, some genotypes appeared to have elements of Type 1 
and Type 2 clades (the unassigned genotypes), suggesting that recombination may have occurred in the 
past. The best explanation is that T. vaginalis is a largely clonal organism, with occasional bouts of 
sexual reproduction. Also previous studies have found evidence for recombination when all T. vaginalis 
variants, in which some STs had multiple representations, but not when STs were analysed as single 
isolates (Cornelius et al., 2012; Hawksworth et al., 2015). The present study found multi-locus 
disequilibrium even when analysing STs as single isolates, as well as T. vaginalis variants with multiple 
ST representation, also suggesting T. vaginalis is a highly clonal species. This observation was not 
different when the Australian and Ghanaian isolates were analysed separately. Population genetic and 





Clonal population structure observed in the multi-locus linkage disequilibrium analysis in this study was 
further evidenced when STs were analysed using geoBUURST. Eight clonal complexes and 10 singleton 
STs were observed within the population. Additionally, over-representation of ST 58 was observed in 
27% and 14.6% of T. vaginalis variants among the Australian and Ghanaian population. This a feature 
of clonally reproducing organisms (Tibayrenc et al., 1990; Asmundsson et al., 2006). 
 
 
4.4 CORRELATION OF GENETIC VARIABILITY WITH CLINICAL SIGNS 
Variability in clinical signs observed in T. vaginalis infection has been linked to the existence of genetic 
diversity in the parasite (Meade & Carlton, 2013). However, in the present study, there was no evidence 
of significant association of the two population groups or of particular alleles being associated with 
clinical signs of infection. These results were likely to be influenced by the small sample sizes, limiting 
the statistical power of the analysis. It may also imply that variation in clinical signs could be due to not 
only the genetic variability expressed by T. vaginalis, but also by a range of host factors (e.g. the 
immune state of the host, age, host genetic factors, etc.). Further study is required on the impact of the 





4.5 IMPLICATIONS OF MIXED T. VAGINALIS INFECTION ON CLINICAL 
PRESENTATION AND TREATMENT 
The T. vaginalis isolate proportion of mixed strain infection observed in this study was 14.6% and 
24.7% for Australia and Ghana respectively. These values were found to be higher than the predicted 
mixed infection value expected to occur in humans (11%) (Conrad et al., 2012). Frequent reinfection of 
host and exposure to multiple sexual partners infected with different strains of T. vaginalis are some of 
the identified contributors of mixed strain infection (Conrad et al., 2012). The occurrence of mixed 
strain infection has been reported to influence disease progression and treatment response in protozoan 
infections (Perez et al., 2018). Also, poor treatment outcome due to selective drug response of different 
isolates has been observed in mixed strain infection (Theisen et al., 1995; Baldeviano-Vidalon et al., 
2005), often resulting in treatment failures and development of resistant strains (Van Rie et al., 2005). 
 
 
4.6 SUGGESTIONS FOR FUTURE RESEARCH 
Despite the medical importance of T. vaginalis infection among women of childbearing age, there are no 
definite risk factors associated with infection. Distinct clinical signs associated with the infection still 
remain unclear and a further study into these variables and the association with T. vaginalis infection 
would improve public health and clinical knowledge on the transmission and pathology of T. vaginalis 
infection, as well as aid control, treatment and management of the infection. Also, further study to 
determine the risk T. vaginalis infection poses to childbirth will help understand the underlying 




The variation in clinical presentation in T. vaginalis infection is believed to be as a result of the genetic 
characteristics of the parasite. Extensive study within a larger sample size and wider population 
coverage (including both clinical and non-clinical samples) to assess this association should be 
undertaken. It would provide important knowledge on the role each of these genetic characters play in 
clinical manifestation and pathology of T. vaginalis infection. Host factors are also likely to interact with 
parasite genetic characteristics to influence clinical presentation and pathology of T. vaginalis infection. 
Thus, further studies are required to partition the variance in clinical signs and virulence to host and 
parasite factors. This may suggest new approaches in treatment and management of T. vaginalis 
infection, and vaccine production to control transmission of the infection. 
 
 
4.7 CONCLUDING REMARKS 
In this study, the polymerase chain reaction technique was significantly more sensitive than wet mount 
microscopy as a diagnostic tool for detecting T. vaginalis. Also, T. vaginalis prevalence is high among 
women attending sexual health and gynaecological clinics in selected hospitals in the Greater Accra and 
Volta regions of Ghana. Vaginal itching is significantly associated with T. vaginalis infection and there 
is evidence of a prior history of stillbirths in women who were currently infected. A history of engaging 
in oral sex is also significantly associated with T. vaginalis infection. This study was hospital based, 
thus, the findings may vary from a community-based study in the same population. Male partners of 
women enrolled in this study were not included in this study and therefore we were unable to assess the 
behavioural risks of the partners. Ano-vaginal transmission of T. vaginalis, which could be a potential 
source of the infection, could not be assessed in this study. Findings from this study will contribute to 
and inform a new approach in public health and clinical diagnosis of T. vaginalis infection in Ghana. 
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Multi-locus sequence typing using next-generation sequence analysis revealed the high genetic diversity 
of T. vaginalis isolates in Australia and Ghana, indicating that geographical origins could influence the 
genetic characteristics of T. vaginalis, as revealed in this study data. Although two main grouping/ types 
of T. vaginalis were identified, a third unassigned group was also identified, which suggests an outcome 
of past recombinant activities between the two population types. Study findings also confirm geographic 
expansion and diversity of the T. vaginalis population. Linkage disequilibrium results suggest that the T. 
vaginalis populations in this study are highly clonal. Results of multi-locus linkage disequilibrium 
within the two separate populations indicate linkage disequilibrium, suggesting free recombination 
occurring between the two group type. Lastly, results show no correlation between any of the locus and 
clinical presentation scores, as well as between population types and clinical presentation scores. This 
study is the first of its kind in these regions and a more comprehensive study on larger sample sizes and 
wider population coverage, taking into consideration all the limitations indicated in this study to assess 
the extent of genetic diversity and population structure and their correlation with clinical presentations 












Abbai, NS., Reddy, T., & Ramjee, G. (2016). Prevalent bacterial vaginosis infection – a risk factor for 
incident sexually transmitted infections in women in Durban, South Africa. Int Journ STD & 
AIDS, 27(14), 1283-1288.  
Abdallah, I., Armstrong-Mensah, E., Alema-Mensah, E., & Jones, C. (2017). Demographic and 
behavioural risk factors associated with Trichomonas vaginalis among South African HIV-
positive men with genital ulcer disease: a cross-sectional study. BMJ Open., 7(7), e013486.  
Abdolrasouli, A., Amin, A., Baharsefat, M., Roushan, A., & Mofidi, S. (2007). Persistent urethritis and 
prostatitis due to Trichomonas vaginalis: A case report. Can Journ Infect Dis Med Microbiol, 
18(5).  
Abioye, JOK., Ihuma, JO., Abdullahi, DK., Kamoh, N., Awari, YS., Gemma, K., & Babatunde, SK. 
(2014). Trichomonas Vaginalis Among Pregnant Women Attending New Nyanya General 
Hospital, Nasarawa State, Nigeria. Int Journ Sci Nat., 5  (3), 437-439.  
Abonyi, A. (1995). Examination of nonflagellate and flagellate round forms of Trichomonas vaginalis 
by transmission electron microscopy. Journ Appl Parasitol., 36(4), 303-310.  
Abou-kamar, WA., Abdel-Mageid, AA., El-Nahas, HA., Atia, RA., & El-Tantawy, NL. (2017). Genetic 
relatedness of Trichomonas vaginalis isolates to the clinical variability. Journ Mol Microbiol, 
1(1), 103-108.  
Adl, SM., Simpson, AGB., Farmer, MA., Andersen, RA., Anderson, OR., Barta, JR.,Bowser, SS., 
Brugerolle, G., Fensome, RA., & Fredericq, S. (2005). The new higher level classification of 
eukaryotes with emphasis on the taxonomy of protists. Journ Eukaryot Microbiol, 52(5), 399-
451.  
Adu-Sarkodie, Y. (2004). Comparison of latex agglutination, wet preparation, and culture for the 
detection of Trichomonas vaginalis. Sex Transm Infect, 80(3), 201-203.  
130 
 
Adu-Sarkodie, Y. (2005). Epidemiology of Trichomonas in Kumasi, Ghana. Lon Sch Hyg Trop Med.  
Adu-Sarkodie, Y., Opoku, BK., Crucitti, T., Weiss, HA., & Mabey, D. (2007). Lack of evidence for the 
involvement of rectal and oral trichomonads in the aetiology of vaginal trichomoniasis in Ghana. 
Sex Transm Infect, 83(2), 130-132.  
Agyei-Mensah, S., & Aikins, AG. (2010). Epidemiological transition and the double burden of disease 
in Accra, Ghana. Journ urb heal, 87(5), 879-897.  
Alderete, JF. (1987a). Trichomonas vaginalis NYH286 phenotypic variation may be coordinated for a 
repertoire of trichomonad surface immunogens. Infect Immun. , 55(9), 1957-1962.  
Alderete, JF. (1988). Alternating phenotypic expression of two classes of Trichomonas vaginalis surface 
markers. Rev Infect Dis., 10(Suppl 2), S408-S412.  
Alderete, JF., Arroyo, R., Dailey, DC., Engbring, J., Khoshnan, MA., Lehker, MW.,&  McKay, J. 
(1992). Molecular analysis of Trichomonas vaginalis surface protein repertoires. Molecul Cell 
Biol Sex Transm Dis., 173-202.  
Alderete, JF., Demts, P., Gombosova, A., Valent, M., Yano§ka, J., Fabu§ova, H., Kasmala, L., Garza, 
GE., & Metcalfe, EC. (1987b). Phenotypes and Protein-Epitope Phenotypic Variation among 
Fresh Isolates of Trichomonas vaginalis. Infect. Immun., 55(5), 1037-1041.  
Alderete, JF., & Garza, GE. (1984). Soluble Trichomonas vaginalis antigens in cell-free culture 
supernatants. Mol. Biochem. Parasitol., 13, 147-158.  
Alderete, JF., & Garza, GE. (1985). Specific nature of Trichomonas vaginalis parasitism of host cell 
surfaces. Infect. Immunol., 50(3), 701-708.  
Alderete, JF., Kasmala, L., Metcalfe, E., & Garza, GE. (1986). Phenotypic variation and diversity 
among Trichomonas vaginalis isolates and correlation of phenotype with trichomonal virulence 
determinants. Infect Immun, 53(2), 285-293.  
131 
 
Alderete, JF., O'Brien, J., Arroyo, R., Engbring, J., Musatovova, O., Lopez, O., Lauriano, C., & Nguyen, 
J. (1995a). Cloning and molecular characterization of two genes encoding adhesion proteins 
involved in Trichomonas vaginalis cytoadherence. Mol microbiol., 17(1), 69-83.  
Alderete, JF., & Pearlman, E. (1984). Pathogenic Trichomonas vaginalis cytotoxicity to cell culture 
monolayers. Journ Vener Dis. , 60, 99-105.  
Alderete, JF., Provenzano, D., & Lehker, MW. (1995b). Iron mediates Trichomonas vaginalis resistance 
to complement lysis. Microb Pathogen., 19, 93-103.  
Alo, MN., Anyim, C., Onyebuchi, AK., & Okonkwo, EC. (2012). Prevalence of asymptomatic co-
infection of candidiasis and vaginal trichomoniasis among pregnant women in Abakaliki, South-
Eastern Nigeria. Journ Natl Sci Res, 2(7), 87-91.  
Ambrozio, CL., Nagel, AS., Jeske, S., Braganca, GC., Borsuk, S., & Villela, MM. (2016). Trichomonas 
vaginalis prevalence and risk factors for women in Southern Brazil. Rev Inst Med Trop Sao 
Paulo, 58(61), 1-5.  
Amindavaa, O., Kristensen, S., Pak, CY, Khalzan, D., Chultemsuren, B., Randall, AS., Mikolon, A., 
Lkhamsuren, E., Tulgaa, K., Chimeddorj ,B., & Natsag U. (2005). Sexually transmitted 
infections among pregnant women attending antenatal clinics in Mongolia: potential impact on 
the Mongolian HIV epidemic. Int J STD AIDS., 16(2), 153-157.  
Anarfi, JK. (2003). To change or not to change: obstacles and resistance to sexual behavioural change 
among the youth in Ghana in the era of AIDS. Inst Afric Stud Res Rev, 19(1), 27-45.  
Annang, L., Grimley, DM., & Hook, EW. (2006). Vaginal douche practices among black women at risk: 
exploring douching prevalence, reasons for douching, and sexually transmitted disease infection. 
Sex Transm Dis, 33(4), 215-219.  
132 
 
Apea-Kubi, KA., Sakyi, B., Yamaguchi, S., & Ofori-Adjei, D. (2006). Bacterial vaginosis, Candida 
albicans and Trichomonas vaginalis infection in antenatal and gynaecological patients in Ghana. 
Trop Journ Obstet Gynaecol., 22(2), 108-112.  
Arroyo, R., & Alderete, JF. (1989). Trichomonas vaginalis surface proteinase activity is necessary for 
parasite adherence to epithelial cells. Infect Immunol., 57(10), 2991-2997.  
Asmundsson, IM., Dubey, JP., & Rosenthal, BM. (2006). A genetically diverse but distinct North 
American population of Sarcocystis neurona includes an overrepresented clone described by 12 
microsatellite alleles. Infect Genet Evol, 6(5), 352-360.  
Australia Bureau of Statistics. (2014). Australia demographic statistics. (3101.0), 1-60.  
Bachmann, GA., & Leiblum, SR. (2004). The impact of hormones on menopausal sexuality: a literature 
review. Menopause, 11(1), 120-130.  
Baldeviano-Vidalon, GC., Quispe-Torres, N., Bonilla-Asalde, C., Gastiaburu-Rodriguez, D., Pro-Cuba, 
J., & Llanos-Zavalaga, F. (2005). Multiple infection with resistant and sensitive Mycobacterium 
tuberculosis strains during treatment of pulmonary tuberculosis patients. Int JournTubercul Lung 
Dis, 9(10), 1155-1160.  
Barrett, LG., Thrall, PH., Burdon, JJ., Nicotra, AB., & Linde, CC. (2008). Population structure and 
diversity in sexual and asexual populations of the pathogenic fungus Melampsora lini. Mol Ecol, 
17(14), 3401-3415.  
Bartoñ, K. (2013). MuMIn: Multi-model inference. Version 1.9.5'. http://cran.r-
project.org/web/packages/MuMIn.  
Belén, A., Pavón, I., & Maiden, MCJ. (2009). Multilocus sequence typing. Methods Mol Biol, 551, 129-
140.  
Besser, J. (2013). Use of molecular epidemiology in infectious disease surveillance. Infect Dis Surveil, 
2nd edition. Chapter 33, 1-18.  
133 
 
Bhatt, R., Abraham, M., Petrin, D., & Garber, G. (1996). New concepts in the diagnosis and 
pathogenesis of Trichomonas vaginalis. The Can Journ Infect Dis, 7(5), 321-325.  
Bhunu, CP., & Mushayabasa, S. (2011). Transmission dynamics of Trichomonas vaginalis: A 
mathematical approach. Journ Math Anal Appl, 379(2), 852-860.  
Botstein, D., White, R., Skolnick, M., & Davis, RW. (1980). Construction of a genetic linkage map in 
man using restriction fragment length polymorphisms. Am Journ Hum Genet, 32(3), 314-331.  
Bowden, FJ., & Garnett GP. (2000). Trichomonas vaginalis epidemiology: parameterising and analysing 
a model of treatment interventions. Sex Transm Inf. , 76, 248-256.  
Bowden, FJ., Paterson, BA., Mein, J., Savage, J., Fairley, CK., Garland, MS., & Tabrizi, SN. (1999). 
Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Neisseria 
gonorrhoeae, and human papillomavirus infection in indigenous women in northern Australia. 
Sex Transm Inf., 75, 431-434.  
Boyer, CB., Shafer, MA., Pollack, LM., Canchola, J., Moncada, J., & Schachter, J. (2006). 
Sociodemographic markers and behavioral correlates of sexually transmitted infections in a 
nonclinical sample of adolescent and young adult women. J Infect Dis, 194(3), 307-315.  
Brotman, RM., Bradford, LL., Conrad, M., Gajer, P., Ault, K., Peralta, L., Forney, LJ., Carlton, JM., 
Abdo Z., & Ravel, J. (2012). Association between Trichomonas vaginalis and vaginal bacterial 
community composition among reproductive-age women. Sex Transm Dis, 39(10), 807-812.  
Brotman, RM., Erbelding, EJ., Jamshidi, RM., Klebanoff, MA., Zenilman, JM., & Ghanem, KG. (2007). 
Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually 
transmitted diseases clinics. Journ Pediatr Adolesc Gynecol, 20(4), 225-231.  
Brotman, RM., Klebanoff, MA., Nansel, TR., Yu, KF., Andrews, WW., Zhang, J., & Schwebke, JR. 
(2010). Bacterial vaginosis assessed by gram stain and diminished colonization resistance to 
134 
 
incident gonococcal, chlamydial, and trichomonal genital infection. Journ Infect Dis, 202(12), 
1907-1915.  
Brugerolle, G. (1976). Cytologie ultrastructurale, systématique et évolution des Trichomonadida. . 
Annales de la Station Biologique de Besse-en-Chandesse, 10, 1-90.  
Brugerolle, G., & Lee, JJ. (2001). Phylum Parabasalia. In: Lee JJ Leedale GF Patterson DJ, Bradbury 
PC. An illustrated guide to the protozoa. 2nd Edition. Lawrence, KS:. Soc Protozool, 1196-1250.  
Bui, ETN., & Johnson, PJ. (1996). Identification and characterization of [Fe]-hydrogenases in the 
hydrogenosome of Trichomonas vaginalis. Mol Biochem Parasitol, 76(1-2), 305-310.  
Burnham, KP., & Anderson, DR. (2002). Model selection and multimodel inference: a practical 
information-theoretic approach. Journ Wildlife Manage, 67(3),    DOI: 10.1007/b97636.  
Carpenter, KJ., Horak, A., & Keeling, PJ. (2010). Phylogenetic position and morphology of 
spirotrichosomidae (parabasalia): new evidence from Leptospironympha of Cryptocercus 
punctulatus. Protist, 161(1), 122-132.  
Carson, B., Dunbar, T., Chenhall, RD., & Bailie, R. (2007). Social determinants of Indigenous health: 
Allen & Unwin. 
Carter-Wicker, K., Utuama, O., & Omole, F. (2016). Can trichomoniasis cause pharyngitis? A case 
report. SAGE Open MedCase Rep, 4, 2050313X16682132. 
Casau, NC. (2005). Perspective on HIV Infection and aging: emerging research on the horizon. Clin 
infect dis, 41, 855-863.  
Cepicka, I., Hampl, V., & Kulda, J. (2010). Critical taxonomic revision of Parabasalids with description 
of one new genus and three new species. Protist, 161(3), 400-433.  
Chen, XS., Yin, YP., Chen, LP., Thuy, NT., Zhang, GY., Shi, MQ., Hu, LH., & Yu, YH. (2006). 
Sexually transmitted infections among pregnant women attending an antenatal clinic in Fuzhou, 
China. Sex Transm Dis., 33(5), 296-301. 
135 
 
Chesson, HW., Blandford, JM., & Pinkerton, SD. (2004). Estimates of the annual number and cost of 
new HIV infections among women attributable to trichomoniasis in the United States. Sex Tansm 
Dis, 31(9), 547-551. 
Chinyere, E., Romanus, II., Collins, ON., Okoro, N., & Anthonia, OE. (2012). Trichomonas vaginalis 
associated with adverse pregnancy outcomes. Brit Journ Med Res, 2, 568-574.  
Cogne, M., Brasseur, P., & Ballet, JJ. (1985). Detection and characterization of serum antitrichomonal 
antibodies in urogenital trichomoniasis. Journ Clin Microbiol, 21(4), 588-592.  
Cone, RA. (2014). Vaginal microbiota and sexually transmitted infections that may influence 
transmission of cell-associated HIV. Journ Infect Dis, 210 Suppl 3, S616-621.  
Conrad, MD., Gorman, AW., Schillinger, JA., Fiori, PL., Arroyo, R., Malla, N., Dubey, ML., Gonzalez, 
J., Blank, S., Secor, WE., & Carlton, J. (2012). Extensive genetic diversity, unique population 
structure and evidence of genetic exchange in the sexually transmitted parasite Trichomonas 
vaginalis. PLoS Negl Trop Dis, 6(3), e1573.  
Conrad, MD., Zubacova, Z., Dunn, LA., Upcroft, J., Sullivan, SA., Tachezy, J., & Carlton, JM. (2011). 
Microsatellite polymorphism in the sexually transmitted human pathogen Trichomonas vaginalis 
indicates a genetically diverse parasite. Mol Biochem Parasitol, 175(1), 30-38.  
Cooper, A., Tait, A., Sweeney, L., Tweedie, A., Morrison, L., Turner, CMR., & MacLeod, A. (2008). 
Genetic analysis of the human infective trypanosome Trypanosoma brucei gambiense: 
chromosomal segregation, crossing over, and the construction of a genetic map. Gen Biol, 9, 
R103.101-112.  
Cooper, JE., & Feil, EJ. (2006). The phylogeny of Staphylococcus aureus - which genes make the best 
intra-species markers? Microbiol, 152(Pt 5), 1297-1305.  
Cornelius, DC., Mena, L., Lushbaugh, WB., & Meade, JC. (2010). Genetic relatedness of Trichomonas 
vaginalis reference and clinical isolates. Am Journ Trop Med Hyg., 83(6), 1283-1286.  
136 
 
Cornelius, DC., Robinson, DA., Muzny, CA., Mena, LA., Aanensen, DM., Lushbaugh, WB., & Meade, 
JC. (2012). Genetic characterization of Trichomonas vaginalis isolates by use of multilocus 
sequence typing. Journ Clin Microbiol, 50(10), 3293-3300.  
Cotch, MF., Pastorek, JG., Nugent, RP., Hillier, SL., Gibbs, RS., Martin, DH., Eschenbach, DA., 
Edelman, R., Carey, CJ., Regan, JA., & Krohn, MA. (1997). Trichomonas vaginalis associated 
with low birth weight and preterm delivery. Sex Transm Dis., 24(6), 353-360.  
Cotch, MF., Pastorek, JG., Nugent, RP., Yerg, DE., Martin, DH., & Eschenbach, DA. (1991). 
Demographic and Behavioral Predictors of Trichomonas vaginalis Infections Among Pregnant 
Women. Obstet Gynecol., 78(6), 1087-1092.  
Cottrell, BH., & Close, FT. (2008). Vaginal douching among university women in the southeastern 
United States. Journ Am Coll Health, 56(4), 415-421.  
Cowan, FM., Hargrove, JW., Langhaug, LF., Jaffar, S., Mhuriyengwe, L., Swarthout, TD., Peeling, R., 
Latif, A., Bassett, MT., Brown, DWG., Mabey, D., Hayes, RJ., & Wilson, D. (2005). The 
appropriateness of core group interventions using presumptive periodic treatment among rural 
Zimbabwean women who exchange sex for gifts or money. Journ Acquir Immune Defic Syndr, 
38(2), 202-207.  
Crosby, R., DiClemente, RJ., Wingood, GM., Harrington, K., Davies, SL., Hook III, EW., & Oh, MK. 
(2002). Predictors of infection with Trichomonas vaginalis- a prospective study of low income 
African-American adolescent females. Sex Transm Infect., 78, 360-364.  
Crucitti, T., Abdellati, S., Ross, D., Changalucha, J., Van Dyck, E., & Bruve, A. (2004). Detection of 




Crucitti, T., Abdellati, S., Van Dyck, E., & Buve, A. (2008). Molecular typing of the actin gene of 
Trichomonas vaginalis isolates by PCR–restriction fragment length polymorphism. Clin 
Microbiol Infect. , 14 (9), 844-852.  
Crucitti, T., Abdellati, S., Van Dyck, E., & Buve, A. (2008). Molecular typing of the actin gene of 
Trichomonas vaginalis isolates by PCR-restriction fragment length polymorphism. Clin 
Microbiol Infect, 14(9), 844-852. 
Crucitti, T., Jespers, V., Mulenga, C., Khondowe, S., Vandepitte, J., & Buve, A. (2010). Trichomonas 
vaginalis is highly prevalent in adolescent girls, pregnant women, and commercial sex workers 
in Ndola, Zambia. Sex Transm Dis, 37(4), 223-227.  
Crucitti, T., Jespers, V., Mulenga, C., Khondowe, S., Vandepitte, J., & Buve A. (2011). Non-sexual 
transmission of Trichomonas vaginalis in adolescent girls attending school in Ndola, Zambia. 
PLoS One, 6(1), e16310.  
Crucitti, T., Van Dyck, E., Tehe, A., Abdellati, S., Vuylsteke, B., Buve, A., & Laga, M. (2003). 
Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self 
collected vaginal swab specimens. Sex Transm Infect., 79(1), 393-398.  
Dailey, DC., Te-Hung, C., & Alderete, JF. (1990). Characterization of Trichomonas vaginalis 
haemolysis. Journ Parasitol., 101(02), 171-175.  
Davies, SC., Otto, B., Partohudoyo, S., Chrisnadarmani, VA., Neilsen, GA., Ciaffi, L., Patten, J., 
Samson, ET., & Sutama IN. (2003). Sexually transmitted infections among female sex workers 
in Kupang, Indonesia: searching for a screening algorithm to detect cervical gonococcal and 
chlamydial infections. Sex Transm Dis., 30(9), 671-679.  
de Waaij, DJ., Dubbink, JH., Ouburg, S., Peters, RPH., & Morré, SA. (2017). Prevalence of 
Trichomonas vaginalis infection and protozoan load in South African women: a cross-sectional 
study. BMJ Open, 7(10), e016959. doi:  
138 
 
Demes, P., Gombosova, A., Valent, M., Fabusova, H., & Janoska, TA. (1988a). Fewer Trichomonas 
vaginalis organisms in vaginas of infected women during menstruation. Genitourin Med., 64, 22-
24.  
Demes, P., Gombosova, A., Valent, M., Janoska, A., Fabusova, H., & Petrenko, M. (1988b). Differential 
susceptibility of fresh Trichomonas vaginalis isolates to complement in menstrual blood and 
cervical mucus. Genitourin Med., 64, 176-179.  
Depuydt, C., Leuridan, E., Van Damme, P., Bogers, J., Vereecken, AJ., & Donders, GGG. (2010). 
Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-
time PCR in Flanders. Gynecol Obstet Invest., 70(4), 273-280.  
dos Anjos Gatti, FA., Ceolan, E., Greco, FSR., Santos, PC., Klafke, GB., de Oliveira, GR., Von Groll, 
A., de Martinez, AMB., Gonçalves, CV., & Scaini, C. (2017). The prevalence of trichomoniasis 
and associated factors among women treated at a university hospital in southern Brazil. PLoS 
One, 12(3), e0173604.  
Draper, D., Jones, W., Heine, RP., Beutz, M., French, JI., & McGregor, JA. (1995). Trichomonas 
vaginalis weakens human amniochorion in an in vitro model of premature membrane rupture. 
Infect Dis Obstet Gynecol, 2, 267-274.  
Du Plessis, DG., Warren, R., Richardson, M., Joubert, JJ., & Van Helden, PD. (2001). Demonstration of 
reinfection and reactivation in HIV-negative autopsied cases of secondary tuberculosis: 
multilesional genotyping of Mycobacterium tuberculosis utilizing IS 6110 and other repetitive 
element-based DNA fingerprinting. Tuberculosis, 81(3), 211-220.  




Eschenbach, DA., Thwin, SS., Patton, DL., Hooton, TM., Stapleton, AE., Agnew, K., Winter, C., Meier, 
A., & Stamm, W. (2000). Influence of the normal menstrual cycle on vaginal tissue, discharge, 
and microflora. Clin infect dis, 30, 901-907.  
Eshete, A., Mekonnen, Z., & Zeynudin, A. (2013). Trichomonas vaginalis Infection among Pregnant 
Women in Jimma University Specialized Hospital, Southwest Ethiopia. ISRN Infect Dis, 2013, 1-
5.  
Etuketu, IM., Mogaji, HO., Alabi, OM., Adeniran, AA., Oluwole, AS., & Ekpo, UF. (2015). Prevalence 
and risk factors of Trichomonas vaginalis infection among pregnant women receiving antenatal 
care in Abeokuta, Nigeria. African Journ Infect Dis, 9(2), 51-56.  
Evanno, G., Regnaut, S., & Goudet, J. (2005). Detecting the number of clusters of individuals using the 
software STRUCTURE: a simulation study. Mol Ecol., 14(8), 2611-2620.  
Felleisen, RSJ. (1997). Comparative genetic analysis of tritrichomonadid protozoa by the random 
amplified polymorphic DNA technique. Parasitol Res, 84(2), 153-156.  
Fichorova, RN. (2009). Impact of Trichomonas vaginalis infection on innate immune responses and 
reproductive outcome. Journ Reprod Immunol, 83(1-2), 185-189.  
Fichorova, RN., Trifonova, RT., Gilbert, RO., Costello, CE., Hayes, GR., Lucas, JJ., & Singh, BN. 
(2006). Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines 
by human female reproductive tract epithelial cells. Infect Immun., 74(10), 5773-5779.  
Fiori, PL., Rappelli, P., Rocchigiani, AM., & Cappuccinelli, P. (1993). Trichomonas vaginalis 
haemolysis: evidence of functional pores formation on red cell membranes. FEMS microbiol let., 
109(1), 13-18.  
Fonck, K., Kidula, N., Jaoko, W., Estambale, B., Claeys, P., Ndinya-Achola, J., Kirui, P., Bwayo, J., 
&Temmerman, M. (2000). Validity of the vaginal discharge algorithm among pregnant and 
nonpregnant women in Nairobi, Kenya. Sex Transm Inf., 76, 33-38.  
140 
 
Fouts, AC., & Kraus, SJ. (1980). Trichomonas vaginalis: Reevaluation of its clinical presentation and 
laboratory diagnosis. Journ Infect Dis., 141(2), 137-143.  
Fraga, J., Rojas, L., Sariego, I., & Fernandez-Calienes, A. (2011). Double-stranded RNA viral infection 
of Trichomonas vaginalis and correlation with genetic polymorphism of isolates. Exp Parasitol, 
127(2), 593-599.  
Fraga, J., Rojas, L., Sariego, I., & Fernández-Calienes, A. (2015). Characterization of specific RAPD 
markers of virulence in Trichomonas vaginalis Isolates. Iran Journ Parasitol, 10(3), 448-456.  
Francis, SC., Ao, TT., Vanobberghen, FM., Chilongani, J., Hashim, R., Andreasen, A., Watson-Jones, 
D., Changalucha, J., Kapiga, S., & Hayes, RJ. (2014). Epidemiology of curable sexually 
transmitted infections among women at increased risk for HIV in northwestern Tanzania: 
inadequacy of syndromic management. PLoS One, 9(7), e101221.  
Francisco, AP., Bugalho, M., Ramirez, M., & Carrico, JA. (2009). Global optimal eBURST analysis of 
multilocus typing data using a graphic matroid approach. BMC Bioinform, 10, 152.  
Garber, GE. (2005). The laboratory diagnosis of Trichomonas vaginalis. Can Journ Infect Dis Med 
Microbiol, 16(1), 35-38.  
Garber, GE., & Lemchuk-Favel, LT. (1994). Analysis of the extracellular proteases ofTrichomonas 
vaginalis. Parasitol Res., 80(5), 361-365.  
Garber, GE., Proctor, EM., & Bowie, WR. (1986). Immunogenic proteins of Trichomonas vaginalis as 
demonstrated by the immunoblot technique. Infect Immun, 51(1), 250-253.  
Garcia, A., Exposto, F., de Farma, F., Prieto, E., Lopes, M., Duarte, A., & da Silva, RC. (2004). 
Association of Trichomonas vaginalis with sociodemographic factors and other STDs among 
female inmates in Lisbon. Int Journ STD & AIDS., 15, 615-618.  
141 
 
Genton, B., D'Acremont, V., Rare, L., Baea, K., Reeder, JC., Alpers, MP., & Müller, I. (2008). 
Plasmodium vivax and mixed infections are associated with severe malaria in children: a 
prospective cohort study from Papua New Guinea PLoS Med, 5(6), e127.  
Gerbod, D., Sanders, E., Moriya, S., Noël, C., Takasu, H., Fast, NM., Delgado-Viscogliosi, P., Ohkuma, 
M., Kudo, T., & Capron, M. (2004). Molecular phylogenies of Parabasalia inferred from four 
protein genes and comparison with rRNA trees. Mol Phylogenet Evol, 31(2), 572-580.  
Ghana Statistical Service. (2013). Nat Analyt Rep., 1-430.  
Ginocchio, CC., Chapin, K., Smith, JS., Aslanzadeh, J., Snook, J., Hill, CS., & Gaydos, CA. (2012). 
Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria 
gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic 
acid amplification assay. Journ Clin Microbiol., 50(8), 2601-2608.  
Goo, YK., Shin, WS., Yang, HW., Joo, SY., Song, SM., Ryu, JS., Lee, WM., Kong, HH., Lee, WK., 
Lee, SE., & Lee, WJ. (2016). Prevalence of Trichomonas vaginalis in Women Visiting 2 
Obstetrics and Gynecology Clinics in Daegu, South Korea. Kor JournParasitol, 54(1), 75-80.  
Gould, SB., Kusdian, G., Zimorski, V., & Martin, WF. (2014). Trichomonads and their cell biology. In 
H. Mehlhorn (Ed.), Encyclopedia of Parasitology (pp. 1-5). Berlin, Heidelberg: Springer Berlin 
Heidelberg. 
Gray, M., & Auld, AJ. (2000). Towards an index of relative indigenous socioeconomic disadvantage.  
Gregson, S., Mason, PR., Garnett, GP., Zhuwau, T., Nyamukapa, CA., Anderson, RM., & Chandiwana, 
SK. (2001). A rural HIV epidemic in Zimbabwe? Findings from a population-based survey. Int J 
STD AIDS, 12(3), 189-196.  
Grundmann, H., Hori, S., & Tanner, G. (2001). Determining confidence intervals when measuring 
genetic diversity and the discriminatory abilities of typing methods for microorganisms. Journ 
Clin Microbiol, 39(11), 4190-4192.  
142 
 
Guenthner, PC., Secor, WE., & Dezzutti, CS. (2005). Trichomonas vaginalis-induced epithelial 
monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: 
implications for the sexual transmission of HIV-1. Infect Immun, 73(7), 4155-4160.  
Gunderson, J., Hinkle, G., Leipe, O., Morrison , HG., Stickel, SK., Odelson, DA., Breznak, JA., Nerad, 
TA., Muller, M, & Sogin, ML. (1995). Phylogeny of trichomonads inferred from small-subunit 
rRNA sequences. Journ Euk Microbiol, 42, 411-415.  
Hainer, BL., & Gibson, MV. (2011). Vaginitis:Diagnosis and treatment. Am Fam Physician, 83(7), 807-
815.  
Hampl, V., Hug, L., Leigh, JW., Dacks, JB., Lang, BF., Simpson, AGB., & Roger, AJ. (2009). 
Phylogenomic analyses support the monophyly of Excavata and resolve relationships among 
eukaryotic “supergroups”. Proceed Nation Acad Sci, 106(10), 3859-3864.  
Hampl, V., Vaňáčová, Š., Kulda, J., & Flegr, J. (2001). Concordance between genetic relatedness and 
phenotypic similarities of Trichomonas vaginalis strains. BMC Evolut Biol. , 1, 11-20.  
Harp, DF., & Chowdhury, I. (2011). Trichomoniasis: evaluation to execution. Eur Journ Obstet Gynecol 
Reprod Biol., 157(1), 3-9.  
Haubold, B., & Hudson, RR. (2000). LIAN 3.0: detecting linkage disequilibrium in multilocus data. . Ox 
Univ Pr., 16(9), 847-848.  
Hawksworth, J., Levy, M., Smale, C., Cheung, D., Whittle, A., Longhurst, D., Muir, P., & Gibson, W. 
(2015). Population structure and genetic diversity of the parasite Trichomonas vaginalis in 
Bristol, UK. Infect Genet Evol, 34, 36-43.  
Helms, DJ., Mosure, DJ., Metcalf, CA., Douglas, JM. Jnr., Malotte, CK., Paul, SM., & Peterman, TA. 
(2008). Risk factors for prevalent and incident Trichomonas vaginalis among women attending 
three sexually transmitted disease clinics. Sex Transm Dis, 35(5), 484-488.  
143 
 
Hobbs, MM., Lapple, DM., Lawing, LF., Schwebke, JR., Cohen, MS., Swygard, H., Atashili, J., Leone, 
PA., Miller, WC., & Seña, A. (2006). Methods for detection of Trichomonas vaginalis in the 
male partners of infected women: implications for control of trichomoniasis. Journ Clin 
Microbiol, 44(11), 3994-3999.  
Hoots, BE., Peterman, TA., Torrone, EA., Weinstock, H., Meites, E., & Bolan, GA. (2013). A Trich-y 
question: should Trichomonas vaginalis infection be reportable? Sex Transm Dis, 40(2), 113.  
Hussein, AH., Saleh, MH., Nagaty, IM., Ghieth, KA., & El-Azab, NA. (2015). Prevalence, clinical 
criteria and sociodemographic predictors of Trichomonas vaginalis infection in suspected 
Egyptian women, using direct diagnostic techniques. Iran Journ Parasitol, 10(3), 432-440.  
Huyse, T., Poulin, R., & Theron, A. (2005). Speciation in parasites: a population genetics approach. 
Trends Parasitol, 21(10), 469-475.  
Ibanez-Escribano, A., Nogal-Ruiz, JJ., Aran, VJ., Escario, JA. Gomez-Barrio,, A , & Alderete, JF. 
(2014). Determination of internal transcribed spacer regions (ITS) in Trichomonas vaginalis 
isolates and differentiation among Trichomonas species. Parasitol Int, 63(2), 427-431.  
Jaakmees, H., Teras, J., Roigas, E., Nigesen, U., & Tompel, H. (1966). Complement-fixing antibodies in 
the blood sera of men infested with Trichomonas vaginalis. Wiad Parazytol., 12, 378–384.  
Johnston, VJ., & Mabey, DC. (2008). Global epidemiology and control of Trichomonas vaginalis. Curr 
Opin Infect Dis, 21(1), 56-64. 
Jolley, KA., Feil, EJ., Chan, MS., & Maiden, MCJ. (2001). Sequence type analysis and recombinational 
tests (START). Oxford Univ Press., 17(12), 1230-1231.  
Jorde, LB. (1995). Linkage disequilibrium as a gene-mapping tool. Am Journ Hum Genet, 56(1), 11-14.  
Joyner, JL., Douglas, JM., Ragsdale, S., Foster, M., & Judson, FN. (2000). Comparative prevalence of 
infection with Trichomonas vaginalis among men attending a sexually transmitted diseases 
clinic. Sex Transm Dis., 27, 236 -240.  
144 
 
Kanno, M., & Sobel, JD. (2003). Late recurrence of resistant Trichomonas vaginalis vaginitis: relapse or 
re-infection? Sex Transm Infect, 79(3), 260-261.  
Kanu, A., Ihekwumere, I., & Kalu, EJ. (2015). Frequency Distribution of Trichomoniasis in Pregnant 
Women in Aba, South East, Nigeria. Univ Journ Microbiol Res., 3(4), 53-55. 
doi:10.13189/ujmr.2015.030403 
Kaul, P., Gupta, I., Sehgal, R., & Malla, N. (2004). Trichomonas vaginalis: random amplified 
polymorphic DNA analysis of isolates from symptomatic and asymptomatic women in India. 
Parasitol Internat 53, 255-262.  
Keeling, PJ. (2004). Polymorphic insertions and deletions in parabasalian enolase genes. Journ Mol 
Evol, 58(5), 550-556.  
Kengne, P., Veas, F., Vidal, N., Rey, JL., & Cuny, G. (1994). Trichomonas vaginalis: repeated DNA 
target for highly sensitive and specific polymerase chain reaction diagnosis. Cell Mol Biol., 
40(6), 819-831.  
Kenyon, C., Buyze, J., & Colebunders, R. (2014). Classification of incidence and prevalence of certain 
sexually transmitted infections by world regions. Int Journ Infect Dis, 18, 73-80.  
Kikuta, N., Yamamoto, A., Fukura, K., & Goto, N. (1997). Specific and sensitive detection of 
Trichomonas tenax by the polymerase chain reaction. Lett. Appl. Microbiol, 24, 193-197.  
Kingston, MA., Bansal, D., & Carlin, EM. (2003). 'Shelf Life' of Trichomonas vaginalis. . Int Journ 
STD AIDS., 14(1), 28-29.  
Kissinger, P. (2015). Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues. 
BMC Infect Dis, 15, 307.  
Kissinger, P., & Adamski, A. (2013). Trichomoniasis and HIV interactions: a review. Sex Transm Infect, 
89(6), 426-433.  
145 
 
Klebanoff, MA., Carey, JC., Hauth, JC., Hillier, SL., Nugent, RP., Thom, EA., Ernest, JM., Heine, RP., 
Wapner, RJ., Trout, W., & Moawad, A. (2001). Failure of metronidazole to prevent preterm 
delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. New Engl 
Journ Med, 345(7), 487-493.  
Klinger, E., Kapiga, SH., Sam, NE., Aboud, S., Chen, CY., Ballard, RC., & Larsen U. (2006). A 
Community-based study of risk factors for Trichomonas vaginalis infection among women and 
their male partners in Moshi urban district, northern Tanzania. Sex Transm Dis., 33(12), 712-718. 
Krieger, JN. (1990). Epidemiology and Clinical Manifestations of Urogenital Trichomoniasis in Men. 
Trichomonads Parasitic in Humans, 235-245.  
Krieger, JN. (1995). Trichomoniasis in men: Old issues and new data. Sex Transm Dis. 
, 22, 83-96.  
Krieger, NJ. (1999). Consider diagnosis and treatment of trichomoniasis in men. Sex Transm Dis, 27, 
241-242.  
Laga, M., Manoka, A., Kivuvu, M., Malele, B., Tuliza, M., Nzila, N., Goeman, J., Behets, F., Batter, V., 
Alary, M., Heyward, WL., Ryder, RW., & Piot, P. (1993). Non-ulcerative sexually transmitted 
diseases as risk factors for HIV-1 transmission in women: results from a cohort study. Aids., 7(1), 
95-102.  
Lahti, CJ., Bradley, PJ., & Johnson, PJ. (1994). Molecular characterization of the α-subunit of 
trichomonas vaginalis hydrogenosomal succinyl CoA synthetase. Mol Biochem Parasitol, 66(2), 
309-318.  
Lai, C.-Q. (2012). Adaptive Genetic Variation and Population Differences. In C. Bouchard & J. M. 
Ordovas (Eds.), Progress in Molecular Biology and Translational Science (Vol. 108, pp. 461-
489): Academic Press. 
146 
 
Lawing, LF., Hedges, SR., & Schwebke, JR. (2000). Detection of trichomonosis in vaginal and urine 
specimens from women by culture and PCR. Journ Clin Microbiol., 38(10), 3585-3588.  
Lee, SJ., Park, DC., Lee, DS., Choe, HS., & Cho, YH. (2012). Evaluation of Seeplex(R) STD6 ACE 
Detection kit for the diagnosis of six bacterial sexually transmitted infections. Journ Infect 
Chemother, 18(4), 494-500.  
Lehker, MW., Chang, TH., Dailey, DC., Te-Hung, C., & Alderete, JF,. (1990). Specific erythrocyte 
binding is an additional nutrient acquisition system for Trichomonas vaginalis. The Journal of 
experimental medicine, 171(6), 2165-2170.  
Lehker, MW., & Sweeney, D. (1999). Trichomonad invasion of the mucous layer requires adhesins, 
mucinases, and motility. Sex Transm Infect, 75, 231-238.  
Leli, C., Castronari, R., Levorato, L., Luciano, E., Pistoni, E., Perito, S., Bozza, S., & Mencacci, A. 
(2016). Molecular sensitivity threshold of wet mount and an immunochromatographic assay 
evaluated by quantitative real-time PCR for diagnosis of Trichomonas vaginalis infection in a 
low-risk population of childbearing women. Infez Med, 24(2), 112-116.  
Leon, SR., Konda, KA., Bernstein, KT., Pajuelo, JB., Rosasco, AM., Caceres, CF., Coates, TJ., & 
Klausner, J. (2009). Trichomonas vaginalis infection and associated risk factors in a socially-
marginalized female population in coastal Peru. Infect Dis Obstet Gynecol., 2009, 1-6.  
Leutscher, P., Jensen, JS., Hoffmann, S., Berthelsen, L., Ramarakoto, CE., Ramaniraka, V., 
Randrianasolo, B., Raharisolo, C., Bottiger, B., Rousset, D., Grosjean, P., McGrath, MMS., 
Christensen, N., & Migliani, R. (2005). Sexually Transmitted Infections in Rural Madagascar at 
an Early Stage of the HIV Epidemic. Sex Transm Dis., 32(3), 150-155.  
Lo, M., Reid, M., & Brokenshire, M. (2002). Epidemiological features of women with trichomoniasis in 
Auckland sexual health clinics: 1998-99. N Zeal Med Journ., 115(1159), 1-6.  
147 
 
Luo, L., Reilly, KH., Xu, J.-J., Wang, G.-X., Ding, G.-W., Wang, N., & Wang, H.-B. (2015). Prevalence 
and correlates of Trichomonas vaginalis infection among female sex workers in a city in Yunnan 
Province, China. Int Journ STD & AIDS, 27(6), 469-475.  
Lymbery, AJ., & Thompson, RCA. (2012). The molecular epidemiology of parasite infections: tools and 
applications. Mol Biochem Parasitol, 181(2), 102-116.  
Madhivanan, P., Bartman, MT., Pasutti, L., Krupp, K., Arun, A., Reingold, AL., & Klausner, JD. 
(2009). Prevalence of Trichomonas vaginalis infection among young reproductive age women in 
India: implications for treatment and prevention. Sex Health, 6(4), 339-344.  
Madico, G., Quinn, TC., Rompalo, A., Mckee, KT. Jnr., & Gaydos, CA. (1998). Diagnosis of 
Trichomonas vaginalis infection by PCR using vaginal swab samples. Journ Clin Microbiol., 
36(11), 3205-3210.  
Mairiga, AG., Balla, HJ., & Ahmad, MI. (2011). Prevalence of Trichomonas vaginalis infections among 
antenatal clients in Maiduguri Nigeria. Int Journ Biol Med Res 2(4), 998-1002.  
Malik, SB., Brochu, CD., Bilic, I., Yuan, J., Hess, M., Logsdon, JM., & Carlton, JM. (2011). Phylogeny 
of parasitic parabasalia and free-living relatives inferred from conventional markers vs. Rpb1, a 
single-copy gene. PLoS One, 6(6), e20774.  
Malik, SB., Pightling, AW., Stefaniak, LM., Schurko, AM., & Logsdon, JM. Jnr. (2008). An expanded 
inventory of conserved meiotic genes provides evidence for sex in Trichomonas vaginalis. PLoS 
One, 3(8), e2879.  
Mallinson, DJ., Lockwood, BC., Coombs, GH., & North, MJ. (1994). Identification and molecular 
cloning of four cysteine proteinase genes from the pathogenic protozoon Trichomonas vaginalis. 
Journ Microbiol., 140(10), 2725-2735.  
Mao, M., & Liu, HL. (2015). Genetic diversity of Trichomonas vaginalis clinical isolates from Henan 
province in central China. Pathog Glob Health, 109(5), 242-246.  
148 
 
Maritz, JM., Land, KM., Carlton, JM., & Hirt, RP. (2014). What is the importance of zoonotic 
trichomonads for human health? Trends Parasitol, 30(7), 333-341.  
Masha, SC., Cools, P., Crucitti, T., Sanders, EJ., & Vaneechoutte, M. (2017). Molecular typing of 
Trichomonas vaginalis isolates by actin gene sequence analysis and carriage of T. vaginalis 
viruses. Parasitol Vec, 10(1), 537.  
Mason, PR. (1979). Serodiagnosis of Trichomonas vaginalis infection by the indirect fluorescent 
antibody test. Journ Clin Pathol, 32(12), 1211-1215.  
Mathews, HM., & Healy, GR. (1983). Evaluation of two serological tests for Trichomonas vaginalis 
infection. Journ Clin Microbiol, 17(5), 840-843.  
Matini, M., Rezaei, H., Fallah, M., Maghsood, A. H., Saidijam, M., & Shamsi-Ehsan, T.. (2017). 
Genotyping, drug susceptibility and prevalence survey of Trichomonas vaginalis among women 
attending gynecology clinics in hamadan, Western Iran, in 2014–2015. Iran Journ Parasitol, 
12(1), 29-37.  
Matini, M., Rezaie, S., Mohebali, M., Maghsood, AH., Rabiee, S., Fallah, M., & Rezaeian, M. (2014). 
Genetic identification of Trichomonas vaginalis by using the actin gene and molecular based 
methods. Iran Journ Parasitol, 9(3), 329-335.  
Matini, M., Rezaien, M., Mohebali, M., Maghsood, AH., Rabiee, S., Rahimi-Foroushani, AS., Fallah, 
M., Miahipour, A., & Rezaie, S. (2012). Genotyping of Trichomonas vaginalis isolates in Iran by 
using single stranded conformational polymorphism-PCR technique and internal transcribed 
spacer regions. Trop Biomed, 29(4), 605-612.  
Maufi, AJ., Mazigo, HD., & Kihunrwa, A. (2016). Prevalence and factors associated with Trichomonas 
vaginalis infection among pregnant women attending public antenatal clinics in Mwanza city, 
North-western Tanzania. Tanz Journ Heal Res., 18(2), 1-7. doi: 
149 
 
Mayta, H., Gilman, RH., Calderon, MM., Gottlieb, A., Soto, G., Tuero, I., Sanchez, S., & Vivar, A. 
(2000). 18S Ribosomal DNA-Based PCR for Diagnosis of Trichomonas vaginalis. Journ Clin 
Microbiol., 38(7), 2683-2687.  
McClelland, RS., Sangare, L., Hassan, WM., Lavreys, L., Mandaliya, K., Kiarie, J., Ndinya-Achola, J., 
Jaoko, W., & Baeten, JM. (2007). Infection with Trichomonas vaginalis increases the risk of 
HIV-1 acquisition. Journ Infect Dis., 195(5), 698-702.  
McKechnie, ML., Hillman, R., Couldwell, D., Kong, F., Freedman, E., Wang, H., & Gilbert, GL. 
(2009). Simultaneous identification of 14 genital microorganisms in urine by use of a multiplex 
PCR-based reverse line blot assay. Journ Clin Microbiol, 47(6), 1871-1877.  
McLellan, R., Spence, MR., Brockman, M., Raffel, L., & Smith, JL. (1982). The clinical diagnosis of 
trichomoniasis. Obstet Gynecol, 60(1), 30-34.  
Meade, JC., & Carlton, JM. (2013). Genetic diversity in Trichomonas vaginalis. Sex Transm Infect, 
89(6), 444-448.  
Meade, JC., de Mestral, J., Stiles, JK., Secor, WE., Finley, RW., Cleary, JD., & Lushbaugh, WB. (2009). 
Genetic diversity of Trichomonas vaginalis clinical isolates determined by Eco RI restriction 
fragment length polymorphism of heat-shock protein 70 genes. Am. Journ. Trop. Med. Hyg., 
80(2), 245-251.  
Meites, E., Gaydos, CA., Hobbs, MM., Kissinger, P., Nyirjesy, P., Schwebke, JK., . . . Workowski, KA. 
(2015). A review of evidence-based care of symptomatic trichomoniasis and asymptomatic 
Trichomonas vaginalis infections. Clin infect dis, 61 (Suppl 8), S837-848.  
Meites, E., Llata, E., Braxton, J., Schwebke, JR., Bernstein, KT., Pathela, P., Asbel, LE., Kerani, RP., 
Mettenbrink, CJ., & Weinstock, HS. (2013). Trichomonas vaginalis in selected U.S. sexually 
transmitted disease clinics: testing, screening, and prevalence. Sex Transm Dis, 40(11), 865-869.  
150 
 
Menezes, CB., Frasson, AP., & Tasca, T. (2016). Trichomoniasis - are we giving the deserved attention 
to the most common non-viral sexually transmitted disease worldwide? Microb Cell, 3(9), 404-
419.  
Mgone, CS., Lupiwa, T., & Yeka, W. (2002). High prevalence of Neisseria gonorrhoeae and multiple 
sexually transmitted diseases among rural women in the Eastern Highlands Province of Papua 
New Guinea, detected by polymerase chain reaction. Sex Transm Dis, 29(12), 775-779.  
Miller, M., Liao, Y., Gomez, AM., Gaydos, CA., & D'Mellow, D. (2008). Factors associated with the 
prevalence and incidence of Trichomonas vaginalis infection among African American women 
in New York city who use drugs. Journ Infect Dis, 197(4), 503-509.  
Miller, W., Swygard H, Hobbs MM, Ford CA, et al. (2005). The Prevalence of Trichomoniasis in 
Young Adults in the United States. Sex Transm Dis., 32(10), 593-598.  
Minkoff, H., Grunebaum, AN., Schwarz, RH., Feldman, J., Cummings, M., Crombleholme, W., Clark, 
L., Pringle, G., &. McCormack, WM. (1984). Risk factors for prematurity and premature rupture 
of membranes: a prospective study of the vaginal flora in pregnancy. Am Journ Obstet Gynecol, 
150, 965-972.  
Miranda, AE., Pinto, VM., & Gaydos, CA. (2014). Trichomonas vaginalis infection among young 
pregnant women in Brazil. Braz Journ Infect Dis, 18(6), 669-671.  
Mirmonsef, P., Hotton, AL., Gilbert, D., Burgad, D., Landay, A., Weber, KM., Cohen, M., Ravel, J., & 
Spear, G. (2014). Free glycogen in vaginal fluids is associated with Lactobacillus colonization 
and low vaginal pH. PLoS One, 9(7), e102467.  
Moodley, P., Wilkinson, D., Connolly, C., Moodley, J., & Sturm, AW. (2002). Trichomonas vaginalis is 
associated with pelvic inflammatory disease in women infected with human immunodeficiency 
virus. Clin Infect Dis. , 34, 519-522.  
151 
 
Morton, AN., Wake, T., Tabrizi, SN., Garland, SM., & Fairley, CK. (1999). An outreach programme for 
sexually transmitted infection screening in street sex workers using self-administered 
samples.pdf. Int Journ STD & AIDS., 10, 741-743.  
Mullick, S., Watson-Jones, D., Beksinska, M., & Mabey, D. (2005). Sexually transmitted infections in 
pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing 
countries. Sex Transm Infect, 81(4), 294-302.  
Nabweyambo, S., Kakaire, O., Sowinski, S., Okeng, A., Ojiambo, H., Kimeze, J., Najjingo, I., &. 
Bwanga, F. (2017). Very low sensitivity of wet mount microscopy compared to PCR against 
culture in the diagnosis of vaginal  trichomoniasis  in Uganda: a cross sectional study. BMC Res 
Notes, 10(1), 259.  
Naing, Z., Rismanto, N., Rayner, B., McIver, C., Cumming, R., McGeechan, K., Rawlinson, W., &. 
Konecny, P. (2010). Trichomonas vaginalis: underdiagnosis in urban Australia could facilitate 
re-emergence. Sex Transm Infect, 86(3), 227-230.  
Nanda, N. (2006). Trichomoniasis and its treatment. Exp Rev Anti-infect. Ther., 4(1), 125-135.  
Nessa, K., Waris, SA., Alam, A., Huq, M., Nahar, S., Chawdhury, FAH., Monira, S., Badal, MU., 
Sultana, J., Mahmud, KF., Das, J., Mitra, DK., Sultan, Z., Hossain, N., & Rahman M. (2005). 
Sexually Transmitted Infections Among Brothel-Based Sex Workers in Bangladesh: High 
Prevalence of Asymptomatic Infection. Sex Transm Dis., 32(1), 13-19.  
Nijhawan, AE., Chapin, KC., Salloway, R., Andrea, S., Champion, J., Roberts, M., & Clarke, JG. 
(2012). Prevalence and predictors of Trichomonas infection in newly incarcerated women. Sex 
Transm Dis, 39(12), 973-978.  
Noda, S., Mantini, C., Bordereau, C., Kitade, O., Dolan, MF., Viscogliosi, E., & Ohkuma, M. (2009). 
Molecular phylogeny of parabasalids with emphasis on the order Cristamonadida and its 
complex morphological evolution. Mol Phylogenet Evol, 52(1), 217-224.  
152 
 
Noda, S., Mantini, C., Meloni, D., Inoue, J., Kitade, O., Viscogliosi, E., & Ohkuma, M. (2012). 
Molecular phylogeny and evolution of parabasalia with improved taxon sampling and new 
protein markers of actin and elongation factor-1-alpha. PLoS One, 7(1), e29938.  
Nybom, H., Weising, K., & Rotter, B. (2014). DNA fingerprinting in botany: past, present, future. 
Investig Genet, 5(1), 1.  
Ohkuma, M., Noda, S., Hongoh, Y., Nalepa, CA., & Inoue, T. (2009). Inheritance and diversification of 
symbiotic trichonymphid flagellates from a common ancestor of termites and the cockroach 
Cryptocercus. Proc Biol Sci, 276(1655), 239-245.  
Ohkuma, M., Saita, K., Inoue, T., & Kudo, T. (2007). Comparison of four protein phylogeny of 
parabasalian symbionts in termite guts. Mol Phylogenet Evol, 42(3), 847-853.  
Oliaee, RT., Babaei, Z., Hatam, GR., Kareshk, AT., Mahmoudvand, H., Vafafar, A., & Ziaal, N. (2017). 
Considerable genetic diversity of Trichomonas vaginalis clinical isolates in a targeted population 
in South of Iran. Iran Journ Parasitol. , 12(2), 251-259.  
Oluwayemisi, A., Ogba, OM, Nkechi, OE. (2014). Urinogenital trichomoniasis in women in relation to 
candidiasis and gonorrhoea in University of Port-Harcourt Teaching Hospital. Afri Journ 
Microbiol Res., 8(26), 2482-2485. doi:10.5897/ajmr2014.6818 
Oyeyemi, OT., Fadipe, O., & Oyeyemi, IT. (2016). Trichomonas vaginalis infection in Nigerian 
pregnant women and risk factors associated with sexually transmitted infections. Int Journ STD 
AIDS, 27(13), 1187-1193.  
Paces, J., Urbankova, V., & Urbanek, P. (1992). Cloning and characterization of a repetitive DNA 
sequence specific for Trichomonas vaginalis. Mol Biochem Parasitol, 54(2), 247-255.  
Patel, SR., Wiese, W., Patel, SC., Ohl, C., Byrd, JC., & Estrada, CA. (2000). Systematic Review of 
Diagnostic Tests for Vaginal Trichomoniasis. Infect Dis Obstet Gynecol. , 8(1), 248-257.  
153 
 
Patil, MJ., Nagamoti, JM., & Metgud, SC. (2012). Diagnosis of Trichomonas vaginalis from vaginal 
specimens by wet mount microscopy, in pouch tv culture system, and PCR. Journ Glob Infect 
Dis, 4(1), 22-25.  
Perez, CJ., Thompson, RCA., Keatley, SK., Walsh, AL., & Lymbery, AJ. (2018). The effect of 
reinfection and mixed Trypanosoma cruzi infections on disease progression in mice. Acta 
Tropica, 178, 107-114.  
Peterson, KM., & Alderete, JF. (1982). Host plasma proteins on the surface of pathogenic Trichomonas 
vaginalis. Infect. Immun., 37(2), 755-762.  
Petrin, D., Delgaty, K., Bhatt, R., & Garber, G. (1998). Clinical and microbiological aspects of 
Trichomonas vaginalis. Clin. Microbiol Rev., 11(2), 300–317.  
Petrova, MI., van den Broek, M., Balzarini, J., Vanderleyden, J., & Lebeer, S. (2013). Vaginal 
microbiota and its role in HIV transmission and infection. FEMS Microbiol Rev, 37(5), 762-792.  
Pindak, FF., Gardner, WA., & De Pindak, MM. (1986). Growth and cytopathogenicity of Trichomonas 
vaginalis in tissue cultures. Journ. Clin Microbiol., 23(4), 672-678.  
Piperaki, ET., Theodora, M., Mendris, M., Barbitsa, L., Pitiriga, V., Antsaklis, A., & Tsakris, A. (2010). 
Prevalence of Trichomonas vaginalis infection in women attending a major gynaecological 
hospital in Greece: a cross-sectional study. Journ Clin Pathol, 63(3), 249-253.  
Poole, DN., & McClelland, RS. (2013). Global epidemiology of Trichomonas vaginalis. Sex Transm 
Infect, 89(6), 418-422.  
Price, MA., Miller, WC., Kaydos-Daniels, SC., Hoffman, IF., Chilongozi, D., Martinson, FE., 
Namakhwa, D., Malanda, J., & Cohen, M. (2004). Trichomoniasis in  Men  and  HIV Infection- 




Pritchard, JK., Stephens, M., & Donnelly, P. (2000). Inference of population structure using multilocus 
genotype data. Genetics, 155, 945-959  
Provenzano, D., & Alderete, JF. (1995). Analysis of human immunoglobulin-degrading cysteine 
proteinases of Trichomonas vaginalis. Infect. Immun., 63(9), 3388-3395.  
Ramesh, MA., Malik, SB., & Logsdon, JM. Jnr. (2005). A phylogenomic inventory of meiotic genes; 
evidence for sex in Giardia and an early eukaryotic origin of meiosis. Curr Biol, 15(2), 185-191.  
Riley, DE., Roberts, MC., Takayama, T., & Krieger, JN. (1992). Development of a polymerase chain 
reaction-based diagnosis of Trichomonas vaginalis. Journ Clin Microbiol., 30(2), 465-472.  
Rivera, WL., Ong, VA., & Masalunga, MC. (2009). Molecular characterization of Trichomonas 
vaginalis isolates from the Philippines. Parasitol Res, 106(1), 105-110.  
Robinson, MA. (1998). Linkage Disequilibrium. In P. J. Delves (Ed.), Encyclopedia Immunology 
(Second Edition) (pp. 1586-1588). Oxford: Elsevier. 
Rogers, SM., Turner, CF., Hobbs, M., Miller, WC., Tan, S., Roman, AM., Eggleston, E., Villarroel, 
MA., Ganapathi, L. Chromy, JR., & Erbelding, E. (2014). Epidemiology of undiagnosed 
trichomoniasis in a probability sample of urban young adults. PLoS One, 9(3), e90548.  
Rojas, L., Fraga, J., & Sariego, I. (2004). Genetic variability between Trichomonas vaginalis isolates 
and correlation with clinical presentation. Infect Genet Evol, 4(1), 53-58.  
Rowley, J., Toskin, I., & Ndowa, F. (2012). Global incidence and prevalence of selected curable 
sexually transmitted infections-2008. WHO: 2012. . 
http://www.who.int/reproductivehealth/publications/rtis/stisestimates/en/index.html.  
Ryder, N., Woods, H., McKay, K., Giddings, N., Lenton, JA., Little, C., Jeoffreys, N., & McNulty, A. 
(2012). Trichomonas vaginalis prevalence increases with remoteness in rural and remote New 
South Wales, Australia. Sex Transm Dis, 39(12), 938-941.  
155 
 
Ryu, JS., Kang, JH., Jung, SY., Shin, MH., Kim, JM., Park, H., & Min, DY. (2004). Production of 
interleukin-8 by human neutrophils stimulated with Trichomonas vaginalis. Infect Immun., 72(3), 
1326-1332.  
Ryu, JS., Min, DY., Shin, MH., & Cho, YH. (1998). Genetic variance of Trichomonas vaginalis isolates 
by southern hybridization. Kor Journ Parasitol, 36(3), 207-211.  
Salem, SA., Azab, ME., Abd el Ghaffar, FM., el Sherif, EA., Makled, KA., & Habib, FS. (1992). 
Characterization of Egyptian isolates of Trichomonas vaginalis I. isoenzyme patterns. Journ 
Egypt Soc Parasitol, 22(3), 675-682.  
Sangkomkamhang, US., Lumbiganon, P., Prasertcharoensook, W., & Laopaiboon, M. (2008). Antenatal 
lower genital tract infection screening and treatment programs for preventing preterm delivery. 
The Cochrane Library (2).  
Schmid, G., Samuelson, J., & Rowley, JT. (2011). Prevalence and incidence of selected sexually 
transmitted infections. world health organization, Geneva, Switzerland.  
Scholes, D., Stergachis, A., Ichikawa, LE., Heidrich, FE., Holmes, KK., & Stamm, WE. (1998). Vaginal 
douching as a risk factor for cervical Chlamydia trachomatis infection. Obstet Gynecol, 91(6), 
993-997.  
Seña, AC., Miller, WC., Hobbs, MM., Schwebke, JR., Leone, PA., Swygard, H., Atashili, J., & Cohen, 
M. (2007). Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, 
treatment, and prevention. Clin infect dis, 44, 13–22.  
Shafir, SC., Sorvillo, FJ., & Smith, L. (2009). Current issues and considerations regarding 
trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microbiol Rev, 
22(1), 37-45.  
Shaio, MF., Lin, PR., & Liu, JY. (1997). Colorimetric one-tube nested PCR for detection of 
Trichomonas vaginalis in vaginal discharge. Journ Clin Microbiol, 35(1), 132-138.  
156 
 
Shaio, M., Lin PR, Liu JY, Yang KD. . ( 1995). Generation of Interleukin-8 from Human Monocytes in 
Response to Trichomonas vaginalis Stimulation. Infect Immun., 63(10), 3864-3870.  
Shaio, M., Lin PR, Liu JY, Yang KD.  . (1994). Monocyte-derived interleukin-8 involved in the 
recruitment of neutrophils induced by Trichomonas vaginalis infection. Journ Infect Dis., 170(6), 
1638-1640.  
Shuter, J., Bellm, D., Graham, D., Holbrook, KA., & Bellin, EY. (1998). Rates of and risk factors for 
trichomoniasis among pregnant inmates in New York city. Sex Transm Dis. , 25, 303-307.  
Sibau, L., Bebb, D., Proctor, EM., & Bowie, WR. (1987). Enzyme-linked immunosorbent assay for the 
diagnosis of trichomoniasis in women. Sex Transm Dis, 14(4), 216-220.  
Silberman, JD., Clark, CG., & Sogin, ML. (1996). Dientamoeba fragilis shares a recent common 
evolutionary history with the trichomonads. Mol Biochem Parasitol, 76, 311-314.  
Silva, LC., Miranda, AE., Batalha, RS., Monte, RL., & Talhari, S. (2013). Trichomonas vaginalis and 
associated factors among women living with HIV/AIDS in Amazonas, Brazil. Braz Journ Infect 
Dis, 17(6), 701-703.  
Simoes-Barbosa, A., Lobo, TT., Xavier, J., Carvalho, SE., & Leornadecz, E. (2005). Trichomonas 
vaginalis: intrastrain polymorphisms within the ribosomal intergenic spacer do not correlate with 
clinical presentation. Exp Parasitol, 110(2), 108-113.  
Simpson, AGB. (2003). Cytoskeletal organization, phylogenetic affinities and systematics in the 
contentious taxon Excavata (Eukaryota). Int Journ System Evol Microbiol, 53(6), 1759-1777.  
Simpson, P., Higgins, G., Qiao, M., Waddell, R., & Kok, T. (2007). Real-time PCRs for detection of 
Trichomonas vaginalis beta-tubulin and 18S rRNA genes in female genital specimens. Journ 
Med Microbiol, 56(Pt 6), 772-777.  
Singh, BN., Hayes, GR., Lucas, JJ., Sommer, U., Viseux, N., Mirgorodskaya, E., Trifonova, RT., Sassi, 
RR., Costello, CE., & Fichorova, RN. (2009). Structural details and composition of Trichomonas 
157 
 
vaginalis lipophosphoglycan in relevance to the epithelial immune function. Glycoconj Journ., 
26(1), 3-17. doi:10.1007/s10719-008-9157-1 
Slatkin, M. (2008). Linkage disequilibrium—understanding the evolutionary past and mapping the 
medical future. Nat Rev Genet., 9(6), 477-485.  
Slattery, ML. (2002). The science and art of molecular epidemiology. Journ Epidemiol Comm Heal, 56, 
728-729.  
Smith, JM. (1992). Analyzing the mosaic structure of genes. Journ Mol Evol, 34(2), 126-129.  
Smith, JM. (1999). The detection and measurement of recombination from sequence data. Genetics. , 
153, 1021-1027.  
Smith, JM., Smith, NH., O'Rourke, M., & Spratt, BG. (1993). How clonal are bacteria? Proceed Nat Aca 
Sci, 90(10), 4384-4388.  
Smith, LM., Wang, M., Zangwill, K., & Yeh, S. (2002). Trichomonas vaginalis infection in a premature 
newborn. Journ Perinatol, 22(6), 502-503.  
Snipes, LJ., Gamard, PM., Narcisi, EM., Beard, CB., Lehmann, T., & Secor, WE. (2000). Molecular 
epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical 
isolates. Journ Clin Microbiol., 38( 8), 3004–3009.  
Soliman, MA., Ackers, JP., & Catterall, RD. (1982). Isoenzyme characterisation of Trichomonas 
vaginalis. Brit Journ Vener Dis., 58, 250-256.  
Sommer, U., Costello, CE., Hayes, GR., Beach, DH., Gilbert, RO., Lucas, JJ., & Singh, BN. (2005). 
Identification of Trichomonas vaginalis cysteine proteases that induce apoptosis in human 
vaginal epithelial cells. Journ Biol Chem, 280(25), 23853-23860.  
Sorvillo, F., & Kerndt, P. (1998). Trichomonas vaginalis and amplification of HIV-1 transmission. The 
Lancet., 351(9097), 213-214.  
158 
 
Sorvillo, F., Kovacs, A., Kerndt, P., & Stek, A. (1998). Risk factors for trichomoniasis among women 
with human immunodeficiency virus (HIV) infection at a public clinic in Los Angeles county, 
California- implications for hiv prevention. Am Journ Trop Med Hyg., 58(4), 495-500.  
Sorvillo, F., Smith, L., Kerndt, P., & Ash, HL. (2001). Trichomonas vaginalis, HIV, and African-
Americans. Emerg Infect Dis, 7(6), 927-932.  
Spence, MR., Hollander, DH., Smith, J., McCaig, LI., Sewell, D., & Brockman, M. (1980). The clinical 
and laboratory diagnosis of Trichomonas vaginalis infection. Sex Transm Dis. , 7, 168 -171.  
Spotin, A., Eghtedar, ST., Shahbazi, A., Salehpour, A., Sarafraz, S., Shariatzadeh, SA., & Mahami-
Oskouei, M. (2016). Molecular characterization of Trichomonas vaginalis strains based on 
identifying their probable variations in asymptomatic patients. Iran Journ Parasitol, 11(4), 507-
514.  
Stark, JR., Judson, G., Alderete, JF., Mundodi, V., Kucknoor, AS., Giovannucci, EL., Plats, EA., 
Sutcliffe, S., Fall, K., Kurth, T., & Ma, J. (2009). Prospective study of Trichomonas vaginalis 
infection and prostate cancer incidence and mortality: physicians' health study. Journ Natl 
Cancer Inst, 101(20), 1406-1411.  
Stiles, J., Shah, PH., Xue, L., Meade, JC., Lushbaugh, WB., Cleary, JD., & Finley, RW. (2000). 
Molecular typing of Trichomonas vaginalis isolates by HSP70 restriction fragment length 
polymorphism.  . Am Journ Trop Med Hyg, 62, 441-445.  
Stoner, KA., Rabe, LK., Meyn, LA., & Hillier, SL. (2013). Survival of Trichomonas vaginalis in wet 
preparation and on wet mount. Sex Transm Infect, 89(6), 485-488.  
Subramanian, S. (2016). The effects of sample size on population genomic analyses–implications for the 
tests of neutrality. BMC Genomics, 17(1), 123.  
Sugathan, S. (2016). Prevalence of Trichomoniasis in Women Attending a Sexually Transmitted Disease 
Clinic in Mumbai. Int Journ Sci Stud., 4(3), 21-24. doi:10.17354/ijss/2016/310 
159 
 
Sullivan, EA., Koro, S., Tabrizi, S., Kaldor, J., Poumerol, G., Chen, S., O'leary, M., & Garland, S. 
(2004). Prevalence of sexually transmitted diseases and human immunodeficiency virus among 
women attending prenatal services in Apia, Samoa. Int Journ STD AIDS, 15(2), 116-119.  
Sun, X., Stephens, JC., & Zhao, H. (2004). The impact of sample size and marker selection on the study 
of haplotype structures. Hum Genomics, 1(3), 179.  
Suresh, KP., & Chandrashekara, S. (2012). Sample size estimation and power analysis for clinical 
research studies. Journ Hum Reprod Sci, 5(1), 7.  
Sutton, M., Sternberg, M., Koumans, EH., McQuillan, G., Berman, S., & Markowitz, L. (2007). The 
prevalence of Trichomonas vaginalis infection among reproductive-age women in the United 
States, 2001-2004. Clin infect dis, 45(10), 1319-1326.  
Swadpanich, U., Lumbiganon, P., Prasertcharoensook, W., & Laopaiboon, M. (2008). Antenatal lower 
genital tract infection screening and treatment programs for preventing preterm delivery. 
Cochrane Database Syst Rev(2), Cd006178.  
Swartzendruber, A., Sales, JM., Brown, JL., Diclemente, RJ., & Rose, ES. (2014). Correlates of incident 
Trichomonas vaginalis infections among African-American female adolescents. Sex Transm Dis, 
41(4), 240-245.  
Swygard, H., Sena, AC., Hobbs, MM., & Cohen, MS. (2004). Trichomoniasis: clinical manifestations, 
diagnosis and management. Sex Transm Infect., 80(2), 91-95.  
Tajima, F. (1983). Evolutionary relationship of DNA sequences in finite populations. Genetics, 105(2), 
437-460.  
Tann, CJ., Mpairwe, H., Morison, L., Nassimu, K., Hughes, P., Omara, M., Mabey, D., Muwanga, M., 
Grosskurth, H.,  & Elliott, AM. (2006). Lack of effectiveness of syndromic management in 
targeting vaginal infections in pregnancy in Entebbe, Uganda. Sex Transm Infect, 82(4), 285-289. 
160 
 
Teras, J., Nigesen, U., Jaakmees, H., Roigas, E., & Tompel, H. (1966). The agglutinogenic properties of 
Trichomonas vaginalis in human organism. Wiad Parazytol., 12, 370–377.  
Than, NG., Kim, SS., Abbas, A., Han, YM., Hotra, J., Tarca, AL., Erez, O., Wildman, DE., Kusanovic, 
JP., Pineles, B., & Montenegro, D. (2008). Chorioamnionitis and increased galectin-1 expression 
in PPROM --an anti-inflammatory response in the fetal membranes? Am Journ Reprod 
Immunol., 60(4), 298-311. doi:10.1111/j.1600-0897.2008.00624.x 
Theisen, A., Reichel, C., Rüsch-Gerdes, S., Haas, W., Rockstroh, J., Spengler, U., & Sauerbruch, T. 
(1995). Mixed-strain infection with a drug-sensitive and multidrug-resistant strain of 
Mycobacterium tuberculosis. The Lancet, 345(8963), 1512-1513.  
Tibayrenc, M., & Ayala, FJ. (2012). Reproductive clonality of pathogens: a perspective on pathogenic 
viruses, bacteria, fungi, and parasitic protozoa. Proc Natl Acad Sci U S A, 109(48), E3305-3313.  
Tibayrenc, M., & Ayala, FJ. (2015). How clonal are Neisseria species? The epidemic clonality model 
revisited. Proceed Nat Acad Sci, 112(29), 8909-8913.  
Tibayrenc, M., Kjellberg, F., & Ayala, FJ. (1990). A clonal theory of parasitic protozoa: the population 
structures of Entamoeba, Giardia, Leishmania, Naegleria, Plasmodium, Trichomonas, and 
Trypanosoma and their medical and taxonomical consequences. Proc Natl Acad Sci USA., 87(7), 
2414-2418.  
Tsai, CC., & Li, CC. (2013). Nonchlamydial nongonococcal urethritis in men. Urolog Sci, 24(3), 73-77.  
Upcroft, JA., Delgadillo-Correa, MG., Dunne, RL., Sturm, AW., Johnson, PJ., & Upcroft, P. (2006). 
Genotyping Trichomonas vaginalis. Int Journ Parasitol, 36(7), 821-828.  
Valadkhani, Z., Assmar, M., Esfandiari, B., Amirkhani, A., Hassan, N., Lotfi, ML., & Ghobadi-rad, S. 
(2008). Trichomoniasis in asymptomatic patients. Iran Journ Publ Heal, 27(3), 113-117.  
Valadkhani, Z., Kazemi, F., Hassan, N., Aghighi, Z., Esmaili, I., & Talebi, M. (2011). Gene diversity of 
Trichomonas vaginalis isolates. Iran Journ Parasitol. , 6(3), 101-106.  
161 
 
Van Der Pol, B. (2007). Trichomonas vaginalis infection- the most prevalent nonviral sexually 
transmitted infection receives the least public health attention. Clin Infect Dis, 44, 23-25.  
Van Der Pol, B. (2016). Clinical and laboratory testing for Trichomonas vaginalis infection. Journ Clin 
Microbiol, 54(1), 7-12.  
Van Der Pol, B., Willias, JA., Orr, DP., Batteiger, BE., & Fortenberry, JD. (2005). Prevalence, 
incidence, natural history, and response to treatment of Trichomonas vaginalis Infection among 
adolescent women. Journ Infect Dis, 192, 2039-2044.  
Van der Veer, C., Himschoot, M., & Bruisten, SM. (2016). Multilocus sequence typing of Trichomonas 
vaginalis clinical samples from Amsterdam, the Netherlands. BMJ Open, 6(10), e013997.  
Van Rie, A., Victor, TC., Richardson, M., Johnson, R., Van Der Spuy, GD., Murray, EJ., Beyers, N., 
Van Pittius, NCG., Van Helden, PD., & Warren, RM. (2005). Reinfection and mixed infection 
cause changing Mycobacterium tuberculosis drug-resistance patterns. Am Journ Resp Crit Care 
Med, 172(5), 636-642.  
Vanacova, S., Tachezy, JAN., Kulda, J., & Flegr, J. (1997). Characterization of Trichomonad species 
and strains by PCR fingerprinting. Journ Eukaryot Microbiol 44, 545-552.  
Viikki, M., Pukkala, F., Nieminem, P., & Hakama, M. (2000). Gynecological infections as risk 
determinants of subsequent cervical neoplasia. Acta Oncologica., 39, 71-75.  
Viscogliosi, E., Edgcomb, VP., Gerbod, D., Noel, C., & Delgado-Viscogliosi, P. (1999). Molecular 
evolution inferred from small subunit rRNA sequences: what does it tell us about phylogenetic 
relationships and taxonomy of the parabasalids? Parasite, 6(4), 279-291.  
Viscogliosi, E., & Muller, M. (1998). Phylogenetic relationships of the glycolytic enzyme, 




Walker, RL., Hayes, DC., Sawyer, SJ., Nordhausen, RW., Van Hoosear, KA., & BonDurant, RH. 
(2003). Comparison of the 5.8S rRNA gene and internal transcribed spacer regions of 
trichomonadid protozoa recovered from the bovine preputial cavity. Journ Vet Diagn Invest, 15, 
14-20.  
Wangnapi, RA., Soso, S., Unger, HW., Sawera, C., Ome, M., Umbers, AJ., Ndrewei, N., Siba, P., Suen, 
CLW., Vallely, A., & Wapling, J. (2015). Prevalence and risk factors for Chlamydia 
trachomatis,Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant women in 
Papua New Guinea. Sex Transm Infect, 91(3), 194-200.  
Watson-Jones, D., Mugeye K, Mayaud P, Ndeki L, Todd J, Mosha F, West B, Cleophas-Frisch B, 
Grosskurth H, Laga M, Hayes R, Mabey D, Buvé A. (2000). High prevalence of trichomoniasis 
in rural men in Mwanza, Tanzania- results from a population based study. Sex Transm Inf., 76, 
355-362.  
Watt, L., & Jennison, RF. (1960). Incidence of Trichomonas vaginalis in marital partners. Brit. Journ 
Vener Dis., 36, 163-166.  
Wendel, KA., Erbelding, EJ., Gaydos, CA., & Rompalo, AM. (2002). Trichomonas vaginalis 
polymerase chain reaction compared with standard diagnostic and therapeutic protocols for 
detection and treatment of vaginal trichomoniasis. Clin Infect Dis., 35, 576-580.  
WHO. (2001). Global prevalence and incidence of selected curable sexually transmitted infections 
overview and estimates. 
Woehle, C., Kusdian, G., Radine, C., Graur, D., Landan, G., & Gould, SB. (2014). The parasite 
Trichomonas vaginalis expresses thousands of pseudogenes and long non-coding RNAs 
independently from functional neighbouring genes. BMC Genomics, 15(906).  
Wølner-Hanssen, P., Krieger, JN., Stevens, CE., Kiviat, NB., Koutsky, L., Critchlow, C., DeRouen, T., 
Hillier, S., & Holmes, K. (1989). Clinical manifestations of vaginal trichomoniasis. Jama, 261(4), 571-576.  
163 
 
Wu, G., Fiser, A., Ter Kuile, B., Šali, A., & Müller, M. (1999). Convergent evolution of Trichomonas 
vaginalis lactate dehydrogenase from malate dehydrogenase. Proc Natl Acad Sci USA., 96(11), 
6285-6290.  
Yang, L., Taylor, DR., Kaufman, HH., Hume, R., & Calhoun, B. (2004). Maternal and fetal outcomes of 
spontaneous preterm premature rapture of membrane. Journ Am Osteopath Assoc, 104(12), 537-
542.  
Yoshikawa, TT. (1981). Important infections in elderly persons. West Journ Med, 135, 441-445.  
Yoshikawa, TT. (1983). Geriatric infectious diseases. Journ  Am Geriat Soc, 31(1), 34-39.  
Yoshikawa, TT. (1997). Perspective: aging and infectious diseases: past, present, and future. Journ 




























Wednesday, 09 March 2016 
A/Prof Andrew Thompson 






Project No. 2015/164 
Division of Research & Development 




MURDOCH  WA 6150 
Telephone: (08) 9360 6677 






Project Title Trichomonas spp. in women in Ghana: genetic variation and risk 
factors for infection 
 
Thank you for addressing the conditions placed on the above application to the Murdoch 
University Human Research Ethics Committee. On behalf of the Committee, I am pleased to 







Approval is granted on the understanding that research will be conducted according the standards of the National 
Statement on Ethical Conduct in Human Research (2007), the Australian Code for the Responsible Conduct of 
Research (2007) and Murdoch University policies at all times. You must also abide by the Human Research Ethics 
Committee’s standard conditions of approval (see attached). All reporting forms are available on the Research 
Ethics and Integrity web-site. 
 
I wish you every success for your research. 
 






Dr. Erich von Dietze 
Manager 
Research Ethics and Integrity 
 
cc: A/Prof Alan Lymbery and Daniel Squire 
169 
 
Human Research Ethics Committee: Standard Conditions of Approval 
 
a) The project must be conducted in accordance with the approved application, 
including any conditions and amendments that have been approved. You must 
comply with all of the conditions imposed by the HREC, and any subsequent 
conditions that the HREC may require. 
b) You must report immediately anything, which might affect ethical acceptance 
of your project, including: 
 Adverse effects on participants 
 Significant unforeseen events 
 Other matters that might affect continued ethical acceptability of the project. 
c) Proposed changes or amendments to the research must be applied for, using 
an Amendment Application form, and approved by the HREC before these 
may be implemented. 
d) An Annual Report for the project must be provided by the due date specified 
each year (usually the anniversary of approval). 
e) A Closure Report must be provided at the conclusion of the project (once all 
contact with participants has been completed). 
f) If, for any reason, the project does not proceed or is discontinued, you must 
advise the committee in writing, using a Closure Report form. 
g) If an extension is required beyond the end date of the approved project, an 
Extension Application should be made allowing sufficient time for its 
consideration by the committee. Extensions of approval cannot be granted 
retrospectively. 
h) You must advise the HREC immediately, in writing, if any complaint is made 
about the conduct of the project. 
i) Other Murdoch approvals (e.g. fieldwork approval) or approval form other 
institutions may also be necessary before the research can commence. 
j) Any equipment used must meet current safety standards. Purpose built or 
modified equipment must be tested and certified by independent experts for 
compliance with safety standards. 
k) Graduate research degree candidates must normally have their Program of 
Study approved prior to commencing the research. Exceptions to this must be 
approved by the HREC. 
l) You must notify Research Ethics & Integrity of any changes in contact details 
including address, phone number and email address. 
m) Researchers should be aware that the HREC may conduct random audits and 
/ or require additional reports concerning the research project. 
 
Failure to comply with the National Statement on Ethical Conduct in Human Research (2007) and 
with the conditions of approval may result in the suspension or withdrawal of approval for the 
project. 
 
The HREC seeks to support researchers in achieving strong results and positive outcomes. 
The HREC promotes a research culture in which ethics is considered and discussed at all stages of the 
research. 
If you have any issues you wish to raise, please contact the Research Ethics Office in the first instance. 
Page 2 
